Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),0.8503329556986152,2.1991978755891024,0.0,0.0,0.0,6/22,4.62%,CYP26B1;ALDH1A2;NR2F2;RBP4;ABCA4;RBP1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.8802547180529053,2.1181528182550684,0.0,0.002459237299555316,0.004,4/15,2.81%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,cadherin binding (GO:0045296),-0.45634734371328545,-2.1092198434255165,0.0,0.005094546022816065,0.005,134/315,21.01%,DOCK9;FMNL2;SPTBN1;PTPRB;STXBP6;BSG;COBLL1;PTPRJ;MRTFB;PTPRM;TJP2;ITGA6;FXYD5;PROM1;LRRFIP1;ESYT2;STK38;HSPA8;KDR;FNBP1L;CDH11;CTNND2;IQGAP1;PKP4;CDH1;TES;CBL;HSP90AB1;HNRNPK;ITGB1;CDH2;EHD4;RPL6;AHNAK;F11R;PLEC;EEF2;SLK;NOTCH3;DAB2IP;CLINT1;RACK1;PKM;TAGLN2;SH3GLB1;BMPR2;RPL34;PACSIN2;CHMP5;SHTN1;RPL24;FLNA;EPS8L2;RPL23A;PPME1;CHMP2B;NCK1;TRIM25;EEF1D;EHD1;CTNNB1;CEMIP2;MPP7;SLC3A2;YWHAB;ATXN2L;RPL14;PCMT1;BAIAP2L1;MYH9;RPS2;TJP1;CTNNA3;TRPC4;LASP1;PAICS;RPL29;PLCB3;SEPTIN9;RTN4;PAK2;APC;RANBP1;HSPA5;LYPLA2;PPP1CA;RPL7A;CD2AP;PTPN1;TXNDC9;RSL1D1;PSMB6;RAB1A;DBNL;RANGAP1;MARK2;TBC1D10A;CDH13;EPN2;EEF1G;EIF4H;TMPO;JUP;ALDOA;PFKP;RPS26;TNKS1BP1;FASN;LDHA;DHX29;DIAPH3;RUVBL1;ARGLU1;DNAJB1;SERBP1;ACVR1;EIF2A;USP8;SCYL1;SNX1;PCBP1;S100A11;CKAP5;PSEN1;CIP2A;CTNNA1;ANK3;SNX2;DBN1;SH3GL1;ARFIP2;MAPRE1;ABI1;ADD1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8958290610991099,2.052984832950007,0.0,0.005902169518932758,0.016,4/13,2.81%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,retinoic acid binding (GO:0001972),0.8732459102779682,1.9835830658645912,0.0,0.021395364506131248,0.073,2/12,1.14%,CYP26B1;NR2F2
prerank,MHC class II protein complex binding (GO:0023026),-0.7896603080941071,-1.8683548359527413,0.0,0.1024003750586029,0.165,7/11,13.69%,HSPA8;HSP90AA1;HSP90AB1;ATP1B1;PKM;CD74;CD81
prerank,organic cation transmembrane transporter activity (GO:0015101),0.7484405361668962,1.8590289285382997,0.002145922746781116,0.1292575124646274,0.411,2/16,0.70%,SLC22A4;SLC22A2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8201813227315456,1.8139609598015332,0.008456659619450317,0.19575528904460318,0.604,3/10,3.73%,SLC6A13;SLC6A12;SLC6A1
prerank,amino acid:sodium symporter activity (GO:0005283),0.7818687091917518,1.7960151511004754,0.00625,0.21318074191002365,0.686,4/11,3.73%,SLC6A13;SLC6A12;SLC1A3;SLC6A1
prerank,LRR domain binding (GO:0030275),0.7472821391958363,1.778392334166347,0.010416666666666666,0.2287090688586444,0.761,2/14,0.82%,ROBO1;PAWR
prerank,ephrin receptor activity (GO:0005003),0.7213288632015283,1.7673183127012522,0.004140786749482402,0.2047069128149845,0.793,4/17,3.71%,EPHA7;EPHA3;EPHA8;EPHA4
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.7213288632015283,1.7673183127012522,0.004140786749482402,0.2047069128149845,0.793,4/17,3.71%,EPHA7;EPHA3;EPHA8;EPHA4
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.7194346587114253,-1.764682247347977,0.0018867924528301887,0.27578475803510966,0.519,4/12,13.44%,ENTPD1;ENTPD7;ENTPD2;SLC25A42
prerank,anion channel activity (GO:0005253),-0.48895664645652653,-1.758214249226409,0.0,0.22237693389592122,0.541,18/61,16.90%,SLC26A7;LRRC8C;ANO1;ANO4;LRRC8D;CLIC4;LRRC8B;GABRB3;CLCN5;GABRB1;TTYH3;ANO3;LRRC8A;GABRG3;SLC1A4;ANO2;CFTR;GLRA3
prerank,translation elongation factor activity (GO:0003746),-0.6800401652835488,-1.7283959087745815,0.0057361376673040155,0.26613908423191124,0.703,11/14,28.81%,EEF1A1;EEF2;GFM1;EEFSEC;EEF1B2;EIF5A;EIF5AL1;GTPBP2;TUFM;EEF1A2;GTPBP1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5425879466525736,-1.72606886509207,0.008146639511201629,0.19548500881834213,0.712,15/34,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5425879466525736,-1.72606886509207,0.008146639511201629,0.19548500881834213,0.712,15/34,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,monocarboxylic acid binding (GO:0033293),0.6856769244762275,1.7176432279274079,0.021825396825396824,0.3128149845034362,0.942,3/18,6.18%,CYP26B1;NR2F2;NAPEPLD
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6492993532396354,-1.7037991148143845,0.008032128514056224,0.19834765848830546,0.799,5/16,6.03%,PTPRB;PTPRG;PTPRM;PTPRN2;PTPRC
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6492993532396354,-1.7037991148143845,0.008032128514056224,0.19834765848830546,0.799,5/16,6.03%,PTPRB;PTPRG;PTPRM;PTPRN2;PTPRC
prerank,amyloid-beta binding (GO:0001540),-0.4519573452997156,-1.6928294711631937,0.002577319587628866,0.20072511329895296,0.828,41/79,31.55%,APBB2;COL25A1;TGFB2;ITM2B;CST3;FZD4;FZD6;ITM2A;APBB1;CRYAB;GRIN1;ATP1A3;APBB3;CD74;CLU;ADRB2;APBA3;IAPP;C1QA;CACNA1B;GRIA2;PFDN6;ITM2C;PFDN5;INSR;MAPK8IP2;FCGR2B;AGER;PFDN4;SORL1;APBA2;TREM2;ITGB2;CLSTN1;APBA1;TLR4;GRIA1;CD36;TLR6;BCHE;GRIN2B
prerank,fatty acid synthase activity (GO:0004312),-0.722811452873858,-1.6815582324411056,0.015122873345935728,0.2089690150449644,0.859,4/10,13.03%,ELOVL7;ELOVL5;ELOVL6;ELOVL1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6519741594039383,-1.6811459854829904,0.013944223107569721,0.19206438506016563,0.859,6/15,15.43%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6401980615362285,-1.677564263017043,0.011494252873563218,0.17212287634228562,0.872,7/16,20.33%,ANO1;ANO4;TTYH3;TTYH2;ANO3;ANO2;ANO8
prerank,intracellular chloride channel activity (GO:0061778),-0.6401980615362285,-1.677564263017043,0.011494252873563218,0.17212287634228562,0.872,7/16,20.33%,ANO1;ANO4;TTYH3;TTYH2;ANO3;ANO2;ANO8
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6584592681957584,1.67643576208417,0.0199203187250996,0.42348066298342546,0.983,2/18,0.23%,ALDH1A1;ALDH1A2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6409706727873513,-1.662270037108396,0.01768172888015717,0.19094358493514613,0.915,6/16,15.43%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR
prerank,semaphorin receptor binding (GO:0030215),-0.5684046114868964,-1.6619032615046623,0.008676789587852495,0.1792643381778403,0.916,10/23,11.38%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,phospholipid transfer activity (GO:0120014),-0.6106412601419735,-1.6611288132100797,0.008316008316008316,0.1703376446687442,0.918,11/21,18.85%,PITPNC1;CERT1;PLTP;PITPNM2;TNFAIP8L3;GLTP;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB
prerank,rRNA binding (GO:0019843),-0.5031055696132322,-1.657556443368614,0.004545454545454545,0.16636523067840459,0.924,21/42,27.59%,RPL11;CAVIN1;RPL23;RPS9;RPS3;RPS14;RPL5;RCC1L;RPLP0;ERAL1;RPS5;RPL12;NOP53;ANG;PPAN;MRPS11;MRPS27;MRPL11;MRPS18C;MRPL18;DDX28
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.7364480901792084,1.655007629757489,0.0379746835443038,0.46763343111544164,0.991,1/11,0.28%,SLC22A4
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.46779205322738765,-1.6475454629269841,0.002331002331002331,0.176003158388235,0.942,23/57,18.29%,COX4I1;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;NDUFS1;UQCR11;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;NDUFB4;NDUFS7;UQCRC1
prerank,CoA-ligase activity (GO:0016405),0.7039594296712544,1.6408145276913562,0.013779527559055118,0.49107455675977435,0.997,2/14,1.86%,ACSS3;ACSL1
prerank,acetyltransferase activity (GO:0016407),0.5882189646861548,1.6386787328726675,0.018832391713747645,0.46646813097965234,0.997,13/31,16.54%,PAFAH2;NAA80;PAFAH1B3;SPHK1;DBT;KAT8;KAT6B;SMARCE1;SAT2;ESCO1;CREBBP;NAT8;NAT14
prerank,poly(U) RNA binding (GO:0008266),0.6411816789515927,1.6327389188542625,0.028735632183908046,0.45864775636706645,0.997,7/20,5.90%,ATXN1;RBMS1;RBMS3;HNRNPC;PABPC4L;HNRNPH1;RBMS2
prerank,sialyltransferase activity (GO:0008373),-0.5813337456492136,-1.6248326134983115,0.014553014553014554,0.21086325988435692,0.97,8/20,9.43%,ST3GAL4;ST6GALNAC3;ST6GAL1;ST3GAL6;ST8SIA4;ST6GALNAC5;ST8SIA1;ST8SIA6
prerank,sodium:proton antiporter activity (GO:0015385),-0.684378123927963,-1.615211296175611,0.01160541586073501,0.22090921944649086,0.98,3/11,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,metallopeptidase activity (GO:0008237),0.4578681430626856,1.6113905911051205,0.009202453987730062,0.5082230871057491,0.999,16/113,8.06%,ADAMTS12;ADAMTS9;PAPPA;ADAM12;TRABD2B;ADAMTS5;THSD4;ADAMTS10;ADAMTS15;MMP2;ACE;ADAMTS7;MMP19;NRDC;MMP9;ADAMTSL4
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6067755024427677,-1.5916481484225484,0.028,0.26047024393015955,0.99,5/17,1.76%,ATP10A;PITPNC1;ATP8B1;PLTP;PITPNM2
prerank,metalloendopeptidase activity (GO:0004222),0.47557247326876473,1.5890832423339203,0.014150943396226415,0.5692861099881718,1.0,13/76,8.06%,ADAMTS12;ADAMTS9;TRABD2B;ADAMTS5;THSD4;ADAMTS10;ADAMTS15;MMP2;ADAMTS7;MMP19;NRDC;MMP9;ADAMTSL4
prerank,calcium:sodium antiporter activity (GO:0005432),0.7339636013240003,1.5858638758208632,0.042222222222222223,0.5520081702707111,1.0,3/10,3.07%,SLC24A3;SLC8A3;SLC8A1
prerank,phospholipase binding (GO:0043274),0.6762695726814252,1.578492663086994,0.04742268041237113,0.5521971432421507,1.0,3/13,1.89%,ARHGAP6;PRKN;PDPK1
prerank,translation initiation factor activity (GO:0003743),-0.49160672092595453,-1.5775328561265385,0.015555555555555555,0.28458577087452525,0.997,19/36,24.24%,EIF3F;EIF1B;EIF4G3;EIF3I;EIF4G1;EIF3D;EIF3B;EIF2B5;EIF3C;EIF1;EIF2B2;EIF2A;EIF5B;EIF2D;EIF3A;EIF3G;EIF4E;EIF5;EIF3K
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6465153677338131,1.5651619652779372,0.05,0.5811763271539582,1.0,5/14,11.64%,SLC7A11;SLC1A3;SLC25A18;SLC25A22;SLC38A7
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5641211085107702,-1.564316951385418,0.03665987780040733,0.3045264885138303,0.999,10/19,30.72%,EFNA5;GAS6;PAK2;NRG3;GREM1;ABI1;AFAP1L2;DGKQ;ANGPT4;EGF
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5003616027638753,1.5611412342782036,0.03098106712564544,0.5710349009567444,1.0,9/47,6.03%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;PDPN;SLC6A1;SLC38A9;SLC43A1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5853120869143694,1.5576377089293516,0.03525046382189239,0.5600217947891705,1.0,7/23,5.90%,ATXN1;RBMS1;RBMS3;HNRNPC;PABPC4L;HNRNPH1;RBMS2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.48028615864942603,1.556736398336848,0.025906735751295335,0.5401714728473251,1.0,18/60,11.42%,EPHA7;EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;DDR2;RYK;MUSK;AXL;EPHA2;ERBB2
prerank,diacylglycerol kinase activity (GO:0004143),-0.6573744043528736,-1.5542509745378774,0.036053130929791274,0.31920387560556335,0.999,7/11,24.15%,DGKH;DGKB;DGKI;DGKZ;DGKG;DGKE;DGKQ
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7029255720085698,1.5534462837122964,0.05660377358490566,0.5308017787360194,1.0,1/10,0.08%,PRKAG2
prerank,AMP binding (GO:0016208),0.6899677924272265,1.547064191688178,0.04230769230769231,0.534222010303401,1.0,3/11,6.95%,PRKAG2;PRKAG3;MPPED2
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.6113064515915898,-1.5425705731214006,0.03294573643410853,0.33765083486602476,0.999,7/13,16.93%,SH3BP4;ARHGDIB;ARHGDIA;CCDC88A;RANBP1;GDI2;GDI1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.48792298015930713,1.542558473389685,0.02891156462585034,0.530575893235912,1.0,14/55,12.29%,SLC22A4;SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A12;PDPN;SLC38A9;SLC16A6;SLC19A2;SLC19A1;SLC36A2;SLC38A7;SLC38A2
prerank,acylglycerol lipase activity (GO:0047372),-0.6582200058122385,-1.5382389257716593,0.026119402985074626,0.3365419365294346,1.0,3/11,9.35%,ABHD2;MGLL;LIPE
prerank,phospholipase activator activity (GO:0016004),0.7092443865235707,1.5374559923108955,0.05555555555555555,0.529719714324215,1.0,2/10,1.89%,ARHGAP6;PDPK1
prerank,acid-thiol ligase activity (GO:0016878),0.6680474328121241,1.531749693762747,0.045454545454545456,0.5312970182473781,1.0,3/13,8.71%,ACSS3;ACSL1;AASDH
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6263815187986214,-1.5260171641830058,0.03333333333333333,0.3575643515727904,1.0,3/12,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,C-C chemokine receptor activity (GO:0016493),0.5849796144148186,1.5256500011715455,0.05040322580645161,0.5349332973992723,1.0,4/21,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,GTPase activity (GO:0003924),-0.35230579351610114,-1.5244847364217982,0.0,0.34899396996297916,1.0,74/192,26.14%,DNM3;EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;EEF2;RAB31;RAB3C;GNAL;ARHGDIB;RAB27A;GCH1;RERG;NRAS;RHOB;GBP4;GNAI1;RHOT1;GNA14;GNA12;ENTPD7;MRAS;GFM1;DNM2;RAB28;NKIRAS1;SEPTIN9;RHOA;RAB38;GPN3;BMS1;GNA11;RALB;RAB3B;ARL8A;GBP5;RHEB;RAB1A;DNM1;GSPT2;AGAP3;GBP3;RABL3;ATL2;TPPP;RHOG;RRAS;GNAZ;RRAGB;RAB1B;GNA13;RIT2;MTG1;RAB8A;RAP1GAP;MFN2;TSR1;RAB8B;GNAO1;GNG3;RAB7A;RAB3A;GEM;DRG2;RAB2A;RAB14;HRAS;RAB5B;RAB6B;RND1;GNB2;GNB1
prerank,cation:chloride symporter activity (GO:0015377),-0.6612917449095765,-1.5242151259314058,0.04618473895582329,0.3378023649528572,1.0,5/10,10.53%,SLC12A7;SLC12A2;SLC12A6;SLC12A8;SLC12A4
prerank,outward rectifier potassium channel activity (GO:0015271),0.7000802450422517,1.5215542471715737,0.057649667405764965,0.531417381363263,1.0,4/11,4.07%,KCNK2;KCNA5;KCNT2;KCND3
prerank,insulin-like growth factor receptor binding (GO:0005159),0.660188289262021,1.5161644749638783,0.05919661733615222,0.5329474632798814,1.0,3/12,3.44%,IGF1;GNAS;IGF2
prerank,chloride channel activity (GO:0005254),-0.42337705486021443,-1.5158281452155304,0.012165450121654502,0.3487956283491876,1.0,21/59,25.74%,SLC26A7;ANO1;ANO4;CLIC4;GABRB3;CLCN5;GABRB1;TTYH3;TTYH2;ANO3;GABRG3;SLC1A4;ANO2;CFTR;GLRA3;GABRA5;GABRE;BEST1;CLCN3;GABRG2;GLRA1
prerank,NAD binding (GO:0051287),0.5496557619523836,1.5060806564946565,0.05009633911368015,0.5503922121089619,1.0,9/26,16.30%,ALDH1A1;CRYL1;SORD;NUDT6;PARP9;CRYZ;BDH2;ALDH2;SIRT3
prerank,MAP kinase activity (GO:0004707),0.6333180545095822,1.5000101478065637,0.07421875,0.5559612229206465,1.0,2/14,4.54%,MAPK4;MAPK9
prerank,cytokine receptor activity (GO:0004896),0.43873969376545263,1.4999356016364165,0.02287581699346405,0.5401890388280363,1.0,7/83,4.03%,IL31RA;LEPR;ACKR2;CCR9;CNTFR;IL13RA1;GFRAL
prerank,frizzled binding (GO:0005109),0.5228725197604724,1.4995295153651085,0.05152671755725191,0.5262221323870697,1.0,8/34,10.14%,WNT4;RNF43;WNT6;NDP;ZNRF3;WNT5B;RYK;DVL3
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3843797947749829,1.495246620392485,0.0014285714285714286,0.5254260189309374,1.0,73/232,19.47%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;TRIM5;MGRN1;NEDD4;KCMF1;NEURL2;RNF138;RNF2;UFL1;RNF217;ZNRF3;LTN1;FBXO44;SH3RF1;RNF181;UBR2;RNF152;RNF145;TRIM56;RNF135;SIAH2;WWP2;AMFR;PIAS1;RNF216;RNF180;RC3H2;NHLRC1;FBXO6;MDM2;ITCH;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;MYCBP2;RNF14;GID4;TRIM26;TRIM43;RCHY1;TRIM24;RNFT2;BIRC2;TRIM62;UBR1;PPIL2;RNF122;CBX4;HECTD1;TRIM17;CBLB;TRIM69;TRIM39;NHLRC3;PELI3;DTX3L;TRIM9;TRAF6;MKRN2;SHPRH;RNF130;PIAS3;HACE1;XIAP
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.6244910440631792,1.49467770916619,0.0855397148676171,0.5131522209377372,1.0,7/16,11.64%,SLC13A3;SLC25A18;SLC13A5;SLC1A5;SLC25A11;SLC25A22;SLC38A7
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6182465528896557,1.493142000677576,0.07770961145194274,0.5041562578821708,1.0,6/15,19.77%,KMT2A;ASH2L;SETD1A;KMT2B;WDR82;SETD4
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.5694276437469317,-1.4913736434018379,0.05070993914807302,0.406544772620722,1.0,11/16,32.33%,RPS3;CD38;ADPRH;SMUG1;NEIL1;NEIL3;NTHL1;SARM1;MACROD2;NEIL2;BST1
prerank,receptor antagonist activity (GO:0048019),0.5974018254094451,1.4889945899468544,0.09019607843137255,0.5045617167497641,1.0,3/17,2.62%,DKK3;PXDN;DKK1
prerank,C-C chemokine binding (GO:0019957),0.5648918570378183,1.4867715726461812,0.06732673267326733,0.49861336155471786,1.0,4/22,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,ubiquitin protein ligase activity (GO:0061630),0.38132956763719245,1.4818786416675156,0.004310344827586207,0.5024807335681881,1.0,65/228,17.80%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;TRIM5;MGRN1;NEDD4;KCMF1;NEURL2;RNF138;RNF2;RNF217;ZNRF3;LTN1;FBXO44;SH3RF1;RNF181;UBR2;RNF152;RNF145;TRIM56;RNF135;SIAH2;WWP2;AMFR;RNF216;RNF180;RC3H2;UBE4A;NHLRC1;FBXO6;MDM2;ITCH;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;MYCBP2;RNF14;GID4;TRIM26;TRIM43;RCHY1;TRIM24;RNFT2;BIRC2;TRIM62;UBR1;PPIL2;RNF122;HECTD1;TRIM17;CBLB;TRIM69;TRIM39;NHLRC3;PELI3;DTX3L;TRIM9;UBE4B
prerank,lysine-acetylated histone binding (GO:0070577),0.5669448792098251,1.479365275310911,0.07421150278293136,0.4869066286092293,1.0,9/20,20.81%,KMT2A;DPF2;PSME4;PHIP;TRIM24;ATAD2B;BRD7;BRDT;CARM1
prerank,acetylation-dependent protein binding (GO:0140033),0.5669448792098251,1.479365275310911,0.07421150278293136,0.4869066286092293,1.0,9/20,20.81%,KMT2A;DPF2;PSME4;PHIP;TRIM24;ATAD2B;BRD7;BRDT;CARM1
prerank,lipase activator activity (GO:0060229),0.6743602679907498,1.4768994081430682,0.06722689075630252,0.48399976043959336,1.0,2/10,1.89%,ARHGAP6;PDPK1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5105548703374684,-1.4761855709386753,0.056910569105691054,0.44057016484583295,1.0,14/22,25.10%,ATP6V0A1;ATP2C1;ATP2A2;ATP2A3;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.5782537637206888,-1.474277771825935,0.056074766355140186,0.4335158986238659,1.0,8/15,23.87%,PIK3R6;SOCS2;SOCS5;PIK3R5;CISH;CCKBR;PIK3R3;SOCS1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6288932381706894,1.4689355509547046,0.0931174089068826,0.4961671636894125,1.0,2/13,1.28%,BMP6;BMP7
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.5274708987077322,-1.4682216951340807,0.05930470347648262,0.4406345634362512,1.0,9/20,17.93%,TJP2;DLG2;MAGI3;CMPK1;GUK1;AK2;CASK;LRGUK;AK6
prerank,pyridoxal phosphate binding (GO:0030170),0.5720082693860228,1.4660493982721687,0.08403361344537816,0.49398228718386866,1.0,6/20,13.02%,ABAT;CBS;ACCS;SRR;THNSL2;SHMT1
prerank,sulfotransferase activity (GO:0008146),0.5128231975360561,1.463396297866186,0.05054151624548736,0.49190894084355213,1.0,9/33,11.73%,HS3ST3A1;UST;TPST1;GAL3ST3;GAL3ST2;CHST3;CHST15;SULT4A1;HS6ST1
prerank,disordered domain specific binding (GO:0097718),-0.5037266234457185,-1.460516249117955,0.055776892430278883,0.45375423243215085,1.0,7/23,10.74%,FN1;HSP90AA1;CALM1;HSP90AB1;FYN;GAPDH;KCNA1
prerank,copper ion binding (GO:0005507),0.4911297998876294,1.4571841111474164,0.051470588235294115,0.5009416190677861,1.0,10/42,11.56%,MOXD1;HEPH;SOD3;LOXL3;LACC1;COX17;CCS;DCT;ATP7B;PAM
prerank,sterol binding (GO:0032934),0.4567628556213702,1.4531054984612977,0.057291666666666664,0.502510712841935,1.0,6/56,4.04%,RORA;SIDT1;OSBPL8;INSIG2;GRAMD1C;ABCA1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.46729179478473115,-1.4508452119414743,0.03655913978494624,0.4724158757914032,1.0,10/31,13.72%,SLC12A7;SLC12A2;KCNK5;ABCC9;SLC12A6;SLC12A8;SLC12A4;KCNA1;HCN1;TMEM38B
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.45123566047086844,1.450661056626544,0.047285464098073555,0.5004306802899033,1.0,17/60,11.42%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;DDR2;RYK;MUSK;AXL;EPHA2;ERBB2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6613910951715856,1.4487032875968775,0.1111111111111111,0.4964632591502286,1.0,4/10,11.74%,EHHADH;ECHDC3;ECHDC1;AUH
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.3254684941594209,-1.4476060715317536,0.0,0.4710309999095254,1.0,95/248,26.14%,DNM3;EEF1A1;RAP1A;RHOJ;KRAS;RAC1;HSP90AA1;MYL6;RASL12;EEF2;RAB31;RAB3C;GNAL;ARHGDIB;RAB27A;GCH1;RERG;NRAS;RHOB;GBP4;GNAI1;RHOT1;GNA14;SMCHD1;GNA12;ENTPD7;KIF26A;MRAS;MYH9;GFM1;DNM2;ABCB10;RAB28;NKIRAS1;SEPTIN9;RHOA;TOR1B;RAB38;GPN3;TOR3A;BMS1;GNA11;KIF1A;RALB;RAB3B;ARL8A;GBP5;RHEB;RAB1A;ATP2B1;DNM1;GSPT2;CLU;AGAP3;GBP3;ABCD2;RABL3;ATL2;CFTR;TPPP;DHX29;RHOG;RUVBL1;ABCA3;RRAS;GNAZ;RRAGB;RAB1B;GNA13;RIT2;MTG1;KIF15;ATAD1;RAB8A;RAP1GAP;VCP;MFN2;TSR1;RAB8B;GNAO1;GNG3;HSPA1B;RAB7A;RAB3A;GEM;DRG2;RAB2A;RAB14;HRAS;RAB5B;RAB6B;RND1;KIF14;GNB2;GNB1
prerank,BMP receptor binding (GO:0070700),0.6288940341330953,1.446296096207587,0.10855949895615867,0.49400045256576824,1.0,2/12,1.28%,BMP6;BMP7
prerank,store-operated calcium channel activity (GO:0015279),-0.630214721661527,-1.442513118837897,0.05426356589147287,0.47499457046573784,1.0,6/10,17.04%,TRPC3;TRPC6;TRPC4;STIM2;TRPC1;ORAI1
prerank,cAMP response element binding (GO:0035497),0.659802364616557,1.4411426931546858,0.1059322033898305,0.49866045805946085,1.0,1/10,0.08%,CREB5
prerank,N-acetyltransferase activity (GO:0008080),0.5689678379584959,1.4402656740466966,0.07889546351084813,0.4922051671546349,1.0,11/19,25.02%,NAA80;AANAT;SMARCE1;SAT2;ESCO1;NAT8;NAT14;KAT2B;NAA50;NAA10;ATAT1
prerank,ankyrin binding (GO:0030506),-0.5220062035620522,-1.4359609914147917,0.07489878542510121,0.4834214721050164,1.0,7/19,14.99%,SPTBN1;CDH1;PLEC;NRCAM;PTPRC;SPTBN4;KCNQ2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5836694378271949,-1.432743536111947,0.054878048780487805,0.48199375664642724,1.0,6/12,18.64%,PIK3R6;PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PIK3R3
prerank,hydro-lyase activity (GO:0016836),0.4757974622930751,1.432526550665545,0.0518783542039356,0.5047935876951508,1.0,13/41,16.18%,GMDS;CBS;HACD1;EHHADH;HACD3;ECHDC3;ECHDC1;L3HYPDH;AUH;ENO2;FAHD2A;ACO2;HACD4
prerank,androgen receptor binding (GO:0050681),-0.48594819501217573,-1.43059027865309,0.07276507276507277,0.47714062465117313,1.0,8/25,9.16%,FOXP1;CALR;KDM4C;KDM3A;ARID5A;DDX5;TMF1;ZBTB7A
prerank,glutamate receptor binding (GO:0035254),-0.5231712174970036,-1.4291547871527979,0.08284023668639054,0.4700251856212999,1.0,5/17,8.94%,HIP1;SHANK3;NSF;HOMER1;SYNDIG1
prerank,poly-purine tract binding (GO:0070717),0.5226846247918925,1.4282177265054286,0.06890130353817504,0.5079489925460464,1.0,6/27,5.90%,ATXN1;RBMS1;RBMS3;RBPMS;PABPC4L;RBMS2
prerank,RNA binding (GO:0003723),-0.28180018896913495,-1.4277507979916877,0.0,0.4640668286237906,1.0,387/1321,22.07%,SPTBN1;MSI2;SORBS2;TMSB4X;SYNE1;EEF1A1;MBNL1;ACTN4;MSN;LRRFIP1;HSPA8;RPL37A;TFRC;FAU;RPL41;NOVA2;RPL11;TPT1;RPL13;RPL27A;HSP90AA1;RPS21;CAVIN1;TES;RPL23;RPL17;HSP90AB1;RPS24;HNRNPK;RPL19;RPL21;RPS9;PPARGC1A;TARDBP;ADARB1;RPL6;RPS15;AHNAK;RPL38;CMSS1;RPL37;PLEC;SUCLG1;EEF2;RPL4;MAP4;RPSA;RPS7;VIM;RPS8;RPS3;RACK1;PPIA;RBFOX1;RPL8;RPS23;SMC1A;RPS19;PKM;RPS11;ADARB2;RPL34;IREB2;PSTK;RPL28;RPL18A;RPL26;CDK11B;QKI;UCHL5;RPL24;LUC7L2;SRSF2;RBFOX3;RPS14;FLNA;ACTN1;RPL18;CKAP4;RPS6;RPL23A;ATP5F1A;RPS12;HSPB1;HNRNPAB;RFTN1;G3BP1;RBFOX2;RBM47;RPS20;PABPC1;PINX1;SRP9;CALR;YBX3;TRIM25;RPS25;RPS18;EIF1B;HSP90B1;RTCB;SRSF1;RPL3;SARS1;SLC3A2;TFB2M;RPL32;LGALS1;ATXN2L;GNL3;RPL36;UBC;RPS27A;COL14A1;RPL14;KCTD12;SRRM3;ARF1;MYH9;TCF20;RPL5;GFM1;PUM2;EIF4G3;DCAF13;RPS2;HNRNPU;HNRNPA3;EIF3I;YBX1;PPIE;MTHFSD;CISD2;JUN;SF3B1;SF3B2;RPL27;MRPL32;RCC1L;LARP7;CPSF7;RPL31;MAK16;RPS27;TIAL1;PATL1;PHF5A;RPL29;SFPQ;KHDC4;RBM14;DDX5;DIDO1;DDX52;CPNE3;GRN;STAU1;LLPH;RALYL;DDX20;PDAP1;CCDC47;PPP1R10;PYM1;SRSF5;ZC3H12C;PPIB;RTN4;IMP3;RPLP0;APEH;RPL35A;DDX39B;EIF4G1;ANKHD1;PDCD11;ZFP36L1;BMS1;ADAR;ZC3H8;STRBP;YWHAG;SSB;EIF3D;MRPS14;NUDT4;MEPCE;RPL7A;RPS28;RPL7;STAT3;CPSF3;TUBB4B;POP5;PTPN1;TUBA1B;RPN1;RSL1D1;KIN;S100A16;HNRNPH2;ALDH18A1;RPS17;SRSF9;YTHDF3;RPS10;CPSF6;LBR;CLNS1A;DGCR8;RPUSD4;CWC15;DDX54;RALY;RPL30;MYO5A;DNM1;RANGAP1;TASOR;ZRANB2;RPS4X;RBM8A;GSPT2;MARK2;YARS1;OAS2;MYBBP1A;HSPD1;DHX37;RRBP1;STRAP;CANX;KHDRBS3;ERAL1;RNPS1;SHFL;SNRPC;SRSF6;BUD23;EIF4H;WDR3;FBL;PRPF40B;ZCCHC9;PPRC1;RPS27L;SRPK1;HNRNPDL;RSL24D1;POP4;EIF3B;ALDOA;GRSF1;MTCL1;SAMSN1;GDI2;RPP21;NUDT1;FUS;SF3B5;TENT5A;RPF1;RPS26;NELFCD;LARP1B;AGFG1;RTRAF;RPS16;ALKBH8;NUFIP2;MRPS5;HNRNPA0;RPS5;RCC2;TBL2;FASN;MRPL23;DHX32;RPL13A;RIDA;EIF3C;IFIH1;RBM42;EIF1;LIN28B;AKAP1;DHX29;SAFB2;AKAP8;GLRX3;POLR2G;RBM28;IMMT;YTHDC2;TOP2A;CPSF2;BTF3;SERBP1;ZC3H7A;SPEN;RPL36A;EIF2A;COA6;RPL12;RPP30;N4BP1;ZC3H12A;CSTF2T;TBL3;UTP18;NELFE;PCBP1;DSP;UTP15;SMG5;EIF5A;PCF11;CSTF2;ZBED4;FASTKD3;DDX17;EIF5B;MTREX;RPL9;EBNA1BP2;NOLC1;BST2;HNRNPUL1;DALRD3;DCN;KRI1;MRPS35;MRPS28;YTHDC1;MRPL13;SUPV3L1;EDC3;R3HDM1;CTNNA1;EXOSC10;PRKRIP1;THUMPD1;MEX3A;PPP1CC;PCBP4;FKBP4;HSPA9;NOP53;HNRNPLL;PTBP1;ANG;AGO3;DDX24;RPL35;NOC2L;RBM22;TRUB2;NKAP;SNIP1;MEX3B;TSN;MAGOH;FARSA;METTL3;MAPRE1;FMR1;ADD1;NHP2;UBA1;LRRC47;SLTM;CCDC124;CCDC137;RPL22;ELP5;EIF3A;TRA2B;PWP2;MAZ;TSNAX;PPAN;RO60;EIF4B;VCP;EIF3G;PUM3;TRMT10C
prerank,leak channel activity (GO:0022840),0.5655097286352687,1.425930630043365,0.09917355371900827,0.5050934208141852,1.0,3/18,5.96%,KCNK2;NALCN;TMEM175
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6096725510428114,-1.42535214341861,0.0625,0.46118094841207824,1.0,6/10,18.18%,CD200;CXADR;JUP;CD47;DSG2;DSP
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5804760822024964,-1.4251640158095265,0.064,0.451775481223289,1.0,3/13,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.44606709667042876,1.4240951199324692,0.0707070707070707,0.5015343539520235,1.0,16/53,12.76%,SLC7A11;SLC22A2;SLC38A3;SLC6A9;SLC1A3;SLC25A18;SLC38A9;SLC43A1;SLC1A5;SLC25A22;SLC36A2;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,ligand-gated anion channel activity (GO:0099095),-0.5358445870661382,-1.4218278252469203,0.08249496981891348,0.452807586291741,1.0,9/17,25.74%,GABRB3;GABRB1;GABRG3;CFTR;GLRA3;GABRA5;GABRE;GABRG2;GLRA1
prerank,death receptor binding (GO:0005123),-0.5488403399463366,-1.4217654509755435,0.09406952965235174,0.44348023128613845,1.0,11/15,32.31%,DAB2IP;NGF;EDA;TMBIM1;CASP8AP2;MADD;MYD88;BID;FADD;NTF3;PIDD1
prerank,chemokine receptor activity (GO:0004950),0.5321035783277543,1.4206864242442392,0.0873015873015873,0.5019631226699007,1.0,4/24,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6094385329607375,1.4204409661829545,0.11020408163265306,0.49449214789222434,1.0,3/14,5.54%,ALDH4A1;AASS;MTHFR
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.5323966101115782,-1.4189446880437246,0.08333333333333333,0.4413124499682668,1.0,8/18,23.87%,PIK3R6;SOCS2;SOCS5;PIK3R5;CISH;CCKBR;PIK3R3;SOCS1
prerank,phosphatidylglycerol binding (GO:1901611),-0.5614425856063083,-1.4185773528155996,0.07632093933463796,0.4334235974370995,1.0,6/13,18.80%,PITPNC1;PLTP;STOML2;PLEKHN1;UQCC3;PITPNA
prerank,histone demethylase activity (GO:0032452),0.49968061819692966,1.418285743732122,0.08273381294964029,0.49173639758140586,1.0,13/27,18.40%,KDM7A;JARID2;KDM2B;PHF8;KDM2A;KDM5B;KDM6B;KDM3B;KDM5C;KDM6A;PHF2;RIOX2;KDM4D
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5519539980149952,-1.415578573149162,0.0974264705882353,0.43357583445942843,1.0,4/13,10.64%,PIP5K1B;PIK3C2B;PIK3CD;PIK3C2A
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5805884486656527,-1.414468950254404,0.07572815533980583,0.427785110654309,1.0,7/12,23.57%,CISD2;ISCU;CISD1;XDH;CIAPIN1;ISCA2;ISCA1
prerank,FAD binding (GO:0071949),0.5243470187309683,1.4122297705871953,0.08498023715415019,0.5004977295234673,1.0,7/24,11.85%,MICAL3;DDO;SQOR;MTHFR;NDOR1;PRODH;CRY1
prerank,leucine zipper domain binding (GO:0043522),0.6416788489526375,1.407632462233868,0.13675213675213677,0.5051119710955397,1.0,1/10,0.82%,PAWR
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5223908174265369,1.4070091052501266,0.10076045627376426,0.4991570698537415,1.0,3/25,1.11%,CYP26B1;MICAL3;CYP27A1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.600799298777702,-1.4036758044605087,0.0996309963099631,0.4487814428551631,1.0,5/10,18.74%,ANKRD13A;IDE;LAPTM5;FAAP20;ANKRD13B
prerank,histone methyltransferase binding (GO:1990226),-0.5917250644449797,-1.4014601416000936,0.10444874274661509,0.4464331811104745,1.0,3/11,6.01%,HSP90AB1;LCORL;CTNNB1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.32668043187940715,1.3974526082934076,0.0,0.5163951195011699,1.0,142/831,13.95%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;OSR1;AEBP1;ARNT2;RBPJ;ZIC1;HOXC6;EPAS1;HLF;PPARA;NR2F2;NPAS3;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;CUX1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;BBX;HOXC5;PKNOX2;VSX2;STAT5B;NFAT5;ZFP90;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZFP37;THAP1;SALL1;RFXAP;ZNF23;SMAD3;EN1;PBX4;NR6A1;RBL2;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;HOXC8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;ZNF177;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;ZNF697;HOXB9;TFDP2;MLXIP;CLOCK;ZNF148;SRF;DMRTA2
prerank,Wnt-activated receptor activity (GO:0042813),-0.5306060134616682,-1.3921961434263381,0.09523809523809523,0.4636963161857676,1.0,5/15,6.13%,ROR1;PKD1;FZD4;FZD6;LRP5
prerank,peptidase inhibitor activity (GO:0030414),0.4921317652869785,1.3910350281487347,0.0761904761904762,0.5256160914870467,1.0,9/33,11.22%,TFPI;ITIH2;SERPIND1;PROS1;A2ML1;GPC3;SIMC1;CST7;RENBP
prerank,GTP binding (GO:0005525),-0.32889581531242207,-1.3907544127505667,0.016722408026755852,0.4592005447279709,1.0,62/172,25.17%,EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;RAB31;RAB27A;GCH1;TGM2;RERG;NRAS;RHOB;TUBB3;GBP4;GNAI1;RHOT1;ARF5;GNL3;SCG5;ARF1;MRAS;DNM2;RAB28;RHOA;RAB38;BMS1;ARHGEF5;RALB;ARL8A;TUBB4B;TUBA1B;GBP5;RHEB;GBP3;TUBB2A;TUBA1A;RABL3;ATL2;RHOG;EIF2B2;RRAS;TUBB4A;RRAGB;RAB1B;RAB39A;RIT2;ARFIP2;INSR;RAB8A;TUBD1;TSR1;RAB7A;ARL4A;GEM;SEPHS1;DRG2;TUBB2B;RAB2A;RAB14;NUDT16;HRAS
prerank,potassium:proton antiporter activity (GO:0015386),-0.6064516983937218,-1.3890776134662866,0.1065891472868217,0.4558456776415175,1.0,2/10,5.56%,SLC9A2;SLC9A8
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5488012663948749,-1.3846789623601605,0.09917355371900827,0.46054696046257226,1.0,5/14,17.59%,SLC26A7;SLC26A2;SLC26A6;SLC25A30;SLC26A11
prerank,GTPase regulator activity (GO:0030695),0.36275227990777753,1.3839020024330708,0.018731988472622477,0.5359112058783896,1.0,34/212,9.48%,ARHGAP28;RANBP3L;ALDH1A1;ARHGAP24;ERRFI1;GMIP;NPRL3;RIN2;ARHGAP29;ASAP1;SMAP2;PLCB1;ARHGAP20;ALS2;ARFGAP3;SYDE2;LLGL2;ARHGAP26;CPEB2;WASL;NPRL2;ARHGAP40;LRRK2;HACD3;TBC1D9B;ASAP3;GNAQ;ARHGAP35;ARHGAP9;MYO9B;TBC1D4;SIRPA;ARHGEF10L;GNB5
prerank,phosphatidic acid binding (GO:0070300),-0.5067899505018258,-1.3812805049472363,0.0918580375782881,0.4621703073308594,1.0,8/19,19.26%,PITPNC1;PLTP;PACSIN2;MARK1;PLEKHN1;ATP13A2;UQCC3;JPH2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.32403425465481195,1.3796121787128344,0.002296211251435132,0.5401625625672544,1.0,130/731,13.95%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;ARNT2;RBPJ;ZIC1;HOXC6;HLF;PPARA;NR2F2;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;HOXC5;PKNOX2;STAT5B;NFAT5;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;THAP1;SALL1;ZNF23;SMAD3;EN1;PBX4;NR6A1;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;ZNF697;HOXB9;MLXIP;CLOCK;TRIM24;ZNF148;SRF;DMRTA2
prerank,PDZ domain binding (GO:0030165),0.4244766663583227,1.3714575322724203,0.08561643835616438,0.5545369318728705,1.0,11/61,8.27%,TGFBR3;SLC22A4;ARHGAP29;PLEKHA2;PRKN;SDC2;LLGL2;SSTR2;SYNJ2;PTEN;SRR
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5625152280567868,1.3687086260652421,0.14979757085020243,0.5543744341808837,1.0,2/15,1.52%,ACKR2;CCR9
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.6269052054532124,1.3653058260356057,0.1394335511982571,0.5561838401533187,1.0,4/10,7.94%,KDM7A;KDM2B;PHF8;KDM2A
prerank,poly(A) binding (GO:0008143),0.5227556146240374,1.3625022769844033,0.111328125,0.5561649373399811,1.0,5/21,5.90%,RBMS1;RBMS3;RBPMS;PABPC4L;RBMS2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3196061183589333,1.3614616551748129,0.004618937644341801,0.5513344162111175,1.0,127/732,13.95%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;ARNT2;RBPJ;ZIC1;HOXC6;HLF;PPARA;NR2F2;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;HOXC5;PKNOX2;STAT5B;NFAT5;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;THAP1;SALL1;ZNF23;SMAD3;EN1;PBX4;NR6A1;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;ZNF697;HOXB9;MLXIP;CLOCK;ZNF148;SRF;DMRTA2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5749221060071191,-1.3601217665504477,0.11823647294589178,0.5149906756264,1.0,2/11,0.97%,SGMS1;SGMS2
prerank,ion gated channel activity (GO:0022839),-0.467509648883628,-1.3574836349797241,0.10441767068273092,0.5145992585931716,1.0,9/24,20.33%,ANO1;ANO4;TTYH3;TTYH2;KCNT1;ANO3;ANO2;TRPM4;ANO8
prerank,CARD domain binding (GO:0050700),-0.534593437716809,-1.3561960110058828,0.12248995983935743,0.5103913413890275,1.0,9/14,32.29%,NOD1;CARD10;CARD14;CARD16;CARD19;CASP1;CARD11;MAVS;NOD2
prerank,ATPase binding (GO:0051117),-0.3708594546081921,-1.356170483742987,0.075,0.5023384110116412,1.0,28/71,19.27%,CAV1;PDE4D;ESR1;ATXN3;ATP1B1;UBXN1;ATP6V0A1;NKD2;DERL1;S100A1;RALB;PIH1D1;TCIRG1;ATP6V1E1;SVIP;FBL;PPP3CA;BBC3;NR1H2;TRPC1;DNAJC10;ATP5IF1;WFS1;ATP6V0A4;PLN;DNAJB1;ATP6V0A2;PSEN1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.5756935134385747,-1.3508488087239279,0.10357815442561205,0.5098526136896391,1.0,5/11,16.21%,SLC25A25;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5305919597844939,-1.3504041701781853,0.12698412698412698,0.5031687162657628,1.0,6/14,19.16%,IREB2;ISCU;NDUFS1;RSAD2;RSAD1;ISCA2
prerank,chemokine binding (GO:0019956),0.47942205454310793,1.3495008527050423,0.1367837338262477,0.5772059470870953,1.0,5/30,4.02%,ACKR2;CCR9;CXCR5;PDPN;CXCR6
prerank,ubiquitin protein ligase binding (GO:0031625),-0.3062524696819108,-1.3476955099483132,0.0038461538461538464,0.5032176429082196,1.0,91/254,23.48%,ACTG1;PRR5L;HSPA8;RPL11;HSP90AA1;RPL23;HSP90AB1;ATXN3;FBXO7;PPARGC1A;MID1;UBB;NFKBIA;DNAJA1;TRIB2;FZD4;UBXN1;FZD6;CALR;NKD2;FAF1;NEDD8;ARRB1;BAG6;UBC;RPS27A;GSK3B;TNFRSF1B;UCHL1;RPL5;CUL3;APBB1;MAP1LC3B;SMAD5;BAG1;JUN;FOXO1;DERL1;CHEK2;UBE2B;RTN4;RBX1;APC;HSPA5;ATP6V0C;RALB;ISG15;TUBA1B;CAMLG;HSPD1;CLU;OTUB1;ELOB;RNF34;PRKAR1A;CUL1;TPI1;CKB;TRAF1;ERLIN2;CASP8;UBE2G1;UBA52;WFS1;LAPTM5;HERC2;SPOPL;PER1;AUP1;CD40;SMG5;UQCRC1;UBE2D1;PINK1;TMBIM6;ARRB2;SCAMP3;JAK1;HSPA9;DIO2;GABARAPL1;ARIH1;KCNH2;CDKN1A;VCP;HDAC6;MFN2;UBOX5;TRIB3;RELA;HSPA1B
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.44886539854734975,-1.3426328389298878,0.12280701754385964,0.5108384938878043,1.0,11/27,17.59%,SLC26A7;SLC26A2;ANO1;SLC39A8;LRRC8A;SLC26A6;SLC25A30;SLC39A14;XPR1;ANKH;SLC26A11
prerank,P-type ion transporter activity (GO:0015662),-0.5457218022588736,-1.341453297644025,0.12909441233140656,0.5067425057224015,1.0,7/12,20.30%,ATP2C1;ATP2A2;ATP2A3;ATP2B1;ATP6V1E1;ATP2B2;ATP2B4
prerank,triglyceride lipase activity (GO:0004806),0.5229431019326988,1.3412591089662511,0.11706349206349206,0.5930774331732849,1.0,4/20,7.58%,CEL;LIPH;LIPC;DAGLB
prerank,deubiquitinase activity (GO:0101005),-0.3484342263087428,-1.34124212742313,0.04896907216494845,0.49997431663914876,1.0,39/88,29.66%,USP53;ATXN3;USP38;OTUD7A;MINDY2;PAN2;UCHL5;MINDY1;EIF3F;USP29;USP31;UCHL1;ZRANB1;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30907197783359835,-1.3394213264956063,0.006944444444444444,0.49770803473757064,1.0,68/196,25.20%,EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;RAB31;RAB27A;GCH1;TGM2;RERG;NRAS;RHOB;TUBB3;GBP4;GNAI1;RHOT1;ARF5;GNL3;SCG5;ARF1;MRAS;PDE2A;DNM2;RAB28;RHOA;RAB38;BMS1;ARHGEF5;RALB;RAB3B;ARL8A;MIEF1;TUBB4B;TUBA1B;GBP5;RHEB;GBP3;TUBB2A;TUBA1A;PDE11A;RABL3;ATL2;RHOG;EIF2B2;RRAS;TUBB4A;RRAGB;RAB1B;RAB39A;RIT2;ARFIP2;INSR;RAB8A;TUBD1;TSR1;RAB8B;RAB7A;ARL4A;GEM;SEPHS1;DRG2;TUBB2B;RAB2A;RAB14;NUDT16;HRAS;RAB5B
prerank,double-stranded RNA binding (GO:0003725),-0.3609391090114359,-1.336050494152595,0.06666666666666667,0.5007005936226832,1.0,20/70,13.36%,MBNL1;MSN;LRRFIP1;TFRC;HSP90AB1;ADARB1;VIM;ADARB2;ACTN1;RFTN1;SLC3A2;HNRNPU;ADAR;STRBP;TUBB4B;TUBA1B;DGCR8;OAS2;HSPD1;EIF4H
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.4617312226806322,1.3342365769031561,0.12921348314606743,0.6049084993971128,1.0,8/32,8.89%,KDM7A;KDM2B;TET1;PHF8;BBOX1;KDM2A;PHYH;TMLHE
prerank,estrogen receptor binding (GO:0030331),-0.41964759523905754,-1.3339367146444219,0.0851528384279476,0.4996192981542255,1.0,9/32,11.82%,LEF1;ESR1;RERG;CTNNB1;DCAF13;ARID5A;WBP2;DDX54;NRIP1
prerank,TBP-class protein binding (GO:0017025),-0.46267883952101374,-1.3233995787476793,0.11847389558232932,0.52130465590728,1.0,10/21,36.61%,ESR1;AHR;HHEX;YEATS2;RUVBL1;THRA;TAF11;PSMC5;PSMC1;TAF1B
prerank,Tat protein binding (GO:0030957),-0.5711951785636157,-1.3224582190481895,0.14071294559099437,0.5167935023631226,1.0,5/10,22.47%,ACTB;DNAJA1;MDFIC;GABARAPL1;DLL1
prerank,alkali metal ion binding (GO:0031420),0.566236106007695,1.3192038834478708,0.1744421906693712,0.6397295961909895,1.0,1/13,0.21%,ATP1A2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.5483219226441591,-1.3175523790758676,0.1323251417769376,0.5244257748606553,1.0,5/12,16.21%,SLC25A25;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5342482071958413,-1.3158262295784564,0.14684014869888476,0.522619981740568,1.0,5/13,13.65%,GSK3B;CSK;KCNQ1;RYR2;PRKAR1A
prerank,glutathione transferase activity (GO:0004364),0.49388884956928303,1.3145394821448904,0.16221374045801526,0.6457396816082994,1.0,3/23,5.01%,GSTM2;GSTT4;GSTT1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.41506151842673633,1.3144976754321562,0.12126537785588752,0.6378523783856623,1.0,10/60,7.48%,LRRK1;PPM1M;CTDSPL;SSU72;PPM1E;CDC14B;MTMR3;LRRK2;LRRC40;PTEN
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2956731335435988,-1.3137517055471906,0.012048192771084338,0.5215359542785704,1.0,93/269,23.48%,ACTG1;PRR5L;HSPA8;RPL11;HSP90AA1;RPL23;HSP90AB1;ATXN3;FBXO7;PPARGC1A;MID1;UBB;NFKBIA;DNAJA1;TRIB2;FZD4;UBXN1;FZD6;CALR;NKD2;FAF1;NEDD8;ARRB1;BAG6;UBC;RPS27A;GSK3B;TNFRSF1B;UCHL1;RPL5;CUL3;APBB1;MAP1LC3B;SMAD5;BAG1;JUN;FOXO1;DERL1;CHEK2;UBE2B;RTN4;RBX1;APC;HSPA5;ATP6V0C;RALB;ISG15;TUBA1B;HGS;CAMLG;HSPD1;CLU;OTUB1;ELOB;RNF34;PRKAR1A;CUL1;TPI1;CKB;TRAF1;ERLIN2;CASP8;UBE2G1;UBA52;WFS1;LAPTM5;HERC2;SPOPL;PER1;SUMO3;AUP1;CD40;SMG5;UQCRC1;UBE2D1;PINK1;TMBIM6;ARRB2;SCAMP3;JAK1;HSPA9;DIO2;GABARAPL1;ARIH1;KCNH2;CDKN1A;VCP;HDAC6;MFN2;UBOX5;TRIB3;RELA;HSPA1B
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5749264321255532,-1.3110381937176059,0.13259668508287292,0.5225697925557279,1.0,2/10,4.53%,MECOM;PRDM16
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.531977672012057,-1.3060057972638182,0.1509433962264151,0.5295619370906451,1.0,6/12,18.28%,DAB2IP;ITGA5;CCDC88A;VEGFA;CADM4;GREM1
prerank,fibroblast growth factor binding (GO:0017134),0.5048581564661537,1.305852288708806,0.15456238361266295,0.6560152120858225,1.0,4/21,3.19%,FGFR2;FGFR4;KL;CXCL13
prerank,GTPase activator activity (GO:0005096),0.3240964329950114,1.3014383819119077,0.02913907284768212,0.6616428000959702,1.0,52/313,9.87%,ARHGAP28;RANBP3L;ALDH1A1;ARHGAP24;ERRFI1;GMIP;NPRL3;RIN2;ARHGAP29;DENND4A;ASAP1;DOCK11;FGD4;SBF2;SMAP2;DENND2A;FNIP1;PLCB1;RAB3IL1;ARHGAP20;ALS2;RAB3IP;ARFGAP3;SYDE2;LLGL2;RCBTB2;ARHGAP26;IQSEC2;AKAP13;NPRL2;ARHGAP40;LRRK2;HACD3;TBC1D9B;ASAP3;ARHGEF11;GNAQ;RABIF;ARHGAP35;EPS8L1;RAPGEF4;ARHGAP9;RGL1;RALGPS1;MYO9B;TBC1D4;FARP1;ARHGEF10L;ARFGEF2;GNB5;ARHGEF18;RIC1
prerank,protein tyrosine kinase activity (GO:0004713),0.3681360552569471,1.3013495413567164,0.0984375,0.653943790253319,1.0,23/108,11.42%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;BAZ1B;DDR1;IGF1R;TTK;DDR2;RYK;MUSK;FRK;AXL;ABL1;EPHA2;JAK2;ERBB2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5527664591941042,-1.3001454780350683,0.14757281553398058,0.53878645100797,1.0,5/10,18.64%,PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PIK3R3
prerank,neurexin family protein binding (GO:0042043),0.5885013208950723,1.297007408773751,0.19916142557651992,0.658794540589447,1.0,3/10,8.59%,CEL;NLGN2;SYTL3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5535943444637186,-1.2946419982649522,0.16666666666666666,0.5475693540078601,1.0,5/10,18.74%,ANKRD13A;IDE;LAPTM5;FAAP20;ANKRD13B
prerank,ephrin receptor binding (GO:0046875),-0.4708138886198152,-1.2933527555337125,0.1443089430894309,0.5443833068429137,1.0,8/21,11.85%,EFNA5;CBL;FYN;CHN1;ANKS1A;PTPN1;CRK;EFNB3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5606697123200056,1.291620283645832,0.1702127659574468,0.6669335827579921,1.0,1/12,0.68%,B3GALT1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5332288795644314,-1.2908831091362427,0.17374517374517376,0.5449936642961909,1.0,6/12,25.00%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2
prerank,transferrin receptor binding (GO:1990459),-0.5713569789655859,-1.2876696208154623,0.16346153846153846,0.5477971260390387,1.0,5/10,20.52%,IKBKB;CHUK;CD81;SNX1;SNX2
prerank,potassium ion leak channel activity (GO:0022841),0.532139013694922,1.285572959613537,0.18105263157894738,0.6774112120537882,1.0,2/15,5.96%,KCNK2;TMEM175
prerank,MHC class I protein binding (GO:0042288),-0.5196542720775086,-1.285417345008571,0.14867617107942974,0.5477056525376207,1.0,5/13,18.50%,ATP5F1A;DERL1;TUBB4B;TAPBP;ATP5F1B
prerank,kinesin binding (GO:0019894),-0.4306953400134913,-1.2841593863970842,0.15257731958762888,0.5450453377526285,1.0,15/27,31.71%,ACTB;AP1AR;TOR1B;ARHGEF10;TTBK2;SPAG9;MAPK8IP2;ATCAY;KLC2;KIF1B;CLSTN1;MAPK8IP3;MAPK8IP1;SPTBN5;FAM83D
prerank,vinculin binding (GO:0017166),-0.5387199329807767,-1.2826151899793712,0.16938775510204082,0.54368760923492,1.0,5/11,6.08%,UTRN;CORO2B;ACTN1;PXN;RTCB
prerank,MHC protein binding (GO:0042287),-0.46523487322921053,-1.2820707571433718,0.14583333333333334,0.5388177129949282,1.0,7/20,18.50%,ATP5F1A;DERL1;TUBB4B;CD74;CD81;TAPBP;ATP5F1B
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31627376164450854,1.2811131650056828,0.04441453566621804,0.682492058107855,1.0,85/346,17.75%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;UBE2E2;TRIM5;MGRN1;NEDD4;RNF213;KCMF1;NEURL2;RNF138;DDB2;RNF2;RNF217;ZNRF3;LTN1;BCOR;FBXO44;SH3RF1;UBE2L3;RNF181;UBR2;RNF152;RNF145;TTC3;TRIM56;RNF135;SIAH2;WWP2;AMFR;BIRC6;RNF216;RNF180;TRAF7;RC3H2;NHLRC1;FBXO6;MDM2;ITCH;UBA7;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;TRIM45;FBXO4;MYCBP2;CUL4B;RNF14;GID4;TRIM26;TRIM43;RNF20;FBXO11;RCHY1;RNF214;TRIM24;RNFT2;UBE2A;CHFR;BIRC2;TRIM62;UBR1;PPIL2;RNF122;UBE2H;PML;HECTD1;TRIM17;CBLB;TRIM69;OBI1;TRIM39;UBE2E1;NHLRC3;PELI3;KLHL13;DTX3L;TRIM9
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.48530712653258723,1.2796408175890734,0.18016194331983806,0.6787383163259056,1.0,2/20,1.78%,AGPAT4;LPGAT1
prerank,protein tyrosine kinase binding (GO:1990782),-0.3454996960469733,-1.2794760514882717,0.08168316831683169,0.5399188426562437,1.0,21/71,14.69%,GRB14;TJP2;PITPNM2;HSP90AA1;PTPN14;GAS6;CBL;ITGB1;RACK1;BMPR2;NCK1;TOB1;SOCS5;CEACAM1;CPNE3;PTPN1;CRK;DUSP3;PITPNM3;NEDD9;NRG3
prerank,histone acetyltransferase activity (GO:0004402),0.4543336961584825,1.2782646837193488,0.17486338797814208,0.6753784053452925,1.0,11/30,14.12%,BAZ1A;NCOA3;KAT8;BRCA2;KAT6B;TADA2A;NAA60;EPC2;SRCAP;CLOCK;CREBBP
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.307073222035215,-1.2774082568371523,0.038922155688622756,0.5392973207619246,1.0,29/147,6.96%,DOCK9;RAPGEF5;FGD5;ARHGEF28;ELMO1;CYTH3;FGD6;RAP1A;TIAM1;RASGEF1B;DOCK1;CYTH1;RASGRF2;DOCK10;ARHGEF15;PREX1;DENND3;RIN3;EPS8L2;DENND1B;SPATA13;ARHGEF17;ARHGEF6;DOCK2;DENND5B;EEF1D;CCDC88A;ABR;BCR
prerank,insulin-like growth factor I binding (GO:0031994),0.548144388575406,1.2772131462951413,0.1991869918699187,0.6712406234559584,1.0,4/13,5.73%,IGFBP2;IGFBP4;IGF1R;LRP2
prerank,sequence-specific DNA binding (GO:0043565),0.3044997142570387,1.275041000292593,0.02530120481927711,0.6703718731073536,1.0,94/590,14.07%,CREB5;RORA;MAF;TCF4;TCF7L2;OSR1;ARNT2;RBPJ;ZIC1;EPAS1;HLF;PPARA;NR2F2;HOXC4;ZEB2;KMT2A;HOXB4;ESRRG;BCL2;CUX1;SATB1;PRDM5;DMRT1;SCX;NR1I2;ASCL2;ZBTB20;ZIC5;BBX;PKNOX2;VSX2;NFAT5;MYRFL;HOXA7;FOXD1;NFIB;TEAD1;ELF4;TEF;GMEB1;KDM2B;IRF8;ZNF250;ACD;GLI3;TET1;ZBTB32;TCF7L1;CXXC5;THAP1;ZNF23;XRCC5;SMAD3;EN1;PBX4;NR6A1;KDM2A;TCF12;ARNT;KDM5B;CEBPG;HOXB6;IRF3;ZSCAN29;IRX1;ABL1;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;RXRA;ZBTB38;NPAS2;KMT2B;ZBTB37;ZNF177;SOX13;GMEB2;HSF1;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;HOXB9;CLOCK;ZNF148;SRF;DMRTA2;BATF
prerank,cation transmembrane transporter activity (GO:0008324),0.4095431674579891,1.2719558104477113,0.15834767641996558,0.6725586320840388,1.0,14/48,12.76%,SLC22A2;SLC38A3;SLC6A9;SLC41A1;MMGT1;CHRNE;SLC38A9;SLC1A5;SLC36A2;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,flavin adenine dinucleotide binding (GO:0050660),0.402489671535193,1.2703883169508814,0.15251299826689774,0.670287602893851,1.0,12/53,13.78%,MICAL3;DPYD;DDO;SQOR;ACADL;MTHFR;GCDH;NDOR1;PRODH;CRY1;MTO1;ACOX1
prerank,calcium activated cation channel activity (GO:0005227),-0.4777287187713627,-1.2686225469439076,0.17751479289940827,0.5577016326383415,1.0,10/17,37.94%,ANO1;KCNMA1;KCNMB4;KCNN2;TRPM4;KCNN4;KCNMB2;TMEM63A;TMEM63B;KCNMB1
prerank,general transcription initiation factor binding (GO:0140296),-0.42884548726314015,-1.2666258348614745,0.14519427402862986,0.5573987103963255,1.0,13/25,37.11%,ESR1;AHR;HHEX;YEATS2;RUVBL1;RELA;THRA;THAP7;TAF11;PSMC5;PSMC1;TAF1B;TBP
prerank,anion:anion antiporter activity (GO:0015301),-0.47222628647366827,-1.2658366651834527,0.18609022556390978,0.5535854224534411,1.0,6/17,21.40%,SLC26A7;SLC26A2;SLC4A2;SLC26A6;SLC26A11;SLC25A4
prerank,inward rectifier potassium channel activity (GO:0005242),-0.4371735314183257,-1.2642227717771228,0.1782178217821782,0.5526390094196899,1.0,10/24,30.45%,KCNJ2;ABCC9;KCNN2;KCNJ8;KCNJ15;KCNH2;KCNJ6;KCNJ16;KCNJ10;ABCC8
prerank,metalloexopeptidase activity (GO:0008235),0.4049948373719005,1.2641969293708528,0.1621160409556314,0.6802041073778552,1.0,6/51,8.19%,CPQ;AEBP1;ACE;NPEPPS;AGBL2;CPXM1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5433926217385595,-1.2636321827566193,0.1875,0.5484841874964016,1.0,6/11,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;ATP11C;ATP11A
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5392840634531411,-1.2603339983984327,0.1937269372693727,0.5509539250924623,1.0,4/10,9.15%,SLCO1C1;SLCO2A1;SLCO2B1;SLCO3A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.476042165035269,-1.2582985132006945,0.16443594646271512,0.545116424441319,1.0,10/16,25.10%,ATP6V0A1;ATP6V1A;ATP6V0C;TCIRG1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.476042165035269,-1.2582985132006945,0.16443594646271512,0.545116424441319,1.0,10/16,25.10%,ATP6V0A1;ATP6V1A;ATP6V0C;TCIRG1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,insulin-like growth factor binding (GO:0005520),0.5281797428199138,1.2570708088381966,0.20040485829959515,0.6935049184745992,1.0,4/15,5.73%,IGFBP2;IGFBP4;IGF1R;LRP2
prerank,GTPase binding (GO:0051020),-0.29141713687474413,-1.2566655814072718,0.0425531914893617,0.5437475868230673,1.0,53/194,18.47%,SPTBN1;UNC13B;FGD5;CAV1;FGD6;FNBP1L;TBC1D30;HSP90AA1;IQGAP1;RASIP1;EXOC4;SH3BP4;ARHGDIB;RABGAP1L;NCKAP1;RIN3;FLNA;YBX3;EHD1;SOD1;PEX5L;SGSM1;YBX1;PAK1;CYRIB;EPS8;EXOC5;PAK2;RANBP1;LAMTOR1;KCTD13;STOML2;EVI5;MYO5A;RANGAP1;WHAMM;ARHGEF2;MLPH;PPP6R1;CDC42EP5;IARS1;RCC2;DMXL2;BICDL1;RAF1;TRIP11;BICD1;RABGAP1;RTKN;KIF3B;CDC42EP2;RABGGTB;RRAGB
prerank,hormone activity (GO:0005179),0.3973694697025959,1.2550063137141507,0.15309446254071662,0.6919371546961327,1.0,1/54,0.03%,IGF1
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.3276529761541801,-1.251801473988156,0.10632911392405063,0.5507102359743711,1.0,36/83,29.66%,USP53;ATXN3;USP38;OTUD7A;PAN2;UCHL5;USP29;USP31;UCHL1;ZRANB1;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,omega peptidase activity (GO:0008242),-0.32594988779608686,-1.2503219794255662,0.0947075208913649,0.5491920612595719,1.0,38/89,29.66%,USP53;ATXN3;USP38;OTUD7A;PAN2;UCHL5;USP29;USP31;UCHL1;ZRANB1;APEH;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;GGT1;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,ribosome binding (GO:0043022),-0.37244245216742533,-1.247691141413905,0.15550239234449761,0.5508902432671772,1.0,24/46,29.99%,EEF2;RPSA;RACK1;NOMO1;BAG6;CCDC47;PYM1;CPEB1;YTHDF3;TMEM147;SHFL;EIF3C;SERBP1;EIF2A;ZC3H12A;FMR1;EIF6;GTPBP6;NAA16;MRPS27;ETF1;CPEB3;SEC61B;MTIF3
prerank,DNA binding (GO:0003677),0.29294766328202465,1.2429269336218676,0.03058823529411765,0.720358775667269,1.0,140/694,15.91%,RORA;TCF4;TCF7L2;RBPJ;DENND4A;APLP2;EPAS1;HLF;PPARA;NR2F2;POLR2D;ZEB2;RBMS1;MEIS1;ARID5B;BCL2;CUX1;SATB1;PRDM5;ZIC2;SCX;SOX6;TSHZ3;NFYB;RAD51B;SSBP2;MYRFL;HOXA7;FOXD1;NFIB;ZDHHC1;TEAD1;SPHK1;ARID4A;RAD51AP2;COLEC11;RNF138;DDB2;RAD51C;KDM2B;CAMTA1;SOX1;TDP2;DMC1;DDX60;GTF3C5;PDS5B;MTERF2;TET1;HIVEP2;ZBTB32;TCF7L1;PARP4;CXXC5;THAP1;XRCC5;SMAD3;BLM;XRCC4;RBM5;PBX4;CHD4;NR6A1;WDR48;MTF2;POLR2A;AUNIP;LYAR;CCNT1;ARNT;SSBP1;MAU2;KDM5B;NUPR1;BRCA2;CEBPG;FUBP1;RC3H2;CLSPN;TIGD4;NFYC;IRF3;MBD4;IRX1;NHEJ1;ABL1;ZMYM4;PRKDC;DCLRE1A;RFC1;SMARCA5;TSHZ1;TFAP2A;ZNF8;DCLRE1B;TFAP2B;ARID3A;GTF3C3;ZIC4;RXRA;PCBP2;NPAS2;BCLAF3;CUL4B;CRY1;SOX13;TRIM26;HSF1;MPG;EZH1;INO80;SMARCB1;CGGBP1;SPO11;FOXK2;ZBP1;MRE11;CLOCK;ZNF148;POLR3C;APEX1;BATF;CREBBP;RAD23B;GLI2;BANF2;CENPX;MLH1;SOX12;SMARCA2;WRN;BARX2;MEIS2;PATZ1;STN1;SMAD4;MCM2;PSIP1;POU3F1;RAD18
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5356771495233944,-1.2424311394148828,0.23134328358208955,0.5594998611736967,1.0,2/11,5.27%,LEF1;GATA2
prerank,GDP binding (GO:0019003),-0.3487262556217681,-1.2417872202078273,0.125,0.5558149710892327,1.0,24/63,25.20%,RAP1A;KRAS;RASL12;RAB31;RAB27A;RERG;NRAS;GNAI1;MRAS;RAB28;RALB;RAB3B;MIEF1;RHEB;RRAS;RIT2;RAB8A;RAB8B;RAB7A;GEM;RAB2A;RAB14;HRAS;RAB5B
prerank,peptidoglycan binding (GO:0042834),-0.5465201707737635,-1.240735287899532,0.2174757281553398,0.5534520721243648,1.0,3/10,6.99%,NOD1;PGLYRP1;HK1
prerank,receptor ligand activity (GO:0048018),0.31403117355046695,1.2383391986963748,0.08882907133243607,0.7265891884310657,1.0,30/245,11.42%,IGF1;EPHA7;BMP6;IL34;WNT4;WNT6;IL18;BMP7;SEMA3B;DKK1;CXCL13;IGF2;ARTN;TAFA4;NDP;FGF1;TAFA5;PTN;IL6;NBL1;WNT5B;CSF1;VEGFB;GDF1;IL17D;CCL4;FGF9;TNFSF13;APLN;TGFA
prerank,syntaxin-1 binding (GO:0017075),0.4716492273149903,1.2360308581742832,0.23552894211576847,0.7262450675737294,1.0,3/22,5.48%,UNC13C;DAPK1;LRRK2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.37872977121135315,1.2307090333279553,0.18166939443535188,0.734711898665948,1.0,10/72,4.92%,FRMPD4;TULP3;ADAP2;SNX21;PARD3;GSDMA;PLCB1;AVIL;TULP1;SNX18
prerank,endopeptidase regulator activity (GO:0061135),0.41263428042974404,1.230280896085473,0.1992818671454219,0.7287718422832716,1.0,5/40,3.76%,TFPI;ITIH2;SERPIND1;PROS1;A2ML1
prerank,microtubule minus-end binding (GO:0051011),0.5339692068218546,1.2225417056534678,0.23640167364016737,0.7441073424383902,1.0,4/13,9.85%,MACF1;HAUS4;TUBGCP6;TUBGCP2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3737348715764128,1.2210633416659573,0.16747967479674797,0.7414003555902103,1.0,11/71,7.48%,EYA4;EYA1;PTPN13;EYA2;PTPN4;CDC14B;PTPRA;MTMR3;PTPN9;PTPRD;PTEN
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5285935731226384,1.2193185811773293,0.25206611570247933,0.7392656494563246,1.0,5/12,14.83%,CDK8;CDK7;CDK1;MAPK1;CDK4
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5284460838998525,-1.2181829457246827,0.24748490945674045,0.6081542222104279,1.0,4/10,17.59%,FAP;NAALAD2;DPP4;PRCP
prerank,cell adhesion mediator activity (GO:0098631),-0.4114919638070146,-1.2166589844064322,0.19206680584551147,0.6064509495496522,1.0,14/24,27.65%,BSG;ESAM;ROBO4;BCAM;CNTN6;CD47;NTNG1;NPTN;DSCAML1;PLXNB3;JAM3;VSTM2L;CNTN2;EMB
prerank,mRNA 3'-UTR binding (GO:0003730),0.36231807307617286,1.2162669179797387,0.16169544740973313,0.7411532266861738,1.0,10/79,5.90%,CELF2;IGF2BP1;CSDC2;RBMS1;RBMS3;CPEB2;HNRNPC;CPEB4;PABPC4L;RBMS2
prerank,N-acyltransferase activity (GO:0016410),0.4217346664421491,1.2132978406578736,0.23782771535580524,0.742838146717754,1.0,10/32,16.54%,NMT2;NAA80;CERS6;CERS5;CERS1;SMARCE1;SAT2;ESCO1;NAT8;NAT14
prerank,carbohydrate kinase activity (GO:0019200),0.5398805182685313,1.210630975430052,0.23890063424947147,0.743636585743665,1.0,3/11,9.67%,HK2;GALK2;GALK1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5535461422732115,1.2081551036819107,0.2709677419354839,0.7443018311398584,1.0,3/10,9.85%,B3GALT1;B4GALT1;B3GALT6
prerank,gap junction channel activity (GO:0005243),0.46628643549337273,1.2056253662823004,0.22007722007722008,0.7451263399551731,1.0,3/22,5.06%,GJB6;GJA3;GJA1
prerank,protein phosphatase binding (GO:0019903),-0.2995298190846739,-1.2055416779813675,0.12138728323699421,0.6309783936147431,1.0,36/117,22.74%,MAP3K5;IQGAP1;PTK2;DAB2IP;RACK1;PPP1R16B;PXN;PPME1;CTNNB1;HSP90B1;SOD1;AKAP11;MET;GRIN3A;CEACAM1;KCNQ1;FLT4;FOXO1;CDKN1B;MAP2K7;STAT3;MTMR9;MASTL;PPP6R1;JUP;VRK3;PPP1R16A;FBXL2;BOD1;SMG5;JAK3;JAK1;ATP2B4;VCP;ANAPC7;STRN4
prerank,E-box binding (GO:0070888),0.4128743724976998,1.2052925077067047,0.2356902356902357,0.7392288468841495,1.0,9/34,13.73%,TCF4;ZEB1;SCX;ASCL2;MITF;ATOH8;NEUROD2;SNAI1;CLOCK
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.35615119438991977,-1.2046288703653885,0.18475750577367206,0.627965894900436,1.0,19/49,22.67%,OTUD7A;MINDY2;UBXN1;MINDY1;BAG6;ZRANB1;UBQLN4;AGAP3;TAB3;ZFAND2B;FAAP20;SPRTN;SHARPIN;RNF168;OTUD7B;VCP;HDAC6;TNFAIP3;UBL7
prerank,cytokine activity (GO:0005125),0.3304119746778238,1.2034675402700774,0.1640625,0.7378598110305427,1.0,15/131,10.07%,BMP6;IL34;WNT4;WNT6;IL18;BMP7;CXCL13;NDP;IL6;WNT5B;CCL19;CSF1;GDF1;IL17D;CCL4
prerank,transcription corepressor binding (GO:0001222),0.438844549081194,1.2028298740101477,0.2349624060150376,0.7331337709588619,1.0,4/27,8.09%,RORA;USP11;MTF2;PER3
prerank,wide pore channel activity (GO:0022829),0.46071868521516424,1.2027860674225614,0.22330097087378642,0.7267416193938989,1.0,3/23,5.06%,GJB6;GJA3;GJA1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.4002578875178743,-1.2024280409423873,0.20614035087719298,0.6283149923993806,1.0,11/30,21.22%,SLC39A10;SLC40A1;SLC30A5;SLC31A1;SLC39A8;SLC30A1;SLC39A7;SLC39A14;TMEM165;SLC39A6;SLC11A1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.40946487207154086,-1.2019829567051163,0.22435897435897437,0.6237468410745486,1.0,8/23,19.26%,HIP1;CLVS2;CLVS1;HIP1R;SNX14;ATP13A2;GBF1;JPH2
prerank,heme binding (GO:0020037),0.3692972835331587,1.1978680772297385,0.20327868852459016,0.7350789721912921,1.0,6/65,7.03%,CYP26B1;CYP27A1;CBS;PXDN;FLVCR2;PGRMC1
prerank,gated channel activity (GO:0022836),-0.48047781773720244,-1.193931712888564,0.24765478424015008,0.6402479740137967,1.0,4/14,10.76%,PIEZO2;PIEZO1;TMC6;TMEM266
prerank,cytokine receptor binding (GO:0005126),0.349712626418308,1.192317341700984,0.19831932773109243,0.7444346537147812,1.0,10/83,8.79%,TGFBR3;IL34;IL18;PXDN;IL13RA1;IL6;SMAD3;CCL19;CSF1;VEGFB
prerank,phospholipase inhibitor activity (GO:0004859),0.5400888620471043,1.1878218386581725,0.25343811394891946,0.7513987565575788,1.0,4/10,18.25%,ANXA1;APOC1;ANXA5;SNCA
prerank,lipid phosphatase activity (GO:0042577),0.4902962424436401,1.1873321773860477,0.2894736842105263,0.7464142529228097,1.0,6/14,18.66%,PLPP3;EPHX2;SGPP1;PLPP2;PLPPR3;PLPP7
prerank,Hsp90 protein binding (GO:0051879),-0.3745894734810336,-1.1869364803713562,0.2113289760348584,0.6545003851542068,1.0,5/33,7.41%,SLC12A2;KDR;RPS3;AHR;CHORDC1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.4217000338707724,-1.1848823109376778,0.2390852390852391,0.6545419103313841,1.0,12/21,26.39%,REV3L;POLQ;POLK;POLA1;POLN;POLE4;POLE;POLD3;POLB;POLD1;POLI;POLL
prerank,MAP-kinase scaffold activity (GO:0005078),0.5248171401350201,1.1841977292000696,0.2911392405063291,0.7489002806967858,1.0,3/11,6.65%,KSR1;AKAP13;SH3RF1
prerank,SH3 domain binding (GO:0017124),-0.32663821165193885,-1.1837000739459458,0.17444717444717445,0.6520044300400197,1.0,16/62,10.85%,AFAP1L1;SHANK3;ELMO1;SGIP1;CBL;ADAM15;ARHGAP27;DAB2IP;PTPN12;WIPF1;SYNJ1;DNM2;ABI3;MICAL1;CD2AP;CRK
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.464113073530535,-1.1819237807124048,0.26587301587301587,0.6511356839161291,1.0,6/14,13.61%,MAL;RACK1;NOD1;ATP2A3;CASP8AP2;RPS27L
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.42676294251990216,1.1816037800466457,0.24169741697416974,0.7499888460976629,1.0,9/29,11.64%,SLC13A3;SLC25A18;SLC13A5;ABCC2;SLC1A5;SLC25A11;SLC25A22;SLC19A1;SLC38A7
prerank,anion transmembrane transporter activity (GO:0008509),-0.48645723772668303,-1.1813851629732985,0.2389558232931727,0.6470421794003604,1.0,4/12,11.06%,ABCG2;SLCO2B1;SLC39A8;SLC4A2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.47076551614928974,1.1791834964583214,0.25806451612903225,0.7510510712841936,1.0,2/17,6.82%,DPYD;PTGR1
prerank,pyrophosphatase activity (GO:0016462),-0.34561681844250963,-1.1776956268703391,0.19419642857142858,0.652024177506549,1.0,13/50,17.32%,ENTPD1;PLPP1;NUDT3;ENTPD7;PRUNE1;ALPL;ENTPD2;BNIP2;NUDT4;NUDT1;PRUNE2;DHX29;DCPS
prerank,chloride channel regulator activity (GO:0017081),-0.4619798047661773,-1.1773992231942807,0.25961538461538464,0.6474012089599084,1.0,8/14,17.14%,STX7;STX1A;VTI1B;VAMP8;WNK3;CFTR;WNK2;SGK1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.37368791375283217,-1.1770183628462576,0.20175438596491227,0.643126999010262,1.0,8/34,10.42%,CYTH3;ARAP2;MYO10;IQGAP1;ARAP3;FERMT2;HIP1R;OGT
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.43049343307186194,1.17374075955592,0.2671232876712329,0.7601035034595814,1.0,4/26,3.73%,SLC6A13;SLC16A12;SLC6A12;SLC6A1
prerank,amino acid binding (GO:0016597),-0.38248161074833903,-1.1732625591749009,0.22440087145969498,0.6479588882043811,1.0,16/31,32.69%,NOS3;GRM7;GRIN3A;DDAH1;GRIN1;NOS1;GLRA3;DDAH2;AARS2;CASTOR1;GLRA1;GLDC;GNMT;GRIN2B;AGXT;NOS2
prerank,myosin V binding (GO:0031489),-0.4424526123810817,-1.1728363491011347,0.24660194174757283,0.6437501761289546,1.0,6/15,25.58%,RAB3C;RAB3B;RAB8A;RAB3A;RAB14;RAB6B
prerank,syntaxin binding (GO:0019905),0.3680670648062062,1.1725409984685864,0.2326388888888889,0.7574128359705841,1.0,11/61,11.30%,UNC13C;STXBP4;DAPK1;ABCA1;SYT12;LRRK2;STX16;SNAP47;GOLGA2;ABL1;STX8
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.34821784745044704,1.1710987985844095,0.2090032154340836,0.7559015669660806,1.0,12/91,5.75%,FRMPD4;TULP3;ADAP2;SNX21;PARD3;GSDMA;PLCB1;AVIL;TULP1;SH3PXD2B;SNX18;WIPI1
prerank,clathrin adaptor activity (GO:0035615),-0.45034968151715327,-1.17077219903721,0.26601941747572816,0.6440251716159919,1.0,5/15,9.34%,HIP1;STON2;AP2A2;HIP1R;AP2M1
prerank,DNA polymerase activity (GO:0034061),-0.40983571463294,-1.168850805098364,0.26931106471816285,0.6442628636530909,1.0,12/22,26.39%,REV3L;POLQ;POLK;POLA1;POLN;POLE4;POLE;POLD3;POLB;POLD1;POLI;POLL
prerank,actin binding (GO:0003779),-0.27560297508770115,-1.168683142060158,0.10801393728222997,0.6395326269729645,1.0,33/170,9.36%,UTRN;MYRIP;TMSB4X;SYNE1;NOS3;ACTN4;KLHL2;FXYD5;PARVB;MICAL2;ABLIM1;MAP1B;GSN;PTK2;ITGB1;CORO2B;KCNMA1;TMSB10;EPS8L2;FERMT2;CCDC88A;SMTN;CAP2;PDLIM7;CEACAM1;MYH9;ADD2;HNRNPU;MICAL1;EPS8;SSH2;LDB3;SSH1
prerank,histone acetyltransferase binding (GO:0035035),0.4592205515567646,1.1677128528555596,0.2980769230769231,0.7589285636663174,1.0,4/21,10.66%,EPAS1;KANSL1L;GLI3;KANSL1
prerank,voltage-gated calcium channel activity (GO:0005245),0.4032545337910507,1.167524995773749,0.2597864768683274,0.7533843956340116,1.0,6/37,7.35%,CACNA2D3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.37460781598770887,1.1652782887050792,0.24253075571177504,0.7538850495055858,1.0,14/51,12.24%,SLC22A4;SLC5A5;SLC20A2;SLCO1B1;SLC28A3;MCU;SLC25A11;SLC20A1;SLC35E2B;SLC35E2A;SLC22A6;SLC35A1;CLCN4;SLC46A2
prerank,kinase binding (GO:0019900),-0.24861739028660743,-1.165147288122303,0.03684210526315789,0.644144695227677,1.0,91/434,12.99%,UTRN;FRMD5;SLC12A7;SLC12A2;CAV1;PTPRJ;ACTB;EEF1A1;TIAM1;ESR1;DLG2;MSN;TFRC;NSF;BCAR3;ADAM10;RAC1;ACVRL1;IQGAP1;CALM1;GSN;HSP90AB1;FBXO7;PTK2;UNC5C;TTC28;PLCG2;NBEA;EEF2;CSPG4;PDE8A;CAV2;DAB2IP;RPS7;RPS3;PIK3IP1;RPS19;PKD1;LIMS1;TRIM14;FLNA;RPS6;HSPB1;BCAR1;CIT;AP2A2;STX1A;WARS1;IKBKB;RHOB;MTCP1;FERMT2;CTNNB1;PTPRC;FAF1;BCL2L1;GSK3B;SPRED2;CEACAM1;ACTA2;CDC37;ADD2;CHP1;LRRC14;PDCD10;EMP2;CHEK2;SRCIN1;RHOA;PAK2;MAP3K1;APC;CDKN1B;MAP2K7;SLC12A4;STAT3;ATF4;PTPN1;CRK;PIH1D1;DUSP3;TOLLIP;CEP68;USP37;PTPN23;DNM1;MSH2;IBTK;PFKM;IRAK3;MAP3K12
prerank,tropomyosin binding (GO:0005523),0.48953625319120453,1.1637194353071663,0.2933070866141732,0.751976673984341,1.0,3/16,3.73%,TNNT2;CALD1;NEBL
prerank,glutamate receptor activity (GO:0008066),-0.4210128568692907,-1.1631900436595128,0.25697211155378485,0.6447208163677149,1.0,7/19,21.18%,GRM3;GRM7;GRIK4;GRM8;GRIA2;GRIK2;GRID2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.42163168580146504,-1.1615248584794187,0.2570281124497992,0.6444123105172683,1.0,6/20,13.34%,SLC39A10;SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14
prerank,chemorepellent activity (GO:0045499),-0.38848122492666837,-1.158477322869448,0.26373626373626374,0.6480341526231691,1.0,11/25,11.38%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;DPP4;SEMA3G
prerank,transcription cis-regulatory region binding (GO:0000976),0.28132840877554327,1.157909107923526,0.15170670037926676,0.7624557842608813,1.0,62/406,13.67%,RORA;SOX5;TCF7L2;OSR1;AEBP1;EPAS1;NPAS3;ARID5B;MXI1;CUX1;SMAD6;SATB1;PRDM5;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;HIF3A;NFYB;BBX;VSX2;ZFP90;ASH2L;TEAD1;ARID4A;GLI3;ZFP37;BCOR;RFXAP;XRCC5;SMAD3;GABPB1;GABPB2;RBL2;TCF12;PER3;ARNT;NFYC;CREB3L2;AGO2;HDAC1;TFAP2A;HOXC8;TFAP2B;ZNF568;RXRA;ZNF177;E2F6;SOX13;HSF1;PSPC1;AR;HOXD4;NONO;NR1I3;FOXK2;SNAI1;TFDP2;MLXIP
prerank,metal ion binding (GO:0046872),-0.24645134627394547,-1.156896829298785,0.08024691358024691,0.6473522064745695,1.0,97/477,15.71%,CSGALNACT1;SLIT2;SPOCK2;LTBP4;ADGRL3;MAP3K5;ITPR2;ACER3;RASGRP3;ESYT2;STK38;TPD52;PITPNM2;THBS1;TPT1;CDH11;IQGAP1;CDH1;CALM1;GSN;SPARCL1;S100A6;AGRN;CDH2;CDC42BPA;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MCTP1;ASPN;TGM2;STK38L;CALR;NUDT3;CAMKK2;HPRT1;HSP90B1;CEMIP2;GNAI1;ADPRH;CLEC3B;MT2A;PDE2A;ATP2A2;CHP1;RPH3A;NOTCH4;RYR2;MARK1;NRXN1;NUCB1;SNN;CCDC47;DYSF;C2CD5;BNIP2;CERK;IDS;S100A1;HSPA5;PIR;STIM2;GRIN1;MAP2K7;SYT10;S100A16;RHEB;PCLO;CALU;MSH2;S100A10;MARK2;CDH13;SYT4;TKT;CANX;SDF4;IRAK3;PITPNM3;PPP3CA;SRPK1;RET;MT3;SPOCK1;ITPR3;SPARC;KCNIP2;PLA2G4A;AASDHPPT;TPM4;CALM2;TPPP
prerank,hexose transmembrane transporter activity (GO:0015149),-0.46892835761719037,-1.1563326192607033,0.28785046728971964,0.6439583952168099,1.0,1/12,0.80%,SLC2A1
prerank,hormone receptor binding (GO:0051427),-0.4583552946837072,-1.1561700858368562,0.2727272727272727,0.639589377128055,1.0,5/14,25.79%,SOCS2;PTHLH;JAK1;ADCYAP1;NPPC
prerank,RNA methyltransferase activity (GO:0008173),0.45857062097052703,1.1533008336242734,0.2736220472440945,0.7698975983721035,1.0,6/19,9.45%,TRMT9B;METTL4;FTSJ3;METTL8;LCMT2;TRDMT1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.35069266387614034,-1.152181688452493,0.23515439429928742,0.645023153288754,1.0,15/42,20.76%,STXBP6;BSG;ESAM;CD200;ROBO4;BAIAP2L1;PPP1CA;CNTN6;CD47;NTNG1;S100A11;NPTN;DSCAML1;PLXNB3;JAM3
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.4421597114217316,-1.151896859166472,0.2859960552268245,0.6409775314706355,1.0,6/15,18.64%,PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PI4KB;PIK3R3
prerank,GTPase inhibitor activity (GO:0005095),-0.4591271277502102,-1.1515845466351922,0.2826923076923077,0.6370522245952782,1.0,2/13,2.13%,SLIT2;IQGAP1
prerank,serotonin receptor activity (GO:0099589),-0.40528716568559114,-1.1515141092345862,0.28964059196617337,0.6233509311916944,1.0,13/22,40.54%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.40528716568559114,-1.1515141092345862,0.28964059196617337,0.6233509311916944,1.0,13/22,40.54%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.40528716568559114,-1.1515141092345862,0.28964059196617337,0.6233509311916944,1.0,13/22,40.54%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,O-acyltransferase activity (GO:0008374),-0.3739847795574728,-1.1483747580710755,0.25523012552301255,0.6267171241909426,1.0,15/30,31.35%,MBOAT1;LPCAT3;GPAT4;GPAT3;DGAT1;LPCAT1;PLA2G4A;LCAT;GPAM;PRDX6;PIGW;PLAAT1;PLA2G15;MBOAT2;LPCAT4
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4826123245602527,-1.147798379659169,0.304029304029304,0.6236233786529145,1.0,3/12,8.36%,PIEZO2;PIEZO1;TMC6
prerank,kinase activator activity (GO:0019209),0.4135836315599401,1.1471198141930004,0.27011494252873564,0.7816666839426575,1.0,1/30,0.08%,PRKAG2
prerank,small GTPase binding (GO:0031267),-0.268062328574947,-1.1451500079204018,0.14838709677419354,0.6262461665663629,1.0,51/169,21.93%,UNC13B;FGD5;CAV1;FGD6;TBC1D30;IQGAP1;EXOC4;SH3BP4;ARHGDIB;RABGAP1L;NCKAP1;RIN3;FLNA;YBX3;EHD1;SOD1;PEX5L;SGSM1;PAK1;CYRIB;EPS8;EXOC5;PAK2;RANBP1;KCTD13;EVI5;MYO5A;RANGAP1;WHAMM;ARHGEF2;MLPH;PPP6R1;CDC42EP5;RCC2;DMXL2;BICDL1;RAF1;TRIP11;BICD1;RABGAP1;RTKN;KIF3B;CDC42EP2;RABGGTB;IFT20;PEX5;ARFIP2;RABGGTA;RAB8A;RAP1GAP;EXOC8
prerank,single-stranded DNA binding (GO:0003697),0.3360962701698715,1.143943184781526,0.23714759535655058,0.7848383635875495,1.0,23/93,17.60%,POLR2D;RBMS1;RAD51B;SSBP2;RAD51AP2;RNF138;TDP2;DMC1;BLM;WDR48;SSBP1;BRCA2;FUBP1;PCBP2;POLR3C;RAD23B;MLH1;STN1;MCM2;RAD51;REXO4;XPC;PURA
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.39704832196442374,1.1420711971683215,0.29273084479371314,0.7845190552608691,1.0,8/34,10.64%,LTF;ALS2;IGF2;FAM20A;RICTOR;CCNT2;CCNT1;MLST8
prerank,symporter activity (GO:0015293),0.5013078569381626,1.1399596666086516,0.316008316008316,0.784411642230492,1.0,3/10,12.24%,SLC5A5;SLC28A3;SLC46A2
prerank,histone deacetylase binding (GO:0042826),-0.2970249530724408,-1.1394691711328735,0.20116618075801748,0.6367895511842739,1.0,28/88,23.48%,LEF1;MEF2C;MEF2D;HSP90AA1;HSP90AB1;HES1;HDAC5;YWHAB;SFPQ;SP2;HEY2;MAPK8;MEF2B;TAL1;KCTD21;AKAP8;BRMS1;TOP2A;RAD9A;SMG5;SPI1;TFAP4;HDAC9;NACC1;HDAC6;SATB2;RELA;HSPA1B
prerank,phosphoric ester hydrolase activity (GO:0042578),0.36525323737890975,1.1379828022380791,0.27240773286467485,0.7842103992904363,1.0,8/49,8.83%,ATP1A2;PXYLP1;LHPP;DUSP10;EPHX2;ACP3;MPPED2;HDHD2
prerank,calcium ion binding (GO:0005509),-0.2503637120135517,-1.1377104865773737,0.11442786069651742,0.6369607576358631,1.0,76/323,18.96%,SLIT2;SPOCK2;LTBP4;ADGRL3;ITPR2;ACER3;RASGRP3;ESYT2;TPD52;PITPNM2;THBS1;TPT1;CDH11;IQGAP1;CDH1;CALM1;GSN;SPARCL1;S100A6;AGRN;CDH2;MCTP1;ASPN;TGM2;CALR;CAMKK2;HSP90B1;CEMIP2;CLEC3B;ATP2A2;CHP1;RPH3A;NOTCH4;RYR2;NRXN1;NUCB1;CCDC47;DYSF;C2CD5;BNIP2;IDS;S100A1;HSPA5;STIM2;GRIN1;SYT10;S100A16;PCLO;CALU;S100A10;CDH13;SYT4;TKT;CANX;SDF4;PITPNM3;PPP3CA;RET;SPOCK1;ITPR3;SPARC;KCNIP2;PLA2G4A;TPM4;CALM2;AOC3;DSG2;TUBB4A;SYT2;CETN2;SYT7;DSPP;S100A11;TRPM4;LETM1;PADI2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4612533168866603,-1.1348574821400654,0.3111111111111111,0.6398749804656978,1.0,6/13,25.74%,GABRG3;GLRA3;GABRA5;GABRE;GABRG2;GLRA1
prerank,protein kinase binding (GO:0019901),-0.23817095059980706,-1.1343726177138391,0.04145077720207254,0.6368955494123543,1.0,93/479,12.08%,UTRN;FRMD5;SLC12A7;SLC12A2;CAV1;PTPRJ;ACTB;EEF1A1;TJP2;ESR1;MSN;STK38;TFRC;NSF;ADAM10;RAC1;ACVRL1;HSP90AA1;IQGAP1;DUSP16;CALM1;FBXO7;PTK2;UNC5C;ITGB1;PLCG2;ROR2;NBEA;EEF2;CSPG4;CAV2;DAB2IP;RPS7;RPS3;RACK1;RPS19;BMPR2;PKD1;TRIB2;LIMS1;GCH1;TRIM14;RPS6;HSPB1;BCAR1;CIT;ADCY4;AP2A2;WARS1;IKBKB;RHOB;HDAC5;MTCP1;FERMT2;PTPRC;CCDC88A;FAF1;CAVIN2;BCL2L1;GSK3B;SPRED2;CEACAM1;ACTA2;CSK;ADD2;KCNQ1;PDCD10;EMP2;RYR2;CHEK2;SRCIN1;RHOA;APPL1;PAK2;MAP3K1;APC;YWHAG;CDKN1B;MAP2K7;SLC12A4;STAT3;ATF4;PTPN1;DUSP8;CRK;PIH1D1;DUSP3;CEP68;HINT1;USP37;PTPN23;DNM1;MSH2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.47415903998107234,1.134334524155643,0.3390191897654584,0.7885589942455594,1.0,1/13,0.83%,AGPAT4
prerank,ADP binding (GO:0043531),0.4326288877289143,1.1334383056563055,0.32053742802303264,0.7852778680532987,1.0,5/25,12.27%,PRKAG2;MYO18A;MYO9B;MYH10;PRKAG1
prerank,beta-tubulin binding (GO:0048487),0.4024535696273286,1.1301387566621075,0.315018315018315,0.789282338441806,1.0,2/31,1.94%,GJB6;EML4
prerank,solute:anion antiporter activity (GO:0140323),0.47628129192510965,1.129632632009782,0.31263383297644537,0.7849742895699434,1.0,1/14,0.11%,SLC7A11
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5175780591694796,1.1258994522458858,0.34080717488789236,0.7894824041050141,1.0,5/10,13.93%,MGME1;DCLRE1A;DCLRE1B;TATDN1;APEX1
prerank,protein heterodimerization activity (GO:0046982),0.29779973204067767,1.1215927730990924,0.2178932178932179,0.7965891196796736,1.0,25/178,11.42%,ATP1A2;BMP6;TCF4;ARNT2;EPAS1;NPAS3;BDKRB2;TPM1;BCL2;IRAK2;TOP2B;ZHX2;PAFAH1B3;ITGA3;ALG2;ARNT;PAFAH1B1;BCL2L2;PGLYRP3;MICU1;NEUROD2;UBA3;TFAP2B;FXR1;ERBB2
prerank,protein kinase activator activity (GO:0030295),0.3483139767199353,1.1213864747274076,0.2709447415329768,0.7915395355904893,1.0,6/60,5.14%,PRKAG2;LTF;ALS2;IGF2;FAM20A;RICTOR
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.267558049362183,1.121140450078875,0.17514792899408285,0.7866857661262007,1.0,93/597,14.07%,CREB5;SOX5;MAF;TCF4;TCF7L2;OSR1;ARNT2;ZIC1;HLF;HOXC4;HOXB4;ESRRG;ARID5B;CUX1;SMAD6;PRDM5;DMRT1;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;NFYB;ZIC5;BBX;PKNOX2;VSX2;NFAT5;HOXA7;ASH2L;NFIB;TEAD1;ELF4;ARID4A;TEF;GMEB1;IRF8;ZNF250;GLI3;ZBTB32;TCF7L1;BCOR;ZNF23;XRCC5;SMAD3;EN1;NR6A1;GABPB1;GABPB2;TCF12;PER3;ARNT;KDM5B;CEBPG;NFYC;HOXB6;CREB3L2;IRF3;MBD4;ZSCAN29;IRX1;ABL1;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;ZNF568;RXRA;NPAS2;ZBTB37;ZNF177;ORC2;SOX13;GMEB2;HSF1;PSPC1;AR;HIVEP1;KLF5;HOXD4;NFATC4;TSPYL2;HOXA6;NONO;NR1I3;FOXK2;SNAI1;HOXB9;CLOCK;SRF;DMRTA2;BATF
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.46161867424975306,1.1154307951992943,0.326,0.7970680444740544,1.0,4/15,15.34%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,manganese ion binding (GO:0030145),0.3595366568900392,1.115189985617235,0.30212014134275617,0.792229633622303,1.0,16/48,19.31%,LARGE1;PPM1M;B4GALT1;TDP2;MPPED2;HMGCL;NEK4;XYLT2;ABL1;PRIMPOL;WRN;POMGNT1;XPNPEP3;XXYLT1;PCK2;GALNT3
prerank,endopeptidase activity (GO:0004175),0.2842414419586292,1.1142793125853356,0.22267206477732793,0.7890725759610426,1.0,26/257,8.96%,ADAMTS12;ADAMTS9;TRABD2B;CORIN;ADAMTS5;THSD4;ADAMTS10;KLK2;ADAMTS15;CTSH;USP11;MMP2;PCSK9;ACE;TPP1;ADAMTS7;MMP19;PSMA2;NRDC;PSMA3;MMP9;USP24;ADAMTSL4;USP25;USP7;USP34
prerank,mRNA 5'-UTR binding (GO:0048027),-0.38050751430983454,-1.1099700756112314,0.3133047210300429,0.6965430814318162,1.0,7/24,10.92%,RPL41;RPS7;RPL26;RPS14;GNL3;RPL5;RSL1D1
prerank,proton transmembrane transporter activity (GO:0015078),-0.3470661912379177,-1.1089173718831329,0.3009478672985782,0.6943970199425292,1.0,16/39,28.36%,COX4I1;CLCN5;NDUFA4;UQCRH;COX6A1;UQCR11;COX8A;COX5A;UQCRQ;UQCRC1;NDUFA4L2;UQCR10;CLCN3;ATP6V1B2;COX15;COX4I2
prerank,CoA hydrolase activity (GO:0016289),0.46493257878862354,1.1085377729087926,0.3489795918367347,0.7998450343619458,1.0,8/16,23.13%,ACOT4;ACAA2;ACOT1;HIBCH;NUDT7;ACOT11;ACOT13;ACOT6
prerank,voltage-gated sodium channel activity (GO:0005248),0.4217847865167487,1.1071527469278644,0.3273453093812375,0.7980174848540683,1.0,1/22,0.09%,SCN7A
prerank,lipoprotein particle receptor binding (GO:0070325),-0.36960782982598966,-1.1051354305315746,0.3163064833005894,0.6998047414503111,1.0,8/27,12.65%,DNAJA1;HSP90B1;APBB1;AP2M1;RELN;APBB3;MESD;CLU
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4381156747967804,1.1047500869861773,0.344294003868472,0.7993784075141035,1.0,3/18,7.08%,TGFBR3;SMAD6;SMAD3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.44889998160789507,1.1036433474324645,0.33542976939203356,0.7971824018362547,1.0,1/15,0.83%,AGPAT4
prerank,transcription coactivator binding (GO:0001223),0.41811918670102177,1.102127230797279,0.33723196881091616,0.7962944796298792,1.0,4/20,8.04%,RORA;VGLL4;SMAD3;CCNT2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.44627950231723434,1.1000387295296072,0.34523809523809523,0.7971642136018154,1.0,5/15,11.64%,SLC1A3;SLC25A18;SLC1A5;SLC25A22;SLC38A7
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.48275291478470933,1.0999144648368449,0.35390946502057613,0.7923597862396187,1.0,1/11,0.79%,ITPR1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4732848634219747,1.0992708833656208,0.33109619686800895,0.788775449990444,1.0,6/12,21.85%,FRS2;PIK3R1;GAB2;BLNK;SHC1;IRS1
prerank,tau protein binding (GO:0048156),-0.33840627661050077,-1.0990073380298482,0.3006535947712418,0.711444804190252,1.0,16/40,23.28%,ACTB;HSP90AA1;HSP90AB1;FYN;LGMN;GSK3B;MARK1;BIN1;MARK2;CLU;CDK5;DCTN1;TTBK2;HDAC6;BRSK2;MAP1A
prerank,"DNA binding, bending (GO:0008301)",-0.4372082773122154,-1.0983816142711058,0.34705882352941175,0.7083796426524978,1.0,3/14,16.87%,LEF1;HHEX;TOP2A
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4545379543028446,-1.0961022027585157,0.3426294820717131,0.7101122381497937,1.0,7/11,15.64%,ITPR2;TRPC3;TRPC6;RPH3A;TRPC4;ITPR3;TRPC1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.44952522317252486,-1.0953405928954663,0.36432637571157495,0.7075251889686711,1.0,5/12,7.62%,PDE4D;PDE3A;PDE8A;PDE2A;PDE8B
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.35023135798767485,1.09439475601326,0.3,0.7970483902299021,1.0,4/48,4.48%,TRPM3;NALCN;SLC41A1;MMGT1
prerank,NADP binding (GO:0050661),0.38134823699908355,1.0940444258937838,0.33214285714285713,0.7929723409157101,1.0,3/32,2.52%,DPYD;GMDS;HSD17B1
prerank,G protein-coupled receptor binding (GO:0001664),0.30480479450735415,1.093182471257975,0.289193302891933,0.7902033902404472,1.0,17/132,7.93%,WNT4;RNF43;WNT6;PRKN;TULP3;GNAS;ADM;NDP;ACE;ZNRF3;TAFA5;ARHGEF11;GNAQ;WNT5B;GRK3;CCL19;RYK
prerank,Toll-like receptor binding (GO:0035325),-0.46913494402091305,-1.0927422574449521,0.34709193245778613,0.7099532913128788,1.0,7/11,32.64%,DAB2IP;TOLLIP;TIRAP;MYD88;CD36;TLR6;TLR1
prerank,double-stranded DNA binding (GO:0003690),0.2625382531165032,1.0900186013651474,0.24175824175824176,0.79388565930562,1.0,87/531,14.90%,CREB5;MAF;TCF4;OSR1;ARNT2;ZIC1;HLF;HOXC4;RBMS1;HOXB4;ESRRG;CUX1;SATB1;DMRT1;NR1I2;ASCL2;ZBTB20;ZIC5;BBX;RAD51B;PKNOX2;VSX2;NFAT5;HOXA7;NFIB;TEAD1;ELF4;RAD51AP2;TEF;GMEB1;CAMTA1;IRF8;ZNF250;DMC1;DDX60;GLI3;ZBTB32;TCF7L1;ZNF23;XRCC5;EN1;NR6A1;WDR48;TCF12;ARNT;MAU2;KDM5B;CEBPG;HOXB6;IRF3;ZSCAN29;IRX1;ABL1;PRKDC;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;RXRA;NPAS2;ZBTB37;CRY1;ZNF177;GMEB2;HSF1;HIVEP1;KLF5;CGGBP1;HOXD4;NFATC4;HOXA6;NR1I3;ZBP1;MRE11;SNAI1;HOXB9;CLOCK;SRF;APEX1;DMRTA2;BATF;GLI2;HOXD8;CENPX;KLF13;SOX12
prerank,WW domain binding (GO:0050699),-0.3666067407821514,-1.0898507457336073,0.3153526970954357,0.7133092224231464,1.0,13/26,37.60%,NDFIP2;TCEAL8;TCEAL9;WBP1;NDFIP1;TCEAL5;PRRG4;TCEAL1;SCNN1A;TCEAL3;TCEAL6;LITAF;NFE2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.47100882659109145,-1.088160497576682,0.375,0.7132890320564201,1.0,4/11,24.63%,MAP3K5;MAP3K1;MAP3K6;MAP3K15
prerank,transforming growth factor beta binding (GO:0050431),-0.37988620779471405,-1.0880125617875012,0.35714285714285715,0.709102023152656,1.0,8/23,12.03%,LTBP4;THBS1;ACVRL1;ENG;TGFBR2;CD109;LTBP1;NRROS
prerank,lipase activity (GO:0016298),0.35885578448017924,1.0864623037221173,0.32897196261682243,0.7986793379717838,1.0,6/43,7.58%,CEL;LIPA;PLA2G10;LIPH;LIPC;DAGLB
prerank,kinase activity (GO:0016301),-0.27452168284943057,-1.0863372083403107,0.29461756373937675,0.7090050495549165,1.0,37/109,25.12%,DGKH;PSTK;DGKB;PRKD3;NADK;GSK3B;PGM2L1;PIK3C2B;DGKI;NMRK1;MTOR;PAPSS2;CERK;PIK3CD;PIK3C2A;DGKZ;DGKG;PIK3C3;MASTL;CKB;RFK;ITPKB;PI4KB;PRKD1;ETNK1;IRAK1;CDK5;PINK1;SEPHS2;PANK2;AKT1;TRIB3;DGKE;DGKQ;IDNK;SEPHS1;SPHK2
prerank,snoRNA binding (GO:0030515),-0.34602082793990463,-1.085932296652853,0.33752620545073375,0.7056204193297607,1.0,13/30,28.82%,IMP3;BMS1;NUDT4;DHX37;WDR3;NUDT1;TBL3;NHP2;TSR1;RRP9;NUDT16;BYSL;NOP10
prerank,UDP-glycosyltransferase activity (GO:0008194),0.33005230510145567,1.085736804133034,0.3226837060702875,0.7957844430940922,1.0,8/70,7.54%,B3GALT1;LARGE1;GXYLT2;B3GNT5;B4GALT1;CHSY1;HAS1;EXTL1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5019072471368078,1.0857169626141991,0.38065843621399176,0.7908722712572429,1.0,3/10,13.65%,DUOX2;NCF2;DUOX1
prerank,protein phosphatase regulator activity (GO:0019888),0.34042753663855113,1.0830104989041922,0.3288364249578415,0.7932430294756947,1.0,6/53,5.91%,RCAN2;PPP2R2B;PPP4R4;DMPK;PTPA;PTN
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4624914697420545,-1.0824419039815851,0.36968576709796674,0.7100643673687221,1.0,2/10,1.63%,SHANK3;NSF
prerank,cytochrome-c oxidase activity (GO:0004129),-0.41754738220102044,-1.0818305405606718,0.38755020080321284,0.7070847788716987,1.0,8/15,28.36%,COX4I1;NDUFA4;COX6A1;COX8A;COX5A;NDUFA4L2;COX15;COX4I2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.296347209706979,1.08172754454081,0.31603053435114503,0.7921233702821988,1.0,28/134,12.76%,SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A9;SLC1A3;PDPN;SLC6A1;SLC25A18;GJA1;SLC38A9;SLCO1B1;SLC2A10;SLC13A5;ABCC2;SLC1A5;SLC25A22;SLC27A1;SLC22A6;SLC19A2;SLC19A1;SLC36A2;SLC35A1;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.4456965188124795,-1.0816055817565609,0.38519924098671726,0.7032561958924095,1.0,5/13,7.87%,PTPRJ;ITGA5;IL1R1;PDGFC;VEGFA
prerank,transaminase activity (GO:0008483),0.4854914829432465,1.081310746741184,0.37731958762886597,0.7883319017578204,1.0,1/11,1.55%,ABAT
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4409110186077972,-1.0799479202960733,0.38330170777988615,0.7032360380383509,1.0,6/12,16.40%,SLC6A6;SLC38A5;SLC3A2;SLC36A1;SLC1A4;SLC36A4
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.41917959514424985,-1.0774104638645572,0.3774703557312253,0.7054227223003594,1.0,12/15,50.87%,GPR34;P2RY12;PTAFR;P2RY1;P2RX5;P2RX7;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,bHLH transcription factor binding (GO:0043425),0.423388809150937,1.0772142333406336,0.3698630136986301,0.794303657057592,1.0,4/19,7.97%,FHL2;SCX;SMAD3;TCF12
prerank,thyroid hormone receptor binding (GO:0046966),0.3967143725358799,1.0762559850330042,0.37545787545787546,0.7921248055273119,1.0,15/28,25.18%,BRD8;NCOA3;NSD1;MED1;MED13;TACC1;ZNHIT3;TRIP6;NCOR1;HMGN3;TRIP12;THRAP3;GTF2H1;MED24;GTF2B
prerank,semaphorin receptor activity (GO:0017154),0.4828187042956331,1.0747627680323713,0.3894736842105263,0.7912640455366812,1.0,2/11,4.57%,PLXNA2;PLXNC1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.35922212205793014,-1.0736210880031907,0.373134328358209,0.711173773341109,1.0,8/27,11.79%,SLC12A2;ITPR2;SLC9B2;MAGT1;ATP2A3;SLC4A8;KCNA1;ATP2B1
prerank,protein serine/threonine kinase activity (GO:0004674),0.2656558813812316,1.0721405290416868,0.29128738621586475,0.7934824865832275,1.0,60/334,14.87%,MAPK4;ROCK2;OXSR1;NRK;WNK4;CDK8;DAPK1;PDPK1;CAMK1D;BMP2K;MYLK;DMPK;MAP4K5;CDK7;FAM20A;IRAK2;SRPK2;ARAF;MAPK9;SIK1;PRKAA2;LRRK2;PRKCZ;PRKCB;STK17B;TTK;PRKCA;GRK3;PRKAA1;NEK4;NRBP1;GRK5;PKN2;CDK1;CAMK2D;PIK3R4;MAP3K2;NEK10;VRK2;SBK3;LATS1;STKLD1;PRKDC;RPS6KB1;IKBKE;BMPR1A;MAPKAPK2;HIPK3;PRKD2;STK24;TBK1;MAPK1;MAP3K7;NIM1K;CDKL5;NLK;CDK15;PRKCI;CDK4;SIK3
prerank,phosphotyrosine residue binding (GO:0001784),-0.335523580875637,-1.0718128005542988,0.33710407239819007,0.7114518082844384,1.0,10/37,20.43%,BCAR3;SHE;PLCG2;NCK2;CRK;SAMSN1;SHB;YES1;PIK3R3;SHC3
prerank,iron ion binding (GO:0005506),0.34430517187276155,1.0708602131622418,0.3589315525876461,0.7923135599745894,1.0,7/48,8.56%,HEPH;AGMO;KDM7A;LTF;TET1;PHF8;PHYH
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.32373778493532523,1.0696315358525923,0.35038759689922483,0.7910362325369633,1.0,7/73,10.63%,NPR3;LGR4;BDKRB2;KISS1R;PTH2R;GLP1R;NPR1
prerank,cholesterol binding (GO:0015485),0.35101453077712796,1.0677926875670638,0.32857142857142857,0.7910990274023638,1.0,4/47,4.04%,SIDT1;OSBPL8;GRAMD1C;ABCA1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3768756560433775,1.066596071632609,0.350187265917603,0.7897804633760208,1.0,1/29,0.08%,PRKAG2
prerank,protein kinase inhibitor activity (GO:0004860),-0.3295575827524432,-1.0665371774269876,0.36515513126491644,0.7205713618656531,1.0,19/42,31.44%,RACK1;CIT;NCK1;YWHAB;SPRED2;CDKN1B;SPRY4;IBTK;SMCR8;CAMK2N1;PRKRIP1;CDKN1A;INKA2;SOCS1;SPRY2;RPTOR;GMFB;MAPK8IP1;CEP43
prerank,transmitter-gated ion channel activity (GO:0022824),-0.3469840399379347,-1.0634561499819615,0.3676148796498906,0.7246945958060438,1.0,12/29,25.00%,GABRB3;GRIK4;GABRB1;GABRG3;GLRA3;GRIA2;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2
prerank,Notch binding (GO:0005112),0.40917134324748583,1.0617541935720365,0.40540540540540543,0.7979024014189776,1.0,2/22,3.29%,SNED1;MEGF10
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.4071988857884945,-1.0608672987932224,0.36419753086419754,0.726809769383609,1.0,8/16,22.59%,SYNJ1;MTM1;MTMR6;MTMR9;SACM1L;MTMR12;INPP5F;MTMR1
prerank,telomeric DNA binding (GO:0042162),0.3767922863007585,1.0607422124303605,0.36095764272559855,0.7959229120921492,1.0,16/32,24.25%,ACD;XRCC5;BLM;APEX1;WRN;STN1;TELO2;PURA;UPF2;HNRNPA2B1;RAD50;UPF3A;TERF2;SMG1;NCL;KDM1A
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.42751220495816405,1.0600470081567737,0.39271255060728744,0.7932199241977179,1.0,4/18,15.05%,HSD17B1;HSD17B10;DHRS11;HSD17B14
prerank,transition metal ion binding (GO:0046914),0.2600397064640221,1.059113876484559,0.3132832080200501,0.7912111190251603,1.0,89/397,16.94%,MOXD1;PAPPA;HEPH;AGMO;KDM7A;PRKN;UPB1;LARGE1;KMT2A;SOD3;ZEB1;PPM1M;LTF;LOXL3;LACC1;B4GALT1;BAZ1B;RNF2;IKZF4;KDM2B;TDP2;SORD;ACE;TET1;ZBTB32;NAPEPLD;ZFP37;PHF8;CXXC5;THAP1;RABIF;ENPP2;MPPED2;SMAD3;NPEPPS;HMGCL;BLM;MMP9;CHD4;NEK4;BBOX1;ZKSCAN5;KDM2A;SLC30A8;SLU7;DPYS;COX17;KDM5B;TRAF7;XYLT2;MDM2;NSD1;CCS;DCT;ABL1;ATP7B;ZNF8;RXRA;ENPP3;MYCBP2;PAM;KMT2B;ITGB1BP2;EEA1;CYLD;RCHY1;S100A9;SHMT1;PRIMPOL;ESCO1;TRIM24;NUDT12;KDM5C;MNAT1;GLI2;BIRC2;ACO2;WRN;SKI;POMGNT1;ZMYM2;NAALADL1;PHF2;SIRT3;SEC24A;XPNPEP3;CBLB;XXYLT1;TYW5
prerank,mRNA binding (GO:0003729),-0.23534542435881703,-1.0545107934490825,0.2932330827067669,0.7384680113664209,1.0,78/249,22.30%,RPL41;NOVA2;HNRNPK;TARDBP;ADARB1;RPS7;RPS3;RBFOX1;PKM;IREB2;RPL26;QKI;LUC7L2;RBFOX3;RPS14;HNRNPAB;G3BP1;RBFOX2;RBM47;PABPC1;CALR;YBX3;SRSF1;GNL3;SRRM3;RPL5;PUM2;EIF4G3;RPS2;HNRNPU;PPIE;SF3B1;RBM14;DDX5;SRSF5;ZC3H12C;CPEB1;EIF4G1;ZFP36L1;SSB;EIF3D;RPL7;RSL1D1;YTHDF3;CPSF6;RBM8A;KHDRBS3;RNPS1;SHFL;SRSF6;GRSF1;RPS26;HNRNPA0;RPS5;RPL13A;RIDA;SERBP1;EIF2A;N4BP1;ZC3H12A;CSTF2T;PCBP1;PCF11;CSTF2;YTHDC1;MRPL13;EDC3;PCBP4;HNRNPLL;PTBP1;RPL35;SNIP1;METTL3;FMR1;EIF3A;TRA2B;PUM3;RBM24
prerank,phosphatase binding (GO:0019902),-0.2645983671443415,-1.0515791869767521,0.3403693931398417,0.7417359330042378,1.0,30/105,22.65%,MAP3K5;IQGAP1;PTK2;RACK1;PXN;PPME1;NFATC2;CTNNB1;HSP90B1;MET;CEACAM1;FLT4;CHCHD3;CDKN1B;MAP2K7;STAT3;SPTBN4;MTMR9;PPP6R1;JUP;TERF2IP;VRK3;FBXL2;PPP3R1;JAK3;JAK1;CTSC;MAPK3;VCP;ANAPC7
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3745986521447128,1.0503523211250025,0.40471512770137524,0.809988928838309,1.0,6/27,13.81%,POLR2D;POLR2A;TENT2;POLR1F;POLR1A;POLR1D
prerank,methylated histone binding (GO:0035064),0.32517348500400584,1.0488860793413677,0.37293729372937295,0.8092363479117514,1.0,15/62,16.26%,KDM7A;PYGO1;L3MBTL2;DPF2;PHF8;MTF2;CBX8;CBX2;KAT8;MBTD1;RRP8;TRIM24;MORC3;PHF1;PHF2
prerank,chloride channel inhibitor activity (GO:0019869),-0.4527772984068007,-1.0485538713752907,0.40630797773654914,0.7454959428053909,1.0,7/10,16.55%,STX7;STX1A;VTI1B;VAMP8;WNK3;CFTR;WNK2
prerank,GABA receptor activity (GO:0016917),-0.37227471935441914,-1.0485231552787773,0.37575757575757573,0.7412268268661165,1.0,7/21,25.16%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2;GABBR1
prerank,phosphatase activity (GO:0016791),0.31675500552063085,1.0476927227165769,0.3860232945091514,0.8078843215957145,1.0,9/73,8.83%,ATP1A2;PXYLP1;PLPP3;LHPP;DUSP10;EPHX2;ACP3;NT5M;HDHD2
prerank,tubulin binding (GO:0015631),-0.2332549273853724,-1.047551343561498,0.2918454935622318,0.7394924965696409,1.0,90/295,24.41%,DNM3;MTUS1;SGIP1;TTLL7;STARD9;MAP1B;UNC5C;REEP3;REEP1;FYN;MAP4;MID1;RPS3;CLIP1;MAP6;BLOC1S2;CLIP2;CCDC88A;RP1;EML6;PRUNE1;EFHC2;KIF26A;MDM1;CHP1;GAPDH;STMN2;MAP1LC3B;DNM2;PAK1;NAV3;APPL1;APC;KIF1A;ARL8A;RMDN3;GIT1;DNM1;WHAMM;ARHGEF2;RAB11FIP5;STMN1;ALDOA;MTCL1;TOGARAM1;GAS2L3;KIF13A;HOOK1;RCC2;CCDC66;NDE1;CCDC88C;RMDN1;TPPP;KIF21B;STMN4;FHDC1;APC2;TPPP3;RABGAP1;CEP295NL;KIF3B;CCDC69;STMN3;GAS2L1;CDK5;CKAP5;MID2;IRAG2;HAUS6;POLB;KIF15;FMR1;B9D2;NUMA1;GABARAPL1;DCTN1;VAPA;TRIM36;HDAC6;MAST1;SPAG5;KIFC1;TRAPPC14;MAP1A;CLASP2;SPEF1;CEP295;TTLL6;SAXO2
prerank,epidermal growth factor receptor binding (GO:0005154),0.3913048130384557,1.0473450486422455,0.4064748201438849,0.8042667682456324,1.0,3/25,3.35%,EFEMP1;FER;FAM83B
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.2616514405764003,-1.0465790939212953,0.3651685393258427,0.7378015243042645,1.0,14/100,7.60%,CERT1;HIP1;CYTH3;ARAP2;MYO10;IQGAP1;ARAP3;DAB2IP;DENND1B;CLVS2;CLVS1;FERMT2;RPH3A;HIP1R
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.22364790672128743,-1.0435233093522147,0.27956989247311825,0.7416145201259124,1.0,139/431,25.17%,EEF1A1;MAP3K5;RAP1A;RHOJ;STK38;HSPA8;KRAS;ATP1A1;RPS6KA5;RAC1;ACVRL1;HSP90AA1;HSP90AB1;CDC42BPA;RASL12;PRAG1;RAB31;RAB27A;MINK1;CDK11B;GCH1;TGM2;STK38L;PRPS2;ATP5F1A;RERG;NRAS;RHOB;TUBB3;GBP4;ATP5F1D;GNAI1;RHOT1;ARF5;GNL3;SCG5;WNK3;ARF1;MRAS;MYH9;HNRNPU;DNM2;RAB28;HSPA14;MARK1;PEAK1;RHOA;RAB38;PXK;EIF4G1;BMS1;CDK6;HSPA5;ARHGEF5;RALB;ARL8A;TUBB4B;TUBA1B;GBP5;NDUFA13;RHEB;ATP1A3;ABCD3;GUK1;MSH2;PDK2;MARK2;OAS2;LMTK2;KCNJ8;PFKM;IRAK3;STK36;IDE;GBP3;TUBB2A;SRPK1;TUBA1A;ABCD2;PFKP;SYN2;RABL3;ATL2;CLP1;MTHFD1L;RHOG;RPS6KA4;EIF2B2;WNK2;PEX1;RRAS;TUBB4A;ACVR1;AK6;UBA2;ABCD4;RRAGB;ABCA2;RAB1B;LIG4;MTREX;PINK1;ABCG1;ACLY;TLK2;RAB39A;HSPA9;RIT2;AKT1;MAP3K6;ARFIP2;INSR;MKNK2;NUAK2;RAB8A;UHMK1;SMC4;TUBD1;PYGL;MAST1;BRSK2;KIFC1;TSR1;SIK2;HSPA1B;NEK11;RAB7A;AARS2;ARL4A;GEM;DDX25;SEPHS1;DRG2;TUBB2B;RAB2A;CDC42BPB;RAB14;NUDT16;HRAS
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2808386542176199,-1.043061601657408,0.3443396226415094,0.7386223344556677,1.0,20/74,16.22%,DGKH;PKM;DGKB;NADK;FAM20C;PGM2L1;PIK3C2B;DGKI;HK1;NMRK1;PAPSS2;PIK3CD;PIK3C2A;DGKZ;DGKG;PIK3C3;RFK;PI4KB;CLP1;ETNK1
prerank,DNA-binding transcription factor binding (GO:0140297),0.2757693428689462,1.0420481130603927,0.374079528718704,0.8130566410636483,1.0,35/189,14.12%,TCF7L2;RBPJ;FHL2;PPARA;PRRX1;RUNX1T1;BCL2;PRDM5;SCX;NFYB;FIZ1;SIK1;TLE3;CXXC5;TTC8;SMAD3;CHD4;RBL2;TCF12;TEAD3;WWP2;LYAR;PIAS1;TLE1;BBS7;HDAC1;GTF2I;AR;CRTC1;CRTC3;CGGBP1;IFI27;SRF;MTDH;CREBBP
prerank,U6 snRNA binding (GO:0017070),-0.40504883352990917,-1.0412413374818905,0.41404805914972276,0.739342393717945,1.0,6/14,26.46%,LARP7;DDX39B;PRPF4;EIF5A;RBM22;LSM8
prerank,cation channel activity (GO:0005261),0.30363835939720024,1.040949147661331,0.39067524115755625,0.8113580916035649,1.0,4/94,1.67%,TRPM3;SLC24A3;KCNQ4;NALCN
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.32340501310519476,-1.040293702477743,0.36425339366515835,0.7375070894153054,1.0,13/37,29.62%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;FARSA;AARS2;CARS1;KARS1;MARS2;GARS1
prerank,adenylate cyclase binding (GO:0008179),0.4692584109794546,1.0392225951681504,0.41163793103448276,0.8116347875275244,1.0,1/10,0.40%,ADCY5
prerank,solute:sodium symporter activity (GO:0015370),0.3754599964411115,1.038291276585236,0.3992673992673993,0.8098496881173866,1.0,7/27,13.39%,SLC20A2;SLC13A5;SLC34A3;SLC28A3;SLC4A9;SLC20A1;SLC5A7
prerank,protease binding (GO:0002020),0.30137917890446814,1.0382652323041237,0.3768996960486322,0.8055499083095562,1.0,15/99,8.91%,BDKRB2;TIMP3;STIM1;PRKN;BCL2;ECM1;A2ML1;CCBE1;COL1A2;ITGA3;NOL3;PTEN;ADAMTSL4;AMFR;BRCA2
prerank,hexosyltransferase activity (GO:0016758),0.29282826855612765,1.0360010349681423,0.39593114241001565,0.8069541877141931,1.0,12/101,8.14%,B3GALT1;TMTC4;LARGE1;TMTC1;B3GNT5;A4GALT;B4GALT1;ALG6;CHSY1;HAS1;EXTL1;ALG9
prerank,BMP binding (GO:0036122),-0.43803888305589966,-1.0351919552802389,0.44294003868471954,0.7468661391750282,1.0,2/11,3.91%,ENG;BMPR2
prerank,pre-mRNA binding (GO:0036002),0.3724977423173739,1.0341537149035003,0.39923224568138194,0.8075394876208609,1.0,1/28,0.17%,CELF2
prerank,ATPase regulator activity (GO:0060590),-0.3183353072917923,-1.0338918800195314,0.40625,0.746226458995329,1.0,10/38,16.82%,FNIP2;ATP1B1;DNAJA1;BAG1;SIL1;DNAJC1;DNAJC10;ATP5IF1;PLN;DNAJB1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3232382833737625,-1.033568762391584,0.4327354260089686,0.7429142847768858,1.0,10/35,20.56%,PTK2;FYN;PTK2B;BMX;CSK;PEAK1;STYK1;YES1;SLA;TXK
prerank,sodium channel activity (GO:0005272),0.35907284198085343,1.0333043835872262,0.39923954372623577,0.8054935877157395,1.0,2/37,2.90%,SCN7A;SHROOM2
prerank,actin monomer binding (GO:0003785),-0.3674470959969265,-1.0329182961935173,0.408675799086758,0.7405006620196494,1.0,3/22,3.94%,TMSB4X;NOS3;TMSB10
prerank,peptide hormone receptor binding (GO:0051428),-0.4377357460789539,-1.032613360291328,0.4269449715370019,0.7372281358853032,1.0,6/11,45.18%,PTHLH;GNRH1;ADCYAP1;PSMC5;VIP;UCN2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.3433654513248458,-1.031127694677217,0.3969298245614035,0.7367931809997487,1.0,11/28,32.31%,DAB2IP;EDA;TMBIM1;CASP8AP2;TRAF1;MADD;MYD88;STAT1;BID;FADD;PIDD1
prerank,sodium channel regulator activity (GO:0017080),0.34929533605578483,1.0289225225374017,0.4028268551236749,0.8125215389335038,1.0,8/37,12.39%,SNTA1;GPD1L;NEDD4;PCSK9;CAMK2D;SCN3B;PTPN3;SCN2B
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.38609448393828494,1.027581620035387,0.4280155642023346,0.8117304745791473,1.0,4/21,6.94%,PDE1A;PDE7B;PDE7A;PDE5A
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.36235007984760714,-1.027578867059905,0.4361904761904762,0.7419531599109658,1.0,7/22,12.65%,DNAJA1;HSP90B1;APBB1;AP2M1;APBB3;MESD;CLU
prerank,phosphatase activator activity (GO:0019211),-0.4013736847006684,-1.025690319818267,0.446360153256705,0.7428615022172483,1.0,7/14,24.07%,CALM1;PPP2R5C;BMP2;CALM2;PPP2R5A;CALM3;PPP1R15A
prerank,death receptor activity (GO:0005035),-0.43242680448688614,-1.0254304738197781,0.44808743169398907,0.7395210314445856,1.0,4/11,19.29%,TNFRSF11A;TNFRSF1B;FAS;TNFRSF10B
prerank,protein phosphatase activator activity (GO:0072542),-0.4109577014456455,-1.0239917386100363,0.43346007604562736,0.7393758000751447,1.0,6/13,24.07%,CALM1;PPP2R5C;CALM2;PPP2R5A;CALM3;PPP1R15A
prerank,thioesterase binding (GO:0031996),-0.43680680671824124,-1.0219676134954325,0.44227005870841485,0.7406014332596611,1.0,2/11,14.71%,RAC1;TRAF1
prerank,phosphatidylinositol binding (GO:0035091),-0.26290049014908795,-1.021929984379998,0.4099722991689751,0.7367678831396354,1.0,30/91,21.93%,PITPNC1;HIP1;EPB41;MCF2L;ITPR2;ESYT2;PITPNM2;SCARB1;TNFAIP8L3;DENND1B;CCDC88A;RPH3A;HIP1R;SNX16;APPL1;MTM1;WDFY3;RNF34;ITPR3;PLEKHN1;SNX1;PITPNA;PITPNB;SNAP91;THY1;MREG;SNX2;NUMA1;PLEKHF2;EXOC8
prerank,phosphate ion binding (GO:0042301),-0.44353865703274575,-1.0217307574829908,0.4555984555984556,0.7333959085557381,1.0,5/10,36.39%,PDE2A;RPH3A;RELA;CHST14;ADSS1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.37734283260998985,-1.021503393559475,0.4343629343629344,0.7301386609886962,1.0,6/17,19.86%,PTK2B;GRIK4;GRIN3A;GRIN1;GRIA2;GRIK2
prerank,GABA-A receptor activity (GO:0004890),-0.3761909213619329,-1.021470632153864,0.4306122448979592,0.7263819557298056,1.0,6/18,25.00%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3810626969073978,-1.0205724091779804,0.41916167664670656,0.7247963357676699,1.0,5/18,13.96%,GAS6;SERPINB9;BIRC3;RPS6KA1;MT3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3792556814441942,-1.0201797052532582,0.42063492063492064,0.7219624861256366,1.0,5/18,5.04%,LTBP4;ACVRL1;ENG;BMPR2;TGFBR2
prerank,potassium channel regulator activity (GO:0015459),-0.30255217139661766,-1.0189095464351545,0.4316546762589928,0.7216112530337968,1.0,12/49,17.14%,ABCC9;NEDD4L;KCNS3;FLNA;KCNAB1;WNK3;CHP1;KCNMB4;ADRB2;KCNIP2;WNK2;SGK1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.3543981946402178,-1.0174603714568016,0.45188284518828453,0.7214601266219421,1.0,12/22,30.54%,DUSP16;DUSP8;DUSP3;SBF1;DUSP1;DUSP12;DUSP6;DUSP4;CDKN3;DUSP18;PPM1F;DUSP7
prerank,ubiquitin binding (GO:0043130),-0.2740482883844553,-1.0147920012234262,0.4256926952141058,0.7241253920672579,1.0,25/73,22.66%,FBXO7;MVB12B;UBXN1;HSPB1;BUB3;UBAP1;FAF1;UCHL1;TOLLIP;NSFL1C;UCHL3;OTUB1;MVB12A;TOP2A;UBAP1L;RNF19B;AUP1;N4BP1;SPRTN;SHARPIN;RNF168;RBCK1;TNFAIP3;USP5;PLAA
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3743958307877699,1.0137162653496834,0.4280155642023346,0.8428556940120143,1.0,3/27,3.07%,SLC8A3;SLC41A1;SLC8A1
prerank,titin binding (GO:0031432),0.4344183921045288,1.0129327901790075,0.45081967213114754,0.8405338324593221,1.0,3/13,11.92%,TRIM63;CAMK2D;ACTN2
prerank,lysophospholipase activity (GO:0004622),-0.3745768142850994,-1.012888855495269,0.4254473161033797,0.7251766254306381,1.0,6/20,15.14%,MGLL;GDPD1;GDPD3;LYPLA2;PNPLA6;PLA2G4A
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3191050684369914,-1.0106035461225304,0.43923240938166314,0.7271853102047194,1.0,9/32,12.14%,SLC6A6;SLC7A5;SFXN1;SLC1A1;SLC38A5;SLC3A2;SLC43A2;SLC36A1;SLC1A4
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4097018896426249,-1.0102757533072297,0.4455252918287938,0.7243379912439677,1.0,5/12,13.61%,RACK1;NOD1;ATP2A3;CASP8AP2;RPS27L
prerank,methylation-dependent protein binding (GO:0140034),0.3176637882196703,1.0098594159779821,0.41235392320534225,0.844374003391277,1.0,14/57,16.26%,KDM7A;PYGO1;L3MBTL2;PHF8;MTF2;CBX8;CBX2;KAT8;MBTD1;RRP8;TRIM24;MORC3;PHF1;PHF2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.3447946222728897,-1.0079001679519424,0.44731182795698926,0.7263914689640554,1.0,9/24,25.06%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17
prerank,myosin II binding (GO:0045159),-0.44297876480078285,-1.0077918185887562,0.4727626459143969,0.7229738020950011,1.0,3/10,8.16%,SHROOM4;GSN;SHROOM1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.4329759862162442,-1.0074675661703505,0.44571428571428573,0.7201840054665404,1.0,4/10,25.00%,GABRG3;GABRA5;GABRE;GABRG2
prerank,hyaluronic acid binding (GO:0005540),0.45535017941457917,1.00652732464081,0.44042553191489364,0.8487350349414523,1.0,1/10,0.75%,CEMIP
prerank,fibroblast growth factor receptor binding (GO:0005104),0.39109670033311567,1.0053691229453876,0.4389312977099237,0.8473264086175064,1.0,5/21,14.51%,KL;FGF1;FRS2;FGF9;FGF20
prerank,SUMO transferase activity (GO:0019789),0.4072151114194988,1.0035228262342606,0.4600389863547758,0.8476776576520546,1.0,5/16,19.02%,PIAS1;MDM2;CBX4;HDAC4;PIAS3
prerank,mannosyltransferase activity (GO:0000030),0.38079564185127096,1.0029722406385346,0.441351888667992,0.8446576730678796,1.0,5/21,9.84%,TMTC4;TMTC1;ALG2;ALG9;PIGV
prerank,carboxylic acid binding (GO:0031406),-0.31502441439210577,-1.0021551400093802,0.4308390022675737,0.7294544955576138,1.0,8/38,10.82%,NOS3;SESN3;GRM7;PSAP;GRIN3A;SESN2;GRIN1;NOS1
prerank,filamin binding (GO:0031005),0.44592543238297,1.0021330230492038,0.46346555323590816,0.8425821358923127,1.0,2/11,3.73%,DPYSL3;NEBL
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.28888209274484344,-1.0008888562944496,0.4302600472813239,0.7290987821215997,1.0,23/49,29.71%,ESYT2;MCTP1;CPNE8;RPH3A;CPNE2;CPNE3;DYSF;C2CD5;SYT10;PCLO;SYT4;PLA2G4A;CPNE9;SYT2;SYT7;SYT15;PLA2G4F;ANXA8;DOC2B;CPNE5;SYT17;SYT1;ESYT3
prerank,potassium ion antiporter activity (GO:0022821),0.4245576895688687,0.9995182346331662,0.4782608695652174,0.8449839998148851,1.0,1/15,0.36%,SLC24A3
prerank,calcium-activated potassium channel activity (GO:0015269),-0.42200724312039595,-0.9991703110842126,0.483271375464684,0.7295734463340815,1.0,3/11,12.36%,KCNMA1;KCNMB4;KCNN2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4108596375034551,-0.9975211169972353,0.4841897233201581,0.7301611129142775,1.0,5/12,5.04%,LTBP4;ACVRL1;ENG;BMPR2;TGFBR2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.30157920013769274,-0.9969702966281028,0.4622425629290618,0.7278716844961571,1.0,11/42,20.43%,BCAR3;SHE;PLCG2;YWHAB;NCK2;CRK;SAMSN1;SHB;YES1;PIK3R3;SHC3
prerank,four-way junction DNA binding (GO:0000400),0.40342944649864143,0.996957481729084,0.4576612903225806,0.8473024061149299,1.0,5/17,15.10%,RAD51B;RAD51C;BLM;ABL1;WRN
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3713929068978384,0.9921977638030282,0.4707070707070707,0.8552292817679559,1.0,4/23,6.94%,PDE1A;PDE7B;PDE7A;PDE5A
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.26470744275687147,0.9921461111895833,0.44508670520231214,0.8510820778200361,1.0,31/181,13.03%,TCF7L2;ARNT2;RBPJ;PPARA;PRRX1;NR1I2;NCOA2;FIZ1;SETD6;TTC8;NCOA3;SMAD3;CHD4;NCOA7;RBL2;TEAD3;WWP2;PIAS1;ARNT;MED1;BBS7;PARP9;HDAC1;SMARCE1;TACC1;RXRA;CRY1;GTF2I;AR;SMARCB1;IFI27
prerank,palmitoyltransferase activity (GO:0016409),-0.32438514060419954,-0.9921249772529392,0.45494505494505494,0.7359678223531951,1.0,11/28,27.62%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;HHAT;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17;ZDHHC5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4169529400617096,-0.9916494769002954,0.476280834914611,0.7300484450695421,1.0,2/11,8.66%,BAG1;SIL1
prerank,adenyl nucleotide binding (GO:0030554),-0.4169529400617096,-0.9916494769002954,0.476280834914611,0.7300484450695421,1.0,2/11,8.66%,BAG1;SIL1
prerank,hexosaminidase activity (GO:0015929),0.44113534358839324,0.9915905763594743,0.47950819672131145,0.8481641608440592,1.0,4/12,15.05%,CEMIP;HEXD;HYAL1;SPAM1
prerank,endopeptidase inhibitor activity (GO:0004866),0.2924181985920134,0.990429251140053,0.44390243902439025,0.8468692559989857,1.0,7/82,3.76%,TFPI;TIMP3;ITIH2;SERPIND1;LTF;PROS1;A2ML1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3622883949176692,0.989122733920927,0.466796875,0.8460017412166321,1.0,3/26,5.56%,B3GALT1;B3GNT5;CHSY1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.4367401918689979,0.987620601299827,0.5,0.8455073768902357,1.0,1/11,0.41%,SASH1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.36616979271771666,0.9844908243098713,0.5037878787878788,0.8494874163192097,1.0,5/24,11.16%,OSBPL8;GSDMA;PLEKHF1;GSDMD;PLEKHA8
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.44310631942410156,0.9784878101697149,0.47761194029850745,0.8600725060817748,1.0,4/10,20.67%,ASH1L;NSD1;SETD2;NSD3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.3443695097743978,-0.9776900456234359,0.4936708860759494,0.7600010271557982,1.0,9/22,22.30%,OTUD7A;MINDY2;ZRANB1;TAB3;FAAP20;SPRTN;RNF168;OTUD7B;TNFAIP3
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2767237054625355,-0.9748724466785321,0.47641509433962265,0.7631915617656381,1.0,14/56,14.69%,GRB14;PITPNM2;PTPN14;GAS6;CBL;RACK1;NCK1;TOB1;SOCS5;CPNE3;PTPN1;DUSP3;PITPNM3;NRG3
prerank,platelet-derived growth factor binding (GO:0048407),0.4264588700411712,0.9746929488038513,0.4737991266375546,0.8655143796709961,1.0,3/11,4.40%,PDGFRB;COL1A2;PDGFRA
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.29808359930042566,-0.9742313337672545,0.47477064220183485,0.7612341753980455,1.0,9/38,14.16%,SERPINE2;SERPINI1;SERPINF1;SERPINB9;APP;A2M;FURIN;SPINT2;SPOCK1
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.31825155925437376,-0.9742111033113404,0.4893162393162393,0.7577382461379961,1.0,4/29,5.66%,PTPRJ;DUSP16;GCH1;NFATC1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.32844771695073893,0.9717130909494772,0.49097472924187724,0.8691250550455226,1.0,9/38,15.96%,SNX21;PARD3;SH3PXD2B;WIPI1;PLEKHF1;ZFYVE26;SNX12;RUFY4;DENND1A
prerank,ATP binding (GO:0005524),0.24739385935170427,0.9692655221608639,0.532235939643347,0.8713054331016871,1.0,45/266,15.15%,PRKAG2;ATP1A2;OXSR1;KSR1;WNK4;DAPK1;CLPX;DMPK;MAP4K5;SRPK2;ABCA1;SPHK1;PTPA;SIK1;STK17B;MYO18A;TRNT1;SARS2;BLM;MYO9B;SRR;PMVK;HSPA1L;GALK1;NOL9;LATS1;ABL1;SMARCA5;ATP7B;MYH10;RTEL1;BMPR1A;PRKAG1;ABCB8;PRKACB;PPIP5K2;STK26;NIM1K;CDKL5;NLK;TAP2;PRKCI;HACL1;SIK3;MTHFS
prerank,calcium channel activity (GO:0005262),0.28734148055119474,0.9691176582590489,0.5126984126984127,0.8676235813443469,1.0,8/84,7.85%,CACNA2D3;SLC24A3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1;MCU
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3094268239726893,-0.9684482919187405,0.513215859030837,0.7684265758690693,1.0,7/32,11.07%,KCNQ3;KCNB2;KCNS3;KCNB1;KCNQ1;KCNA1;KCNQ5
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.350009574260932,0.968428503591979,0.508,0.8651736021946898,1.0,6/27,13.81%,POLR2D;POLR2A;POLR1F;POLR1A;PRIMPOL;POLR1D
prerank,transcription coregulator binding (GO:0001221),0.3121703937067931,0.9665372747382516,0.5071942446043165,0.8656607660154882,1.0,10/50,12.49%,RORA;USP11;VGLL4;SMAD3;MTF2;CCNT2;PER3;CHD6;CNOT2;AR
prerank,protein homodimerization activity (GO:0042803),0.22987208927282776,0.9657769763069107,0.561282932416953,0.8634313208160221,1.0,60/589,8.49%,MAPK4;CPQ;DPYD;NPR3;MTUS2;APPL2;FGFR2;NR2F2;KIT;NADK2;TPM1;UPB1;KMT2A;JAML;FBLN5;SNX6;LHPP;CBS;BCL2;TNNC1;HSD17B1;CRYL1;GSTM2;SOX6;TPST1;TRIM5;ALS2;IRAK2;RBPMS;ZHX2;PAFAH1B3;CRPPA;CBY1;PDGFRA;PTPA;GLIPR2;NDP;LRRK2;SNX9;EPHX2;THAP1;BNIP3;PDCD6;ACP3;HOGA1;PGRMC1;SMAD3;BLM;RPE;NR6A1;KLHL7;NRBP1;SLC30A8;MYO9B;MUC13;CSF1;ZDHHC3;SRR;ARNT;SSBP1
prerank,NAD+ binding (GO:0070403),0.41953653105173744,0.9642918798027514,0.4967741935483871,0.8630893473267253,1.0,5/12,23.83%,CRYL1;PARP9;SIRT3;SIRT5;HADH
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2959286288772474,-0.9628640791903572,0.5110619469026548,0.7784559800771622,1.0,14/37,18.29%,SLCO1C1;SLCO2A1;SLCO2B1;COX4I1;SLCO3A1;NDUFA4;UQCRH;COX6A1;UQCR11;COX8A;COX5A;UQCRQ;SLCO4A1;UQCRC1
prerank,calcium channel regulator activity (GO:0005246),0.3268474994319376,0.9619120057821537,0.49466192170818507,0.8650185035459932,1.0,4/37,4.90%,ITPR1;STIM1;CACNG1;CACNG7
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.31445209513847416,-0.9612101097551357,0.5075268817204301,0.7790700744479908,1.0,9/30,16.04%,GAS6;CST3;SERPINB9;BIRC3;RPS6KA1;MT3;SPOCK1;PTTG1;CARD16
prerank,adenyl ribonucleotide binding (GO:0032559),0.2428297851277862,0.9572139208134338,0.5716234652114598,0.8722835371287235,1.0,48/291,14.87%,PRKAG2;ATP1A2;OXSR1;KSR1;WNK4;DAPK1;PRKAG3;CLPX;DMPK;MAP4K5;SRPK2;ABCA1;SPHK1;PTPA;SIK1;STK17B;MYO18A;TRNT1;MPPED2;SARS2;BLM;RAPGEF4;MYO9B;SRR;PMVK;HSPA1L;GALK1;NOL9;LATS1;ABL1;SLC19A1;SMARCA5;ATP7B;MYH10;RTEL1;BMPR1A;PRKAG1;ABCB8;PRKACB;PPIP5K2;STK26;NIM1K;CDKL5;NLK;TAP2;PRKCI;HACL1;SIK3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.39291770479380794,-0.9567273546518541,0.5337078651685393,0.7861625538081234,1.0,7/12,30.54%,DUSP16;DUSP8;DUSP3;DUSP1;DUSP6;DUSP4;DUSP7
prerank,protein kinase C activity (GO:0004697),-0.3724449308279497,-0.956336168781684,0.5308411214953271,0.7836011141446734,1.0,6/14,20.19%,PRKCH;PRKD3;PRKD1;PRKCE;PRKCG;PRKCD
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.44215658665396873,0.9558898089657694,0.5116772823779193,0.8714589393600358,1.0,2/10,8.35%,DPYSL3;DPYS
prerank,microtubule binding (GO:0008017),-0.2199893495276814,-0.953236291896135,0.6472727272727272,0.787460765969908,1.0,79/222,26.90%,DNM3;MTUS1;SGIP1;STARD9;MAP1B;REEP3;REEP1;MAP4;MID1;RPS3;CLIP1;MAP6;CLIP2;CCDC88A;RP1;EML6;KIF26A;MDM1;CHP1;GAPDH;MAP1LC3B;DNM2;NAV3;APC;KIF1A;RMDN3;DNM1;WHAMM;ARHGEF2;MTCL1;TOGARAM1;GAS2L3;KIF13A;HOOK1;RCC2;CCDC66;NDE1;CCDC88C;RMDN1;TPPP;KIF21B;FHDC1;APC2;CEP295NL;KIF3B;CCDC69;GAS2L1;CDK5;CKAP5;MID2;IRAG2;HAUS6;MAPRE1;POLB;KIF15;FMR1;NUMA1;DCTN1;TTBK2;VAPA;HDAC6;KNSTRN;MAST1;SPAG5;KIFC1;MAP1A;CLASP2;SPEF1;CEP295;CAMSAP3;SAXO2;CAMSAP1;KIFC2;REEP2;KIF14;KIF1B;CETN3;EZR;NEFM
prerank,pentosyltransferase activity (GO:0016763),0.3302765477535098,0.9531755206535175,0.5104529616724739,0.8739972151102726,1.0,10/36,20.04%,LARGE1;LACC1;PARP4;PARP10;PARP9;UPP2;SIRT3;QPRT;TIPARP;PARP14
prerank,FMN binding (GO:0010181),-0.3953191028788422,-0.9508952457470556,0.5219047619047619,0.7898556739176594,1.0,6/11,32.69%,NOS3;NOS1;PPCDC;PNPO;POR;NOS2
prerank,voltage-gated ion channel activity (GO:0005244),-0.3756793653289373,-0.9486928993660716,0.5386100386100386,0.7913649454155783,1.0,4/14,19.59%,CACNA1E;CACNA1H;HCN1;KCND2
prerank,phosphatase inhibitor activity (GO:0019212),-0.34113662567396436,-0.9484694774731575,0.5356415478615071,0.7884002430935388,1.0,9/20,29.65%,PPME1;PPP1R2;SET;LMTK2;BOD1;MGAT5;URI1;ARPP19;SAG
prerank,cAMP binding (GO:0030552),-0.40857762532492037,-0.9464099531664543,0.539179104477612,0.7895915152671807,1.0,3/11,12.59%,PDE4D;PDE2A;HCN1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.3580430710080309,-0.9455893530737042,0.5411764705882353,0.7881105596758305,1.0,5/16,5.22%,PLTP;THBS1;SCARB1;SCARF1;STAB1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.27165850612229364,-0.9453045834926536,0.5463414634146342,0.7852885182169363,1.0,20/55,20.30%,ITPR2;TRPC3;PKD1;ATP2C1;ATP2A2;ATP2A3;RYR2;SLC24A2;GRIN1;ATP2B1;PANX1;CACNB2;TRPV2;SLC24A5;TRPC1;ORAI1;TMEM165;PSEN1;ATP2B2;ATP2B4
prerank,actinin binding (GO:0042805),0.3624903391545315,0.9414002772189546,0.5214007782101168,0.8982476020139408,1.0,3/21,4.74%,KCNA5;CSRP3;CACNA1D
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.282851396788696,0.9407048203773252,0.5384615384615384,0.8958300432733084,1.0,15/69,14.32%,LPGAT1;ZDHHC1;SPHK1;CERS6;CERS5;DBT;ZDHHC3;KAT8;KAT6B;CERS1;SOAT2;ESCO1;PLA2G4C;CREBBP;AWAT2
prerank,lipoprotein particle binding (GO:0071813),-0.33665803458310223,-0.9384728358160777,0.5557851239669421,0.7971651957081176,1.0,7/20,12.42%,PLTP;THBS1;SCARB1;SCARF1;STAB1;CDH13;HSPD1
prerank,steroid hydroxylase activity (GO:0008395),0.39263705551476896,0.9366201089418943,0.5531914893617021,0.9016893257629007,1.0,1/16,1.11%,CYP27A1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.27499213278447165,0.9346364567053904,0.5655058043117744,0.9023482022596159,1.0,9/85,7.58%,CEL;LIPA;PLA2G10;PAFAH2;PAFAH1B3;ENPP2;LIPC;H6PD;DAGLB
prerank,glycine binding (GO:0016594),-0.39356357688408006,-0.9342367448359505,0.540952380952381,0.8038174714799187,1.0,7/11,31.55%,GRIN3A;GRIN1;GLRA3;GLRA1;GLDC;GNMT;GRIN2B
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.29005146536036713,-0.9294509242761713,0.5842450765864332,0.8110120290711008,1.0,9/35,14.10%,GPCPD1;PLCB4;SMPD4;GDPD1;PLCB3;GDPD3;PLCXD3;PLD3;PDE11A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3954371061609463,-0.9292374356360852,0.5540275049115914,0.8079949992186279,1.0,5/11,25.11%,NUDT3;NUDT4;NUDT1;DCPS;NUDT16
prerank,glucuronosyltransferase activity (GO:0015020),0.3686634380563334,0.9289479563636233,0.5506445672191529,0.9122101613182666,1.0,3/19,7.54%,LARGE1;CHSY1;EXTL1
prerank,potassium channel activity (GO:0005267),-0.24064673166237013,-0.9270319516124508,0.6272493573264781,0.8093550024916716,1.0,19/89,15.62%,KCNK5;ABCC9;KCNQ3;KCNB2;KCNMA1;KCNS3;KCNB1;GRIK4;KCNK13;KCNQ1;KCNT1;KCNMB4;KCNA1;KCNQ5;KCNN2;HCN1;TMEM38B;KCNQ2;KCNH7
prerank,glucose transmembrane transporter activity (GO:0005355),-0.34734597752427226,-0.9268526758469445,0.5760649087221096,0.8062968172110226,1.0,1/17,0.80%,SLC2A1
prerank,aspartic-type peptidase activity (GO:0070001),-0.39653814115530406,-0.9246663869455162,0.5745098039215686,0.8080860506794613,1.0,3/10,27.35%,CTSD;PSEN1;CTSE
prerank,ligand-gated cation channel activity (GO:0099094),-0.24631647126937256,-0.9235197607270074,0.6397984886649875,0.8070753904873907,1.0,28/75,34.82%,KCNJ2;PTK2B;GRIK4;GRIN3A;GRIN1;KCNN2;KCNJ8;KCNJ15;GRIA2;TRPM4;GRIK2;KCNH2;CHRNB1;KCNJ6;MCOLN1;TRPM2;KCNJ16;SCNN1A;ASIC1;KCNJ10;GRIA1;GRIN2B;P2RX5;GRIK1;P2RX7;TRPM8;P2RX3;P2RX6
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2429334590915573,0.9224811183653093,0.6332378223495702,0.923956220335684,1.0,29/188,13.21%,SOX5;TCF7L2;ARID5B;SMAD6;PRDM5;SOX6;TBL1XR1;ZBTB20;NFYB;ASH2L;ARID4A;BCOR;XRCC5;SMAD3;GABPB1;GABPB2;TCF12;PER3;NFYC;CREB3L2;TFAP2A;ZNF568;RXRA;SOX13;HSF1;PSPC1;AR;NONO;FOXK2
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.348550288333864,0.9206004408702883,0.5419847328244275,0.9243424245712658,1.0,5/21,10.07%,AKAP7;WASF1;WASF3;ARFGEF2;AKAP8L
prerank,nuclear receptor binding (GO:0016922),0.2573085927289102,0.9189349203095833,0.6146926536731634,0.9243438818402593,1.0,21/111,11.89%,TCF7L2;BRD8;NR1I2;PPARGC1B;NCOA2;GRIP1;STAT5B;WIPI1;PRKCB;NCOA3;SMAD3;NCOA7;NSD1;MED1;LATS1;MED13;SMARCE1;TACC1;RXRA;CRY1;RNF14
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.40838988631960765,0.918924600503356,0.5543933054393305,0.9203199431674457,1.0,1/11,1.77%,AGMAT
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.24233490270471642,0.9170558763273864,0.6404011461318052,0.9207899922855535,1.0,31/173,13.84%,AEBP1;PPARA;ZEB2;KCNIP3;MXI1;SATB1;PRDM5;ZEB1;ASCL2;ZBTB20;VSX2;ZFP90;IRF8;MXD1;ZBTB32;ZFP37;THAP1;EN1;MITF;IRX1;TFAP2A;ZBTB39;ZBTB37;ZNF177;E2F6;SOX13;HSF1;NFATC4;FOXK2;SNAI1;ZNF148
prerank,magnesium ion binding (GO:0000287),0.2543248681247234,0.9169431526935672,0.6362275449101796,0.9171030506846025,1.0,31/135,16.89%,OXSR1;EYA2;SRPK2;SPHK1;SIK1;TDP2;LRRK2;EPHX2;PDCD6;HMGCL;SRR;IDH2;XYLT2;LATS1;CLYBL;ABL1;RAP2A;IDH3G;FOXK2;THTPA;PRKACB;NUDT12;STK26;NIM1K;NLK;HACL1;SIK3;WRN;BRSK1;PI4K2A;XXYLT1
prerank,growth factor receptor binding (GO:0070851),0.2672353095368757,0.9166312957560325,0.6186708860759493,0.9138270299973577,1.0,15/95,12.50%,EFEMP1;PDGFRB;KL;FER;FAM83B;PDGFRA;PDGFD;FGF1;FRS2;IL6;VEGFB;FGF9;JAK2;TGFA;AREG
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3351283848400458,0.9132643236369463,0.5798479087452472,0.9179188021876409,1.0,5/27,8.48%,PPARA;PRKN;RNF217;SIAH2;RNF180
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2995625262571402,0.9125402846757031,0.6,0.9156510956900525,1.0,3/46,2.72%,B3GALT1;LARGE1;B3GNT5
prerank,voltage-gated cation channel activity (GO:0022843),0.2623058242064568,0.911764249308874,0.6123076923076923,0.9135288860325917,1.0,9/97,7.35%,CACNA2D3;KCNQ4;KCNA5;KCND3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1
prerank,dynactin binding (GO:0034452),0.3935724366819897,0.9110461085437055,0.5807127882599581,0.9113535768248242,1.0,3/12,13.96%,SNX6;PAFAH1B1;BICD2
prerank,exonuclease activity (GO:0004527),0.30197736656386603,0.9105671549572674,0.5954861111111112,0.9084964450403002,1.0,16/46,20.64%,REXO5;APEX2;ENPP2;EXOSC8;DCLRE1B;ENPP3;ISG20L2;MRE11;APEX1;ERI1;WRN;CNOT7;REXO4;EXOSC3;PDE12;RAD50
prerank,adenylyltransferase activity (GO:0070566),0.3391528105594598,0.9102208620342419,0.5543933054393305,0.9054143873839606,1.0,7/21,14.44%,NMNAT2;TENT2;ABL1;TUT1;NMNAT1;FLAD1;PAPOLB
prerank,tRNA methyltransferase activity (GO:0008175),0.37128739183778137,0.9100820631997196,0.5477099236641222,0.9019159799750652,1.0,4/16,15.02%,TRMT9B;LCMT2;TRDMT1;THUMPD3
prerank,calcium channel inhibitor activity (GO:0019855),0.40406347559110906,0.9096176474540693,0.5638297872340425,0.8991095043524004,1.0,1/11,0.79%,ITPR1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.23144315492213602,0.9082411424149422,0.6702269692923899,0.89837987917172,1.0,44/254,15.33%,TCF4;RBPJ;HLF;PPARA;HOXC4;PRRX1;MEIS1;MYBL1;SCX;NR1I2;HOXB3;NFYB;NFAT5;HOXA7;NFIB;ELF4;GMEB1;RFXAP;SMAD3;TCF12;NFIA;MITF;CEBPG;MDM2;NFYC;IRF3;TFAP2A;TFAP2B;MYB;GTF2I;AR;KLF5;HOXD4;NR1I3;FOXK2;TFDP2;MLXIP;CLOCK;SRF;HOXD8;NKRF;SOX12;BARX2;MEIS2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.40123250619213324,0.9072024455103158,0.5926724137931034,0.8969501711247828,1.0,3/12,9.01%,KDM7A;PHF8;KDM3B
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3674220692077622,0.9054359622906812,0.5549132947976878,0.897467149846148,1.0,7/17,24.79%,ACOT4;ACAA2;ACOT1;ACOT11;ACOT13;ACOT6;PPT1
prerank,metallocarboxypeptidase activity (GO:0004181),0.3377132264700765,0.9053471399630643,0.5755258126195029,0.8939641313744834,1.0,3/26,8.19%,AEBP1;AGBL2;CPXM1
prerank,myosin binding (GO:0017022),-0.26264788931883765,-0.9052229518872262,0.6265060240963856,0.8448734935508778,1.0,11/55,12.90%,MYRIP;SHROOM4;GSN;RAB3C;NKD2;MYOC;SHROOM1;RHOA;RAB3B;LMTK2;MLPH
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4041532770958687,0.9010383723819864,0.569620253164557,0.8999316847846496,1.0,2/10,12.98%,NAA80;NAA60
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3772616207452779,0.8999506574451267,0.5694164989939637,0.8985992866355543,1.0,2/15,2.14%,HS3ST3A1;HS3ST3B1
prerank,nucleotidyltransferase activity (GO:0016779),0.35716048545305257,0.8997993797337451,0.5794979079497908,0.895298334872582,1.0,9/19,23.50%,CRPPA;TENT2;REV1;TUT1;MOCS3;TUT4;TUT7;THG1L;PAPSS1
prerank,NF-kappaB binding (GO:0051059),-0.3066700578920851,-0.899770896241263,0.5947136563876652,0.853126683397222,1.0,12/24,35.88%,NFKBIA;FAF1;GSK3B;COMMD7;BRMS1;RNF25;RELA;HDAC3;HIF1AN;NPM1;CDK5RAP3;ANXA4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4015790063857101,0.8997242633058748,0.5936842105263158,0.8918130352261091,1.0,1/11,2.04%,PPP1R1A
prerank,nucleosomal DNA binding (GO:0031492),0.3481967958012722,0.8974910271343509,0.5950095969289827,0.8929093983508005,1.0,7/21,15.42%,RBBP4;HNRNPC;CHD4;HDAC1;SMARCE1;SMARCB1;SMARCC1
prerank,tau-protein kinase activity (GO:0050321),0.35291151442897134,0.8953713618429154,0.6058700209643606,0.8940996704781666,1.0,1/20,0.39%,ROCK2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.30670721758713015,-0.8935103445699729,0.6012396694214877,0.863382733049947,1.0,5/23,8.81%,EDNRA;PLCG2;PLCB4;CHRM3;PLCB3
prerank,voltage-gated potassium channel activity (GO:0005249),0.2647505235781476,0.8931340084075587,0.6312292358803987,0.895272550869155,1.0,5/80,4.07%,KCNK2;KCNQ4;KCNA5;KCNT2;KCND3
prerank,carboxy-lyase activity (GO:0016831),-0.3135476699280419,-0.8911359328938236,0.6185567010309279,0.8652322237849664,1.0,7/23,17.39%,DDC;AMD1;AZIN1;GAD1;PPCDC;UROD;CSAD
prerank,ion channel inhibitor activity (GO:0008200),0.3043664226620373,0.8874073742748945,0.617059891107078,0.9042860494419037,1.0,8/35,12.63%,ITPR1;WNK4;NEDD4;PCSK9;CAMK2D;SCN3B;STX8;PACSIN3
prerank,neuropeptide receptor activity (GO:0008188),0.3179050752585992,0.8841199745946778,0.6081560283687943,0.9076303197917535,1.0,7/29,15.81%,SSTR2;KISS1R;GPR143;NTSR1;TACR3;HCRTR2;NPY2R
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.32733880206426424,0.8820342767145201,0.6282527881040892,0.908475307494542,1.0,4/24,11.80%,DAPK1;CAMK1D;CAMK2D;MAPKAPK2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3141308591856286,0.8807272612003303,0.6048689138576779,0.9076328401949352,1.0,5/28,10.77%,MAP2K6;PRKAA2;LRRK2;TTK;RPS6KB1
prerank,cysteine-type peptidase activity (GO:0008234),-0.23869795810522976,-0.8805466339611052,0.7139107611548556,0.8839608107853989,1.0,40/73,41.38%,USP38;LGMN;CTSB;CAPN2;USP29;UCHL1;USP50;USP37;CTSZ;CASP8;USP28;USP9X;USP8;ATG4A;CTSL;CTSC;OTUD7B;CASP1;USP5;OTULIN;USP49;USP33;USP2;USP10;USP9Y;BLMH;ATG4D;CTSF;USP35;ESPL1;ATG4B;CASP9;USP40;GGH;USP30;USP26;CTSO;CTSK;ATG4C;TINAGL1
prerank,nucleotide diphosphatase activity (GO:0004551),0.3741853331471585,0.8791808820810155,0.5969162995594713,0.907529929637938,1.0,4/14,13.82%,FHIT;NUDT13;NUDT6;NUDT12
prerank,DNA replication origin binding (GO:0003688),-0.30426413033681543,-0.8779207337859561,0.643652561247216,0.8858405045209801,1.0,10/23,33.17%,HSPD1;MCM4;MCM8;POLA1;MCM5;MCM10;ORC1;DHX9;MCM6;CDC6
prerank,G protein-coupled receptor activity (GO:0004930),0.22554493509367937,0.8776846597988335,0.7472527472527473,0.9072549079470422,1.0,16/239,8.30%,ADGRV1;NPR3;LGR4;BDKRB2;ADGRL1;LPAR1;CXCR5;PDGFRB;CXCR6;LPAR2;SSTR2;ADRA1D;KISS1R;PTH2R;GPR143;F2RL2
prerank,endopeptidase activator activity (GO:0061133),-0.3818964614150682,-0.8774649996164258,0.6604477611940298,0.883075609164755,1.0,4/10,28.77%,PSME3;PSME1;VSIR;NLRC4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.37900868329498416,-0.8765408736019781,0.6436567164179104,0.8778339472685465,1.0,6/10,30.54%,DUSP16;DUSP8;DUSP1;DUSP6;DUSP4;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.37900868329498416,-0.8765408736019781,0.6436567164179104,0.8778339472685465,1.0,6/10,30.54%,DUSP16;DUSP8;DUSP1;DUSP6;DUSP4;DUSP7
prerank,ligand-gated calcium channel activity (GO:0099604),0.35081270728749614,0.8758589898694183,0.6052104208416834,0.9078164447616056,1.0,1/19,0.79%,ITPR1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3484550997917585,-0.872932540418758,0.6480331262939959,0.8818203555687691,1.0,6/14,22.59%,SYNJ1;MTM1;MTMR6;MTMR9;MTMR12;MTMR1
prerank,ribonuclease P activity (GO:0004526),-0.37312003826105006,-0.8723530074242574,0.6492248062015504,0.8793763954767729,1.0,7/11,34.18%,POP5;POP4;RPP21;RPP30;PRORP;POP7;RPP40
prerank,RNA polymerase binding (GO:0070063),0.34580596296131183,0.8715458525296943,0.6369047619047619,0.9133759841388726,1.0,4/18,8.59%,NEDD4;CCNT2;CCNT1;PKN2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.31969022199454855,0.8713576505860793,0.6291512915129152,0.9102976058238154,1.0,2/25,2.11%,PLEKHA2;ADAP2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.4015240933065568,0.8704142830622507,0.6196319018404908,0.9087525006996776,1.0,5/10,21.84%,KAT8;BRCA2;NAA60;MSL3;NAA50
prerank,phospholipase C activity (GO:0004629),-0.2915333199629084,-0.8701956037035574,0.6363636363636364,0.8804279398494724,1.0,5/25,8.81%,EDNRA;PLCG2;PLCB4;CHRM3;PLCB3
prerank,death domain binding (GO:0070513),-0.36383182914312906,-0.8690002606432424,0.6311926605504588,0.8793800236106168,1.0,4/11,13.99%,RACK1;DAPL1;BCL2L1;DAP
prerank,zinc ion binding (GO:0008270),0.21874808809901847,0.8674202782341688,0.7663185378590078,0.9114743755553387,1.0,56/293,14.68%,PAPPA;KDM7A;PRKN;UPB1;KMT2A;ZEB1;BAZ1B;RNF2;IKZF4;KDM2B;SORD;ACE;TET1;ZBTB32;NAPEPLD;ZFP37;PHF8;CXXC5;THAP1;RABIF;ENPP2;SMAD3;NPEPPS;BLM;MMP9;CHD4;BBOX1;ZKSCAN5;KDM2A;SLC30A8;SLU7;DPYS;KDM5B;TRAF7;MDM2;NSD1;ZNF8;RXRA;ENPP3;MYCBP2;PAM;KMT2B;ITGB1BP2;EEA1;CYLD;RCHY1;S100A9;SHMT1;PRIMPOL;ESCO1;TRIM24;NUDT12;KDM5C;MNAT1;GLI2;BIRC2
prerank,nuclear receptor coactivator activity (GO:0030374),0.28067863387697,0.8670641190773319,0.6654991243432574,0.9086863049053079,1.0,11/52,12.86%,BRD8;PPARGC1B;NCOA2;PRKCB;ZMIZ1;NCOA3;NCOA7;MED1;MED13;TACC1;ZMIZ2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.3080804732689685,-0.86539959258304,0.6626262626262627,0.8833005407094858,1.0,16/21,56.66%,GRIK2;CHRNB1;P2RX5;P2RX7;P2RX3;P2RX6;CHRNA9;GLRB;CHRNA5;CHRNA4;CHRNA3;P2RX1;CHRNB4;TRPV1;CHRNA1;P2RX2
prerank,ubiquitin-specific protease binding (GO:1990381),0.3573039446434873,0.8653864060895805,0.6396761133603239,0.9086535845506765,1.0,3/19,8.17%,PRKN;PTEN;AMFR
prerank,nuclear localization sequence binding (GO:0008139),-0.32243598654435085,-0.863843492495697,0.648,0.8830776472170391,1.0,9/18,35.08%,NFKBIA;KPNA4;KPNA3;POM121;NUP153;CABP1;TNPO2;KPNA2;IPO4
prerank,ferrous iron binding (GO:0008198),-0.3048560451435116,-0.862516864734819,0.6795131845841785,0.8821812932080162,1.0,5/21,12.25%,FTH1;FTL;EGLN3;ISCU;EGLN2
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.27153165930523737,-0.8613782580140594,0.7191780821917808,0.8808449936903432,1.0,9/35,24.36%,FOXP1;H3-3A;PIH1D1;RRN3;ZBTB17;TAF4;KLF10;RELA;STAT1
prerank,ATPase activator activity (GO:0001671),-0.3122017938974978,-0.860242826081301,0.6798336798336798,0.8796275254622707,1.0,7/20,25.93%,ATP1B1;DNAJA1;DNAJC1;DNAJC10;DNAJB1;DNAJA2;DNAJB6
prerank,peptidase activator activity (GO:0016504),-0.2971718973421253,-0.8565188478078634,0.6666666666666666,0.883386288911564,1.0,8/22,24.17%,CAV1;MAL;PSME3;CASP8AP2;PSME1;PINK1;VCP;VSIR
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.33736230262752503,0.8537938447434074,0.6561181434599156,0.9256272231022111,1.0,5/21,14.83%,CDK8;CDK7;CDK1;CDK15;CDK4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.33736230262752503,0.8537938447434074,0.6561181434599156,0.9256272231022111,1.0,5/21,14.83%,CDK8;CDK7;CDK1;CDK15;CDK4
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.3613783834845389,0.853017890045041,0.6437246963562753,0.9237560955346188,1.0,5/14,18.55%,DUOX2;NCF2;DUOX1;CYB5R4;AIFM1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.34112410236287727,-0.8530152302137283,0.670863309352518,0.8866340932176903,1.0,3/14,5.19%,ATXN3;MINDY2;MINDY1
prerank,ribonuclease P RNA binding (GO:0033204),-0.36719879524352467,-0.85192988890594,0.6647619047619048,0.8851783626211052,1.0,4/10,17.52%,POP5;POP4;RPP21;RPP30
prerank,mRNA methyltransferase activity (GO:0008174),-0.34157947806115807,-0.8514063040812601,0.6462093862815884,0.8827584494185744,1.0,5/12,23.62%,TRMT61B;METTL3;CMTR2;TRMT10C;PCIF1
prerank,retinoic acid receptor binding (GO:0042974),-0.32262994264364697,-0.8489406905070651,0.6757894736842105,0.8842243569669731,1.0,4/17,16.90%,ACTN4;ARID5A;NRIP1;NR4A2
prerank,tRNA binding (GO:0000049),-0.2549702389401871,-0.8460525622565154,0.7409200968523002,0.8862707394184187,1.0,17/43,30.11%,EEF1A1;PSTK;SARS1;SSB;RPUSD4;ALKBH8;EIF2A;DALRD3;ELP5;TRMT10C;AARS2;MRPS27;YRDC;CARS1;KARS1;PUS1;TRNAU1AP
prerank,voltage-gated chloride channel activity (GO:0005247),-0.37297978950134664,-0.8418611358668785,0.6937984496124031,0.8910458590572401,1.0,2/10,5.60%,ANO1;CLCN5
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3274516185977361,-0.8410169967780473,0.6865979381443299,0.8892782865643367,1.0,2/15,2.50%,EPB41;SCARB1
prerank,DNA polymerase binding (GO:0070182),-0.3084431179293823,-0.8381232885858397,0.7085714285714285,0.8912704872493742,1.0,2/18,2.37%,HSP90AA1;HSP90AB1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.3041134487939101,-0.8365604267594111,0.6876267748478702,0.8908508431715183,1.0,11/19,35.17%,GRIK4;GABRG3;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2;GRIK1;GRID1;GABRG1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3817191941798189,0.8351027431960533,0.6450304259634888,0.9565751508902512,1.0,2/10,4.85%,CACNA1D;CACNB4
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.348502523614284,0.8337936381753333,0.6561844863731656,0.9557623887032967,1.0,2/14,4.07%,KCNA5;KCND3
prerank,DNA secondary structure binding (GO:0000217),0.291423327931728,0.8317271883132857,0.6923076923076923,0.956261167820247,1.0,6/31,10.44%,KMT2A;RAD51B;RAD51C;BLM;CLSPN;ABL1
prerank,galactosyltransferase activity (GO:0008378),0.3681229712548528,0.8316215996024636,0.6659340659340659,0.9528979822026582,1.0,4/11,12.58%,A4GALT;B4GALT1;B3GALT6;B4GALT2
prerank,serine-type endopeptidase activity (GO:0004252),0.24837365835585473,0.8315222753789374,0.7381756756756757,0.9495632470136858,1.0,5/80,3.79%,CORIN;KLK2;CTSH;MMP2;PCSK9
prerank,protein phosphatase 2A binding (GO:0051721),-0.2895548893217194,-0.8295969741278071,0.7123893805309734,0.9002466541057418,1.0,7/23,18.21%,DAB2IP;PPME1;GRIN3A;FOXO1;MASTL;BOD1;SMG5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36180600434658206,-0.8279734448581404,0.708171206225681,0.899738962972363,1.0,6/10,31.42%,ADARB2;GDA;CDA;ADA;DCTD;CDADC1
prerank,pseudouridine synthase activity (GO:0009982),-0.33151683162465617,-0.8267579888628944,0.7034068136272545,0.89855580196578,1.0,7/13,29.61%,RPUSD4;RPUSD1;TRUB2;PUS7;PUSL1;RPUSD2;PUS1
prerank,protein kinase C binding (GO:0005080),-0.25144575807430064,-0.8257762997207252,0.7589285714285714,0.8967655627161893,1.0,17/43,24.50%,RACK1;HSPB1;ADCY4;HDAC5;CCDC88A;CAVIN2;YWHAG;HINT1;PICK1;TOP2A;ADAM9;DSP;TIRAP;HDAC7;HDAC9;DACT2;DACT3
prerank,carbohydrate:cation symporter activity (GO:0005402),0.3665228482421887,0.8232133113348481,0.6659836065573771,0.9622670065870303,1.0,1/11,6.09%,SLC2A10
prerank,lysine N-methyltransferase activity (GO:0016278),0.3164230243969977,0.8219860508110516,0.7070707070707071,0.9611672251747714,1.0,3/20,9.77%,SETD6;SETD7;EEF1AKMT1
prerank,voltage-gated anion channel activity (GO:0008308),-0.31974901221919433,-0.8151013402946694,0.7424547283702213,0.9119502524499937,1.0,2/15,5.60%,ANO1;CLCN5
prerank,signal sequence binding (GO:0005048),-0.25209946016629187,-0.8144642545348338,0.7703862660944206,0.9095689257001963,1.0,19/35,35.08%,NFKBIA;TOMM20;PEX5L;AP2M1;KCNIP2;KPNA4;AP2B1;PEX5;TIMM22;KPNA3;POM121;KDELR3;NUP153;CAT;CABP1;SEC61A2;TNPO2;KPNA2;IPO4
prerank,growth factor activity (GO:0008083),0.24257818606515186,0.8143164077318962,0.7860696517412935,0.9721239390681602,1.0,12/74,12.83%,DKK1;IGF2;ARTN;FGF1;PTN;IL6;CSF1;VEGFB;FGF9;TGFA;AREG;GDNF
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3062535115664177,-0.81426736633679,0.722567287784679,0.9066186425577337,1.0,7/16,32.08%,PIR;ALOX12;ETHE1;HGD;ADI1;ALOXE3;HAAO
prerank,ion channel activity (GO:0005216),0.24124705919162603,0.8100661136281853,0.7831932773109244,0.9765836998199213,1.0,2/80,1.67%,TRPM3;NALCN
prerank,kinase inhibitor activity (GO:0019210),-0.26223271432831385,-0.8084762164948992,0.7699115044247787,0.9129239173400256,1.0,12/33,30.50%,WARS1;NCK1;YWHAB;CDKN1B;SPRY4;SMCR8;PRKRIP1;CDKN1A;SOCS1;GMFB;AHSG;MAPK8IP1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.29121390212174203,-0.8069072800545775,0.7325102880658436,0.9121849968544764,1.0,9/20,33.41%,RPS3;EXOG;RBBP8;APLF;EXO1;ERCC5;DNA2;DCLRE1C;FEN1
prerank,microtubule motor activity (GO:0003777),0.25723357992289386,0.8025293435101393,0.75,0.9865105683245158,1.0,5/51,7.06%,KIF13B;KIF2A;KIF6;DNAH2;KIF27
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2697778917299332,0.7984230857317998,0.7323688969258589,0.9900232387648088,1.0,12/38,20.28%,SORBS1;GRIP1;LRRK2;FRS2;PIK3R1;MAGI2;GAB2;AXIN1;BLNK;PTPN11;SHC1;LAT
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3513245346715793,0.796834442315916,0.7080610021786492,0.989335242491898,1.0,6/11,25.53%,AMFR;UBE4A;PPIL2;UBE4B;UBE2K;PRPF19
prerank,ligand-gated channel activity (GO:0022834),-0.2555956532069127,-0.7951269709604779,0.7683982683982684,0.9277874850427131,1.0,8/29,22.89%,GRIK4;GABRB1;GRIN3A;GRIN1;GRIA2;GRIK2;GRID2;CHRNB1
prerank,MAP kinase kinase activity (GO:0004708),0.32763756811847666,0.7949438781880825,0.722,0.9891422626577006,1.0,2/15,5.48%,MAP2K6;LRRK2
prerank,cholesterol transfer activity (GO:0120020),-0.3015550962908279,-0.7938752131629895,0.76171875,0.9265997357541661,1.0,6/16,23.65%,PLTP;GRAMD1A;STARD5;MTTP;ABCG1;NPC2
prerank,single-stranded RNA binding (GO:0003727),-0.2389460805500712,-0.7924502775431697,0.8321995464852607,0.9254907356448357,1.0,22/43,35.90%,ADARB2;HNRNPU;STRBP;SNRPC;EIF4H;IFIH1;POLR2G;EXOSC10;PTBP1;AGO3;FMR1;EIF4B;HNRNPF;TLR7;CNBP;PUS1;ZFR;JMJD6;DHX9;RBM11;HNRNPA1;TLR8
prerank,adrenergic receptor binding (GO:0031690),0.31838108059672154,0.7909420244450767,0.6902834008097166,0.9925973588465167,1.0,5/16,15.92%,GNAS;NEDD4;DLG4;MAGI2;GRK2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.278080367572247,0.7896470177513157,0.7695238095238095,0.9913579382544775,1.0,5/33,8.48%,PPARA;PRKN;RNF217;SIAH2;RNF180
prerank,motor activity (GO:0003774),0.24603241964021022,0.7887694716364219,0.814625850340136,0.9894331401877554,1.0,6/60,7.06%,KIF13B;KIF2A;KIF6;DYNC2H1;DNAH2;KIF27
prerank,microtubule plus-end binding (GO:0051010),0.2983945761071849,0.7879701530020666,0.7231075697211156,0.987296007938507,1.0,3/20,8.84%,STIM1;MAPRE2;PAFAH1B1
prerank,ligand-gated ion channel activity (GO:0015276),-0.25075590510981705,-0.7838050598801645,0.8123620309050773,0.9355867088889679,1.0,8/30,22.89%,GRIK4;GABRB1;GRIN3A;GRIN1;GRIA2;GRIK2;GRID2;CHRNB1
prerank,chemokine receptor binding (GO:0042379),0.27103583260576936,0.7793695693705005,0.7716390423572744,0.9978303387228098,1.0,7/35,18.01%,CXCL13;CCL19;ITCH;CCL4;CKLF;CX3CL1;CCL28
prerank,sterol transfer activity (GO:0120015),-0.2932684376397149,-0.7776685497533402,0.7888446215139442,0.9415710638240463,1.0,6/17,23.65%,PLTP;GRAMD1A;STARD5;MTTP;ABCG1;NPC2
prerank,calcium-release channel activity (GO:0015278),0.3032624566193614,0.7748819455966286,0.747104247104247,1.0,1.0,1/17,0.79%,ITPR1
prerank,CXCR chemokine receptor binding (GO:0045236),0.3409077887987302,0.7697343279277,0.7297872340425532,1.0,1.0,2/11,9.79%,CXCL13;ITCH
prerank,nucleotidase activity (GO:0008252),-0.2990499101638201,-0.7688601864198059,0.7845528455284553,0.9514639888288996,1.0,5/15,19.90%,NT5C2;NT5C;BPNT2;NT5E;NT5DC1
prerank,ATP hydrolysis activity (GO:0140603),-0.23421854097587735,-0.7674268426408787,0.8627450980392157,0.950107360525082,1.0,12/41,16.69%,HSP90AA1;SMCHD1;KIF26A;ABCB10;TOR1B;TOR3A;ATP2B1;CLU;ABCD2;CFTR;RUVBL1;ABCA3
prerank,serine-type peptidase activity (GO:0008236),0.2222387385155665,0.7669113126236559,0.8729641693811075,1.0,1.0,7/96,7.32%,CORIN;KLK2;CTSH;MMP2;PCSK9;TPP1;MMP9
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.318037497691302,-0.7662722043800565,0.7858546168958742,0.9485899654027348,1.0,2/12,8.61%,PAN2;CNOT6L
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.28625626122674075,-0.7622958791728823,0.7870563674321504,0.9509674716461681,1.0,3/18,10.32%,STXBP6;BAIAP2L1;PPP1CA
prerank,Hsp70 protein binding (GO:0030544),0.26510664083938557,0.7612053147883662,0.7903525046382189,1.0,1.0,2/31,4.20%,PRKN;HDAC8
prerank,chemokine activity (GO:0008009),0.26942484439383285,0.7610721394996625,0.7863894139886578,1.0,1.0,6/31,18.01%,CXCL13;CCL19;CCL4;CKLF;CX3CL1;CCL28
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.27592956221316495,0.7595229739112088,0.7957610789980732,1.0,1.0,8/29,15.86%,MGAM;HEXD;GANC;CTBS;GBA2;MOGS;PGGHG;GLA
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.30025970552941494,-0.7589294518220913,0.794921875,0.952518088901921,1.0,7/14,26.33%,SPOCK2;NGF;SPOCK1;TIMP2;BST2;SPOCK3;TIMP1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2473444875324843,0.7511251381393715,0.8535714285714285,1.0,1.0,8/44,11.77%,KMT2A;ASH2L;SETD7;SETD1A;ASH1L;NSD1;SMYD3;KMT2B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.21529566048478188,-0.7504569980940053,0.897172236503856,0.9606268805205039,1.0,15/54,23.56%,ACER3;ACER2;GLS;TGM2;HDAC5;HINT1;SIRT4;HDAC11;NIT1;HINT3;SIRT7;HDAC9;HDAC6;AMDHD2;SIRT6
prerank,carboxypeptidase activity (GO:0004180),0.26190593522663863,0.7500594363068779,0.8374291115311909,1.0,1.0,4/35,8.19%,AEBP1;SCPEP1;AGBL2;CPXM1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2524969938431331,-0.7483359049219734,0.8413361169102297,0.9598553721387388,1.0,7/26,20.06%,PPME1;PPP1R2;SET;PPP1R14A;LMTK2;BOD1;MGAT5
prerank,SH2 domain binding (GO:0042169),0.264939327732525,0.7471424782698471,0.8096153846153846,1.0,1.0,8/31,16.22%,AFAP1;SH3PXD2B;ABL1;JAK2;PAG1;NLK;RUFY1;BLNK
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.3420549314703297,0.7455286684435842,0.7510373443983402,1.0,1.0,3/10,16.03%,USP27X;CYLD;DESI2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.33409894433850834,0.7439955201459258,0.7556008146639511,1.0,1.0,2/10,12.18%,CASP12;CFLAR
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.28341953211163823,0.7402834626904471,0.807909604519774,1.0,1.0,3/22,8.05%,RBMS3;CPEB2;EXOSC8
prerank,chemoattractant activity (GO:0042056),-0.25383069280151194,-0.738829317841336,0.85546875,0.968540888709665,1.0,11/26,35.25%,VEGFA;FGF7;SCG2;MIF;BMP4;CXCL10;FGF2;NTF3;VEGFC;GPNMB;CCL5
prerank,ribosomal small subunit binding (GO:0043024),-0.274953850850135,-0.7377519794848969,0.857707509881423,0.9665365614074064,1.0,11/17,39.25%,EIF1B;ERAL1;EIF4H;EIF1;DHX29;EIF4B;MTIF3;NME1;NPM1;PIM1;UNG
prerank,phospholipase A2 activity (GO:0004623),0.2681112925069222,0.737169303915433,0.8089668615984406,1.0,1.0,4/26,15.34%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,channel activity (GO:0015267),-0.22494341844996057,-0.733063885542789,0.8894009216589862,0.968979115660433,1.0,11/41,23.79%,AQP4;AQP11;TMEM266;PANX1;TRPV2;MCUB;TMEM120A;SLC14A1;TRPA1;CHRNB1;BAX
prerank,protein kinase regulator activity (GO:0019887),0.21355771958238418,0.7319101236210774,0.9029126213592233,1.0,1.0,10/95,12.89%,PRKAG2;PRKAG3;MBIP;CCNT2;CCNT1;GPRC5C;PARVA;PRKAG1;CCNE1;GPRC5B
prerank,methyl-CpG binding (GO:0008327),0.27568376285659907,0.7305409085174981,0.8052208835341366,1.0,1.0,6/22,23.34%,TET1;CXXC5;ZBTB38;CXXC4;TET3;LRWD1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.2981151312356162,0.7291767939834057,0.8148148148148148,1.0,1.0,3/15,13.12%,SH3PXD2B;PLEKHF1;VEPH1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.32153480488024266,0.722727050138604,0.7552301255230126,1.0,1.0,2/11,12.98%,NAA80;NAA60
prerank,neuropeptide hormone activity (GO:0005184),-0.2528637350302563,-0.7207347551249372,0.871900826446281,0.9802118086141272,1.0,16/22,56.39%,SPX;NPY;PNOC;ADCYAP1;PENK;NMB;VIP;CRH;GAL;PPY;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3037429681261374,0.7163043589800362,0.8090349075975359,1.0,1.0,1/13,1.22%,SLC38A3
prerank,NADPH binding (GO:0070402),-0.2898307253640585,-0.7157007861944031,0.844,0.9824427954798972,1.0,3/13,15.96%,KCNAB1;LBR;QDPR
prerank,RNA polymerase II complex binding (GO:0000993),0.2587059435932866,0.7155418840851394,0.8448905109489051,1.0,1.0,14/32,23.73%,NCOA3;RPRD1B;AGO2;RPRD2;CDC73;SCAF1;CTR9;RECQL5;ELP2;PAF1;AGO1;SUPT4H1;WAC;BRD4
prerank,alpha-actinin binding (GO:0051393),0.2652674903857194,0.7154110661872269,0.807909604519774,1.0,1.0,7/24,19.88%,KCNA5;CACNA1D;PKD2;PALLD;PDLIM5;DAG1;PKD2L1
prerank,phosphatidate phosphatase activity (GO:0008195),0.30340875329466216,0.7123682984250217,0.8194726166328601,1.0,1.0,1/13,1.84%,PLPP3
prerank,sequence-specific mRNA binding (GO:1990825),-0.310296633049112,-0.710604076992716,0.8361266294227188,0.984791502538251,1.0,6/10,31.96%,SSB;SHFL;FMR1;RBM24;ETF1;DHX9
prerank,vitamin D receptor binding (GO:0042809),0.2955000363570722,0.7085302881562353,0.8032128514056225,1.0,1.0,3/14,11.41%,MED1;MED13;RXRA
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.21341801211719133,0.7076591938254734,0.942367601246106,1.0,1.0,13/75,14.17%,CRYL1;EHHADH;SORD;HSD17B10;PTGR1;H6PD;BDH1;DHRS3;UGDH;DHDH;ME3;DHRS11;BDH2
prerank,water transmembrane transporter activity (GO:0005372),0.31735873864647385,0.7042991077930056,0.7955465587044535,1.0,1.0,1/11,3.58%,PDPN
prerank,cardiolipin binding (GO:1901612),0.3138193165614879,0.7022821327697423,0.7877551020408163,1.0,1.0,3/10,13.28%,GSDMD;GSDME;NME4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.24577154640953727,0.70209175986634,0.8625678119349005,1.0,1.0,6/31,17.44%,UBE2E2;UBE2L3;BIRC6;UBE2A;UBE2H;UBE2E1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.23966754719300493,0.7012900640864184,0.8724954462659381,1.0,1.0,9/34,20.67%,SETD6;SETD7;CAMKMT;EEF1AKMT1;SMYD3;N6AMT1;SETD2;SETD4;NSD3
prerank,SUMO binding (GO:0032183),0.296521737144673,0.6984400781358375,0.7939914163090128,1.0,1.0,5/13,19.65%,USP25;SIMC1;CBX4;PML;USPL1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.2860052836063758,0.6952486462711098,0.8282208588957055,1.0,1.0,1/14,2.68%,CAPN9
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3072860913262021,0.6937585758993823,0.8061855670103093,1.0,1.0,2/11,12.18%,CASP12;CFLAR
prerank,antiporter activity (GO:0015297),0.2743509482988421,0.6876008410294048,0.847953216374269,1.0,1.0,7/20,17.58%,SLC25A11;SLC35E2B;SLC35E2A;SLC35A1;CLCN4;TMEM241;SLC35D2
prerank,5'-nucleotidase activity (GO:0008253),-0.27734661549674505,-0.6867310765079808,0.8415637860082305,1.0,1.0,7/13,35.23%,NT5C2;NT5C;NT5E;NT5DC1;NT5C1A;NT5DC2;NT5DC3
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.29370856127924083,-0.6862361509171488,0.858508604206501,1.0,1.0,5/11,22.47%,RPS3;NEIL1;NEIL3;NTHL1;APLF
prerank,cyclic nucleotide binding (GO:0030551),-0.2507600877545744,-0.6854698252622579,0.9010309278350516,0.9995222042559796,1.0,4/21,14.10%,PDE4D;PDE2A;HCN1;PDE11A
prerank,nuclease activity (GO:0004518),0.21775333527322688,0.6804437933866906,0.9306260575296108,1.0,1.0,10/52,16.83%,REXO5;RNASEL;SND1;ISG20L2;MRE11;APEX1;WRN;PARN;REXO4;RNASEH2A
prerank,3'-5' DNA helicase activity (GO:0043138),0.2789246339340046,0.6760222306236856,0.857707509881423,1.0,1.0,6/16,20.57%,BLM;HELQ;WRN;MCM2;MCM7;RECQL5
prerank,RNA stem-loop binding (GO:0035613),0.2958464667959243,0.6759915248834739,0.8329809725158562,1.0,1.0,3/12,11.58%,RC3H2;MYH10;LARP6
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.24453172928905326,0.6756799252008308,0.8929889298892989,1.0,1.0,14/33,22.89%,NCOA3;RPRD1B;AGO2;RPRD2;CDC73;AR;CTR9;RECQL5;ELP2;PAF1;AGO1;DRAP1;SUPT4H1;WAC
prerank,I-SMAD binding (GO:0070411),0.28097486701211777,0.6720630329883847,0.8343685300207039,1.0,1.0,4/13,15.68%,SMAD6;SMAD3;AXIN1;SMAD4
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2379942372317091,0.6698193802315817,0.9031657355679702,1.0,1.0,11/35,24.48%,TRMT9B;LCMT2;TRDMT1;DUS2;DTWD1;GATC;AARS1;TARS2;ELAC2;DUS1L;GATB
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.22462050814254178,0.6640447398414271,0.920774647887324,1.0,1.0,11/40,17.84%,METTL4;METTL8;PRMT7;DPH5;AS3MT;RRP8;LRTOMT;THUMPD3;N6AMT1;ASMT;NNMT
prerank,retinoid X receptor binding (GO:0046965),-0.2787145205493903,-0.6622554859865932,0.8921389396709324,1.0,1.0,3/11,16.90%,ARID5A;NRIP1;NR4A2
prerank,protein phosphatase 1 binding (GO:0008157),-0.23735606216990343,-0.6619044594935252,0.8997912317327766,1.0,1.0,3/21,7.61%,PPP1R16B;AKAP11;KCNQ1
prerank,CCR chemokine receptor binding (GO:0048020),0.23991248046761018,0.6610660502452361,0.892925430210325,1.0,1.0,3/28,10.07%,CXCL13;CCL19;CCL4
prerank,histone methyltransferase activity (GO:0042054),-0.20923004936248846,-0.6591748478122155,0.9519650655021834,1.0,1.0,12/32,34.64%,PRMT8;KMT2E;MEN1;FBL;SMYD1;EHMT2;DOT1L;EED;SUZ12;KMT5A;TTLL12;SMYD2
prerank,ribosomal large subunit binding (GO:0043023),0.3018576607561143,0.6580445102763804,0.8685258964143426,1.0,1.0,3/11,13.47%,CPEB2;LTN1;NEMF
prerank,gamma-tubulin binding (GO:0043015),-0.23139328217820274,-0.6524381999453981,0.9369747899159664,1.0,1.0,4/21,13.52%,BLOC1S2;PAK1;GIT1;RAB11FIP5
prerank,alpha-tubulin binding (GO:0043014),-0.20835987221628594,-0.6486138920199764,0.9415887850467289,1.0,1.0,4/31,10.56%,TTLL7;FYN;EFHC2;ARL8A
prerank,RNA polymerase core enzyme binding (GO:0043175),0.23254802650150047,0.6476445820672251,0.9194991055456172,1.0,1.0,13/33,22.89%,NCOA3;RPRD1B;AGO2;RPRD2;ERBB2;CDC73;CTR9;RECQL5;ELP2;PAF1;AGO1;SUPT4H1;WAC
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.21241658664148083,-0.6460953406076817,0.9515789473684211,1.0,1.0,8/28,25.00%,GRIK4;GABRG3;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.225714581905034,0.6430040711207845,0.9339622641509434,1.0,1.0,13/33,24.66%,ERI3;ERI2;DCP2;ERI1;PARN;CNOT8;CNOT7;EXOSC3;PDE12;XRN1;DIS3L;EXOSC4;DIS3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.21366149286866168,-0.6387179452248954,0.9526881720430107,1.0,1.0,13/28,34.18%,POP5;POP4;RPP21;RPP30;EDC3;AGO3;PRORP;NUDT16;EXO1;POP7;DROSHA;FEN1;RPP40
prerank,cysteine-type endopeptidase activity (GO:0004197),0.1884724177813729,0.6370392751776723,0.9738562091503268,1.0,1.0,8/78,8.96%,CAPN9;CTSH;USP11;CASP12;USP24;USP25;USP7;USP34
prerank,R-SMAD binding (GO:0070412),0.24712002478025055,0.6362121779653925,0.9171597633136095,1.0,1.0,6/18,20.62%,SMAD6;SMAD3;LDLRAD4;SMAD4;PMEPA1;SMAD2
prerank,endoribonuclease activity (GO:0004521),0.2279761310069796,0.6338206291540507,0.9260628465804066,1.0,1.0,6/32,15.25%,RNASEL;ZC3H12B;SND1;AGO2;DICER1;NYNRIN
prerank,GABA receptor binding (GO:0050811),0.27875685195682803,0.6337941481062718,0.884453781512605,1.0,1.0,3/11,15.36%,ARFGEF2;TRAK1;TRAK2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.23553533277216243,0.630571637111443,0.9316888045540797,1.0,1.0,10/25,25.62%,PARP4;PARP10;PARP9;SIRT3;TIPARP;PARP14;SIRT5;TNKS2;ART4;PARP2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.2794897827274282,-0.6301583480597052,0.8914285714285715,1.0,1.0,4/10,30.59%,CDKN1B;CDKN1A;CDKN2D;INCA1
prerank,O-methyltransferase activity (GO:0008171),0.2877386761797157,0.6301315575352688,0.86652977412731,1.0,1.0,3/10,17.31%,FTSJ3;LRTOMT;ASMT
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.27041616973196914,0.6299613602207852,0.8731501057082452,1.0,1.0,12/12,72.98%,GPR88;OPN1MW;OPN1MW3;RRH;OPN4;GNAT2;OPN1SW;OPN5;RHO;ELOVL4;GPR52;OPN3
prerank,aminopeptidase activity (GO:0004177),0.22801375861964868,0.629537146658291,0.9077212806026366,1.0,1.0,6/26,22.21%,CTSH;NPEPPS;NAALADL1;XPNPEP3;MMP14;MMP17
prerank,phospholipase activity (GO:0004620),0.19130009893968308,0.6274430183890943,0.9842931937172775,1.0,1.0,11/67,15.34%,PLA2G10;FAM83B;NAPEPLD;ENPP2;LIPH;LIPC;PLA2G4B;PLA2G4C;PLCL1;PLCE1;PLA2G12A
prerank,muscle alpha-actinin binding (GO:0051371),-0.2357676085641377,-0.6160904038809437,0.9383429672447013,1.0,1.0,2/15,9.04%,PDLIM7;LDB3
prerank,exopeptidase activity (GO:0008238),-0.17652779035275767,-0.6132924799434244,0.9903381642512077,1.0,1.0,22/50,40.36%,FAP;NAALAD2;DPP4;ACE2;CTSZ;PRCP;RCE1;ENPEP;NUDT16;LTA4H;JMJD7;DPP9;BLMH;CPB1;PM20D2;CPA2;DPEP1;KDM8;GGH;DPP10;DPEP3;DPP6
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2102733350481604,0.613191273256881,0.9525483304042179,1.0,1.0,6/34,17.44%,UBE2E2;UBE2L3;BIRC6;UBE2A;UBE2H;UBE2E1
prerank,cGMP binding (GO:0030553),0.27154363784243546,0.6115753372060452,0.8997867803837953,1.0,1.0,4/11,21.35%,PDE5A;CNGA3;CNGB3;RAPGEF2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.1867141232555075,-0.6103577598439133,0.9869281045751634,1.0,1.0,20/42,42.36%,CCNY;CDKN1B;CCNYL1;CCNF;CCNL2;CCNG2;CDKN1A;CDKN2D;CCNB2;CKS2;CCNQ;INCA1;CDK5R2;CCND1;CCND3;CCNA2;CKS1B;CCNB1;CCNC;CDKN2C
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2637520769345594,0.6060657841121524,0.9065817409766455,1.0,1.0,4/12,19.02%,AGO2;EIF4E3;LARP1;GEMIN5
prerank,methyltransferase activity (GO:0008168),0.19989323627537722,0.6048034508067992,0.9758620689655172,1.0,1.0,12/46,18.47%,METTL4;FTSJ3;PRMT7;EEF1AKMT1;AS3MT;RRP8;LRTOMT;METTL27;N6AMT1;ASMT;NNMT;NSUN3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.2571254729431607,-0.6016442100119785,0.9309701492537313,1.0,1.0,2/11,17.87%,HCN1;HCN2
prerank,single-stranded DNA helicase activity (GO:0017116),-0.21606887426760435,-0.5990598092903643,0.9623015873015873,1.0,1.0,10/19,36.54%,WRNIP1;POLQ;MCM5;RFC5;DHX9;MCM6;DNA2;PIF1;HELB;RFC2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.2430916552196801,-0.5978746954768019,0.9487179487179487,1.0,1.0,4/13,23.66%,SREBF2;MIF;IDI1;DDT
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.22911694510739866,0.5943785620613776,0.9516441005802708,1.0,1.0,21/21,77.12%,CHRNE;CHRNB2;ANXA9;CHRNA7;CHRFAM7A;DRD4;CHRNA2;CHRNA6;DRD1;CHRNA1;DRD5;GRM5;CHRNB3;CHRNB4;CHRNA3;CHRNG;CHRNA4;CHRNA5;GRM1;GRIA1;CHRNB1
prerank,N-methyltransferase activity (GO:0008170),-0.21631148399963715,-0.5943340203108718,0.9587628865979382,1.0,1.0,2/20,6.67%,TFB2M;TRMT11
prerank,ribonuclease activity (GO:0004540),0.18884023649003767,0.5924485710650536,0.9794168096054888,1.0,1.0,16/56,21.80%,RNASEL;ZC3H12B;EXOSC8;SND1;AGO2;DICER1;NYNRIN;CNOT7;RNASEH2A;EXOSC3;NOB1;SAMHD1;AGO1;PIWIL4;PPP1R8;ELAC2
prerank,mannose binding (GO:0005537),-0.24558190403969166,-0.5889849527623235,0.9370229007633588,1.0,1.0,4/12,27.69%,LMAN2;LMAN2L;CLN5;ACR
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.2297560169905306,-0.586037161648613,0.9693251533742331,1.0,1.0,7/14,39.38%,CMPK1;AK5;NME2;AK9;NME1;NME6;DTYMK
prerank,endonuclease activity (GO:0004519),0.19191179332974997,0.5833158518672583,0.9786476868327402,1.0,1.0,10/49,16.69%,RNASEL;ZC3H12B;MBD4;SND1;AGO2;MRE11;DICER1;APEX1;NYNRIN;REXO4
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.24756426928980269,0.582493332023583,0.9298969072164949,1.0,1.0,2/14,5.99%,RPP14;TSEN34
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.2104018122706905,-0.5823244386290459,0.9836065573770492,1.0,1.0,6/20,26.34%,EIF3F;USP50;OTUB1;USP9X;YOD1;SENP5
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.23371462622097777,-0.5823203692572375,0.9426386233269598,1.0,1.0,3/12,24.36%,H3-3A;RELA;STAT1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.22013486182872416,0.5813613412150659,0.9485714285714286,1.0,1.0,9/24,22.25%,PMVK;AK1;NME4;PPIP5K2;ITPKA;AK8;IP6K2;AK4;AK3
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2481407324925014,-0.5812590854149565,0.9324055666003976,1.0,1.0,6/11,39.92%,RPA1;TERF2IP;RPA2;HNRNPA1;TERF1;CTC1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.26890094732961706,0.5806414755248311,0.9056603773584906,1.0,1.0,3/10,15.83%,RPE;RENBP;DSEL
prerank,5'-3' exonuclease activity (GO:0008409),0.24883411316099074,0.5795260352463757,0.9386892177589852,1.0,1.0,4/14,13.44%,DCLRE1A;DCLRE1B;DCP2;MRE11
prerank,histone deacetylase activity (GO:0004407),-0.20802598510517162,-0.5786326787468313,0.9547413793103449,1.0,1.0,9/19,35.79%,HDAC5;HDAC11;SIRT7;HDAC9;HDAC6;SIRT6;HDAC3;MIER1;HDAC10
prerank,miRNA binding (GO:0035198),-0.18742368133626416,-0.5683968330197287,0.9753363228699552,1.0,1.0,8/30,23.63%,PUM2;YBX1;ZC3H7A;SOX2;ZC3H12A;AGO3;FMR1;ZNF346
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.24473821649948932,0.5677187080085021,0.9336016096579477,1.0,1.0,4/12,19.67%,TENT2;TUT1;PAPOLB;PAPOLG
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.23445874559751578,-0.5626893136045255,0.9584120982986768,1.0,1.0,7/11,54.21%,CHRNB1;CHRNA9;CHRNA5;CHRNA4;CHRNA3;CHRNB4;CHRNA1
prerank,neuropeptide receptor binding (GO:0071855),0.2346302033588638,0.5613344091154584,0.9321357285429142,1.0,1.0,2/14,11.05%,AGRP;APLN
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.24770160549627693,0.5601969121736798,0.927038626609442,1.0,1.0,1/11,4.07%,KCND3
prerank,snRNA binding (GO:0017069),-0.16434025080160708,-0.5465639303658102,0.9976580796252927,1.0,1.0,8/42,20.49%,HNRNPU;LARP7;DDX39B;MEPCE;SNRPC;PRPF4;EIF5A;RBM22
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.19239407409801565,0.5460609492099285,0.9810964083175804,1.0,1.0,12/34,24.66%,ERI3;ERI2;CNOT2;ERI1;PARN;CNOT8;CNOT7;EXOSC3;PDE12;DIS3L;EXOSC4;DIS3
prerank,telomerase RNA binding (GO:0070034),-0.1903303577228771,-0.5407869374155119,0.9796334012219959,1.0,1.0,8/22,30.96%,PINX1;HNRNPU;SMG5;EXOSC10;NHP2;SMG6;NOP10;TENT4B
prerank,solute:proton symporter activity (GO:0015295),-0.20155582935755156,-0.5389372421889299,0.9767441860465116,0.9986997773089545,1.0,6/16,29.59%,SLC39A8;SLC36A1;SLC25A3;SLC2A9;SLC15A4;SLC2A13
prerank,damaged DNA binding (GO:0003684),0.17669929006111645,0.5354194410659129,0.9905123339658444,1.0,1.0,10/44,17.37%,DDB2;AUNIP;DCLRE1A;DCLRE1B;CUL4B;MPG;APEX1;CREBBP;RAD18;XPC
prerank,3'-5' exonuclease activity (GO:0008408),0.17553132616601283,0.532545679198782,0.99644128113879,1.0,1.0,14/45,20.64%,ERI3;ERI2;TATDN1;MRE11;APEX1;ERI1;WRN;PARN;CNOT8;CNOT7;REXO4;EXOSC3;PDE12;RAD50
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.21953669407998003,0.5134616060314912,0.9656488549618321,1.0,1.0,14/14,78.07%,DHRS3;RDH11;SDR16C5;ADH1A;RDH5;ADH7;ADH4;SDR9C7;HSD17B6;RDH16;DHRS9;RDH12;RDH10;AKR1A1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.2274179106134152,0.5123557378487171,0.9549356223175965,1.0,1.0,4/12,21.33%,SULF1;ARSG;ARSK;GALNS
prerank,neuropeptide binding (GO:0042923),0.20413269270945145,0.509425444086342,0.9731800766283525,1.0,1.0,1/18,5.44%,SSTR2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.22990075642068403,0.5077376629432021,0.9454926624737946,1.0,1.0,2/11,12.51%,PRMT7;FBXO11
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.20954861441468103,-0.5052789767932993,0.9810246679316889,1.0,1.0,4/11,30.47%,RDH14;DHRS13;AKR1A1;RDH12
prerank,deoxyribonuclease activity (GO:0004536),-0.19985154858080817,-0.5001393062600534,0.9756592292089249,1.0,1.0,1/14,3.54%,RPS3
prerank,regulatory RNA binding (GO:0061980),0.1661176643215188,0.4936413277247085,0.9945750452079566,1.0,1.0,11/38,21.93%,ZC3H7B;AGO2;DICER1;RBM10;TUT4;HNRNPA2B1;RBM4;AGO1;ELAVL1;PIWIL4;TUT7
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.21519146264908973,0.49358805643814535,0.9683794466403162,1.0,1.0,13/13,78.50%,ZGRF1;DICER1;DNASE1L3;FAN1;SLX4;DNASE1L2;DNASE1;ENDOV;DNASE1L1;FEN1;DNA2;EXO1;GEN1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.19700862514001888,-0.49241907395052337,0.9840954274353877,0.9995814748531238,1.0,3/13,22.91%,TRMT11;TRMT10C;METTL1
prerank,RNA cap binding (GO:0000339),0.19789154452328164,0.48638947971163615,0.9819639278557114,1.0,1.0,5/16,19.30%,AGO2;EIF4E3;LARP1;GEMIN5;LSM1
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.18183066382980373,-0.47782242518333323,0.9935760171306209,0.9986819699837359,1.0,6/17,30.88%,CMPK1;CLP1;AK5;NME2;AK9;NME1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.1964169580219623,-0.47198210999394447,0.9923224568138196,0.9963960138002331,1.0,4/12,30.07%,NDUFS7;DCXR;CBR1;NQO2
prerank,nuclear export signal receptor activity (GO:0005049),-0.1914472780332825,-0.4581670644100632,0.9886363636363636,0.9950523519299891,1.0,6/11,44.55%,CSE1L;NUP42;XPO6;RAN;XPO1;XPO7
prerank,nuclear import signal receptor activity (GO:0061608),0.19255399296835735,0.45638946673981046,0.9833333333333333,1.0,1.0,15/15,80.76%,TNPO1;IPO9;KPNB1;TNPO3;HIKESHI;RANBP6;KPNA6;IPO5;KPNA7;KPNA1;IPO4;KPNA2;TNPO2;KPNA3;KPNA4
prerank,acetylcholine receptor activity (GO:0015464),0.17241257871407714,0.4526935441243782,0.9944029850746269,1.0,1.0,1/22,4.61%,CHRNE
prerank,aspartic-type endopeptidase activity (GO:0004190),0.19270604481827874,0.4443851949604109,0.9893842887473461,1.0,1.0,12/12,80.74%,BACE1;SPPL3;DDI2;PGC;BACE2;ASPRV1;NAPSA;SPPL2A;SPPL2B;HM13;CTSE;PSEN1
prerank,exoribonuclease activity (GO:0004532),0.17828601912274938,0.40793542545815187,0.993963782696177,1.0,1.0,4/12,23.35%,EXOSC8;CNOT7;EXOSC3;EXOSC4
prerank,tumor necrosis factor receptor binding (GO:0005164),0.17589131645108852,0.39937234535723104,0.989517819706499,1.0,1.0,3/12,18.37%,BABAM2;TRAP1;TRAF6
prerank,metalloaminopeptidase activity (GO:0070006),0.15567616924094796,0.3859832393772364,0.9979633401221996,0.9985446705295782,1.0,4/16,22.21%,NPEPPS;XPNPEP3;MMP14;MMP17
